
<html lang="en"     class="pb-page"  data-request-id="a2e8e0a6-ea34-4624-bceb-ec6250921006"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.8b00125;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="4,6-Diaminopyrimidines as Highly Preferred Troponin I-Interacting Kinase (TNNI3K) Inhibitors" /></meta><meta name="dc.Creator" content="Joanne  Philp" /></meta><meta name="dc.Creator" content="Brian G.  Lawhorn" /></meta><meta name="dc.Creator" content="Alan P.  Graves" /></meta><meta name="dc.Creator" content="Lisa  Shewchuk" /></meta><meta name="dc.Creator" content="Katrina L.  Rivera" /></meta><meta name="dc.Creator" content="Larry J.  Jolivette" /></meta><meta name="dc.Creator" content="Dennis A.  Holt" /></meta><meta name="dc.Creator" content="Gregory J.  Gatto, Jr." /></meta><meta name="dc.Creator" content="Lara S.  Kallander" /></meta><meta name="dc.Description" content="Structure-guided progression of a purine-derived series of TNNI3K inhibitors directed design efforts that produced a novel series of 4,6-diaminopyrimidine inhibitors, an emerging kinase binding mot..." /></meta><meta name="Description" content="Structure-guided progression of a purine-derived series of TNNI3K inhibitors directed design efforts that produced a novel series of 4,6-diaminopyrimidine inhibitors, an emerging kinase binding mot..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 21, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00125" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00125" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00125" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00125" /></link>
        
    
    

<title>4,6-Diaminopyrimidines as Highly Preferred Troponin I-Interacting Kinase (TNNI3K) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00125" /></meta><meta property="og:title" content="4,6-Diaminopyrimidines as Highly Preferred Troponin I-Interacting Kinase (TNNI3K) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0013.jpeg" /></meta><meta property="og:description" content="Structure-guided progression of a purine-derived series of TNNI3K inhibitors directed design efforts that produced a novel series of 4,6-diaminopyrimidine inhibitors, an emerging kinase binding motif. Herein, we report a detailed understanding of the intrinsic conformational preferences of the scaffold, which impart high specificity for TNNI3K. Further manipulation of the template based on the conformational analysis and additional structure–activity relationship studies provided enhancements in kinase selectivity and pharmacokinetics that furnished an advanced series of potent inhibitors. The optimized compounds (e.g., GSK854) are suitable leads for identifying new cardiac medicines and have been employed as in vivo tools in investigational studies aimed at defining the role of TNNI3K within heart failure." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00125"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00125">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00125&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00125&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00125&amp;href=/doi/10.1021/acs.jmedchem.8b00125" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3076-3088</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00106" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00139" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">4,6-Diaminopyrimidines as Highly Preferred Troponin I-Interacting Kinase (TNNI3K) Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Joanne Philp</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joanne Philp</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Heart Failure Discovery Performance Unit, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joanne++Philp">Joanne Philp</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brian G. Lawhorn</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian G. Lawhorn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Heart Failure Discovery Performance Unit, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#83e1f1eae2edadb1adefe2f4ebecf1edc3e4f0e8ade0ecee"><span class="__cf_email__" data-cfemail="492b3b202827677b6725283e21263b27092e3a22672a2624">[email protected]</span></a>. Phone: 484-923-3513.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+G.++Lawhorn">Brian G. Lawhorn</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4618-5314" title="Orcid link">http://orcid.org/0000-0003-4618-5314</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alan P. Graves</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alan P. Graves</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Platform Technology and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alan+P.++Graves">Alan P. Graves</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lisa Shewchuk</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lisa Shewchuk</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Platform Technology and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Shewchuk">Lisa Shewchuk</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katrina L. Rivera</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katrina L. Rivera</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Heart Failure Discovery Performance Unit, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katrina+L.++Rivera">Katrina L. Rivera</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Larry J. Jolivette</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Larry J. Jolivette</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Heart Failure Discovery Performance Unit, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Larry+J.++Jolivette">Larry J. Jolivette</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dennis A. Holt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dennis A. Holt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Heart Failure Discovery Performance Unit, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+A.++Holt">Dennis A. Holt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gregory J. Gatto Jr.</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory J. Gatto, Jr.</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Heart Failure Discovery Performance Unit, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+J.++Gatto%2C++Jr.">Gregory J. Gatto, Jr.</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Lara S. Kallander</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lara S. Kallander</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Heart Failure Discovery Performance Unit, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lara+S.++Kallander">Lara S. Kallander</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00125&amp;href=/doi/10.1021%2Facs.jmedchem.8b00125" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3076–3088</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 21, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 January 2018</li><li><span class="item_label"><b>Published</b> online</span>21 March 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00125" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00125</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3076%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJoanne%2BPhilp%252C%2BBrian%2BG.%2BLawhorn%252C%2BAlan%2BP.%2BGraves%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D7%26contentID%3Dacs.jmedchem.8b00125%26title%3D4%252C6-Diaminopyrimidines%2Bas%2BHighly%2BPreferred%2BTroponin%2BI-Interacting%2BKinase%2B%2528TNNI3K%2529%2BInhibitors%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3088%26publicationDate%3DApril%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00125"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1368</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00125" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;4,6-Diaminopyrimidines as Highly Preferred Troponin I-Interacting Kinase (TNNI3K) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Joanne&quot;,&quot;last_name&quot;:&quot;Philp&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;G. Lawhorn&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;P. Graves&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Shewchuk&quot;},{&quot;first_name&quot;:&quot;Katrina&quot;,&quot;last_name&quot;:&quot;L. Rivera&quot;},{&quot;first_name&quot;:&quot;Larry&quot;,&quot;last_name&quot;:&quot;J. Jolivette&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;A. Holt&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;J. Gatto&quot;},{&quot;first_name&quot;:&quot;Lara&quot;,&quot;last_name&quot;:&quot;S. Kallander&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3076-3088&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00125&quot;},&quot;abstract&quot;:&quot;Structure-guided progression of a purine-derived series of TNNI3K inhibitors directed design efforts that produced a novel series of 4,6-diaminopyrimidine inhibitors, an emerging kinase binding motif. Herein, we report a detailed understanding of the intrinsic conformational preferences of the scaffold, which impart high specificity for TNNI3K. Further manipulation of the template based on the conformational analysis and additional structure–activity relationship studies provided enhancements in kinase selectivity and pharmacokinetics that furnished an advanced series of potent inhibitors. The optimized compounds (e.g., GSK854) are suitable leads for identifying new cardiac medicines and have been employed as in vivo tools in investigational studies aimed at defining the role of TNNI3K within heart failure.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00125&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00125" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00125&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00125" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00125&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00125" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00125&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00125&amp;href=/doi/10.1021/acs.jmedchem.8b00125" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00125" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00125" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00125%26sid%3Dliteratum%253Aachs%26pmid%3D29561151%26genre%3Darticle%26aulast%3DPhilp%26date%3D2018%26atitle%3D4%252C6-Diaminopyrimidines%2Bas%2BHighly%2BPreferred%2BTroponin%2BI-Interacting%2BKinase%2B%2528TNNI3K%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D7%26spage%3D3076%26epage%3D3088%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (8)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/jmcmar.2018.61.issue-7/20180412/jmcmar.2018.61.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Structure-guided progression of a purine-derived series of TNNI3K inhibitors directed design efforts that produced a novel series of 4,6-diaminopyrimidine inhibitors, an emerging kinase binding motif. Herein, we report a detailed understanding of the intrinsic conformational preferences of the scaffold, which impart high specificity for TNNI3K. Further manipulation of the template based on the conformational analysis and additional structure–activity relationship studies provided enhancements in kinase selectivity and pharmacokinetics that furnished an advanced series of potent inhibitors. The optimized compounds (e.g., GSK854) are suitable leads for identifying new cardiac medicines and have been employed as <i>in vivo</i> tools in investigational studies aimed at defining the role of TNNI3K within heart failure.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70163" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70163" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Troponin I-interacting kinase (TNNI3K) is a self-regulating, cardiac specific kinase that currently lacks a clearly defined biological function.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Overexpression of <i>Tnni3k</i> has been demonstrated to lead to impaired cardiac structure and function in murine models of cardiomyopathy, pressure overload induced heart failure, and in response to acute ischemic injury.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Conversely, both deletion of <i>Tnni3k</i> via transgenic studies and pharmacological inhibition of TNNI3K have been assigned a cardioprotective role within an ischemia/reperfusion setting.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Extrapolation of these findings suggests that inhibition of TNNI3K represents a potential novel mechanism for the treatment of heart failure. Accordingly, selective inhibitors of TNNI3K would prove valuable tools in the characterization of the biological role of TNNI3K and provide prospective leads for drug development in an area of continuing unmet medical need.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a></div><div class="NLM_p last">Our efforts to identify potent and selective inhibitors of this promising target uncovered a series of 4,6-diaminopyrimidines that displayed excellent kinase selectivity. Although 2,4-diaminopyrimidines have proven to be a clinically relevant<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> and an extensively explored structural class of kinase inhibitors, we noted a much rarer incidence of 4,6-diaminopyrimidines reported in the literature.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> Consideration of the bioactive conformation of the 4,6-diaminopyrimidine template identified the origin of its innate selectivity, and application of these learnings allowed further enhancement of potency, pharmacokinetics, and the kinase selectivity profile of the series.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Conception and Design of 4,6-Diaminopyrimidines</h3><div class="NLM_p">As previously disclosed, exploratory screening efforts identified the purine motif, exemplified by compound <b>1</b>, as providing potent and tractable TNNI3K inhibitors with promising levels of kinase selectivity.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Initial investigation of this scaffold demonstrated that the 7-position nitrogen was not a prerequisite for activity as deazapurine <b>2</b> retained potency and selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Based on this observation and with the availability of TNNI3K cocrystal structures to direct the design strategy,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> efforts to identify additional alternatives to the purine core were initiated.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial Purine and 4,6-Diaminopyrimidine SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0007.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">A</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">TNNI3K IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">% kinases >10-fold selectivity<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="char" char=".">500</td><td class="colsep0 rowsep0" align="left">87% (62 of 71)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="left">94% (61 of 65)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">3-Me-Ph</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="left">96% (69 of 72)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>–Ph</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="left">97% (34 of 35)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">800</td><td class="colsep0 rowsep0" align="left">87% (21 of 24)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Percent of kinases where off-target kinase IC<sub>50</sub>/TNNI3K IC<sub>50</sub> > 10.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div></div></div><div class="NLM_p">Examination of the crystal structure of <b>1</b> bound to TNNI3K highlighted five key hydrogen bond interactions that anchor the molecule within the ATP binding site (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). The sulfonamide moiety projects toward the backpocket and contacts TNNI3K via interaction of its NH with Thr539, the “gatekeeper” residue. The sulfonamide oxygens participate in two additional hydrogen bonding interactions, one of which is mediated by a resident water molecule. A bidentate hinge binding interaction was also observed between amino acid Ile542 and the purine core, mediated via the H-bond acceptor capacity of the 3-position nitrogen and the donating ability of the 9-position NH. Notably, in order to simultaneously accommodate each of these key H-bond interactions, <b>1</b> must adopt a coplanar binding conformation.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cocrystal structures of <b>1</b> (A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YFI">4YFI</a>)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and <b>4</b> (B, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J">6B5J</a>) bound to TNNI3K and (C) a 2D representation of the binding mode of <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to guiding exploration of the deazapurine scaffold<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> study of the crystal structure of <b>1</b> led to the conception of 4,6-diaminopyrimidines, such as <b>3</b>, which were anticipated to maintain the crucial network of H-bonding interactions of <b>1</b> while allowing exploration of the previously unoccupied front pocket from an alternative trajectory. This proved a successful design concept as potency at TNNI3K was improved (16-fold), and critically, the promising kinase selectivity of starting point <b>1</b> was upheld with initial 4,6-diaminopyrimidine <b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Indeed, broader evaluation of <b>3</b> against a range of kinases indicated an appreciable level of inhibition against only 4% (8 of 189) of kinases when tested at 1 μM inhibitor concentration in the Millipore KinaseProfiler panel (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). A cocrystal structure of <b>4</b>, a close analog of <b>3</b>, bound to TNNI3K confirmed that the intricate H-bond mediated recognition pattern of <b>1</b> and consequent coplanar configuration were maintained (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). The critical binding contribution of the aromatic ring of the C6 aniline in the front pocket is highlighted by the fact that truncated analog <b>5</b> displays over an order of magnitude reduction in TNNI3K affinity, perhaps indicating a benefit imparted by space filling or the influence of conformational preferences, or a combination of both of these factors.</div><div class="NLM_p">Following the encouraging data observed with <b>3</b>, an exploration of alternative C6 substituents was initiated, and evidence of a tractable structure–activity relationship (SAR) against TNNI3K readily emerged (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), with a clear indication of a steric driven intolerance to substitution at the C2 ring position, reflected in the reduced activity observed with analogs <b>7</b>–<b>9</b>. In contrast, incorporation of a variety of functional groups at both the meta and para positions was permitted by the target. At these positions, electron withdrawing (<b>10</b>, <b>12</b>, <b>13</b>, <b>4</b>, and <b>16</b>) and electron donating (<b>3</b>, <b>11</b>, <b>14</b>, and <b>15</b>) groups of differing sizes could be accommodated. Favorable kinase selectivity<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> was maintained across this range of analogs, which encouraged us to further investigate the series and the underlying origins of its specificity for TNNI3K.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Initial Modifications of the C6-Aniline</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0008.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">TNNI3K IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">% kinases with >10-fold selectivity<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="left">95% (36 of 38)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char=".">630</td><td class="colsep0 rowsep0" align="left">80% (30 of 38)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">2-Me</td><td class="colsep0 rowsep0" align="char" char=".">1300</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">2-OMe</td><td class="colsep0 rowsep0" align="char" char=".">3200</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="left">95% (35 of 37)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="left">96% (69 of 72)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="left">92% (34 of 37)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">3-SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="left">88% (22 of 25)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="left">84% (22 of 26)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">4-Me</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="left">95% (35 of 39)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="left">97% (34 of 35)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="char" char=".">160</td><td class="colsep0 rowsep0" align="left">92% (23 of 25)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">4-SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="left">96% (27 of 28)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Percent of kinases where off-target kinase IC<sub>50</sub>/TNNI3K IC<sub>50</sub> > 10.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">nd, not determined.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> General Kinase Selectivity</h3><div class="NLM_p">To decipher the features of <b>3</b> that contribute to its unique affinity and selectivity for TNNI3K, a series of heterocyclic core analogs were evaluated. Replacement of the pyrimidine N3 atom with CH to give pyridine <b>17</b> resulted in a substantially less effective inhibitor (>100-fold) of TNNI3K, illustrating a critical role for the N3 nitrogen (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In some instances where 4,6-diaminopyrimidines exhibit preferential binding to a kinase, N3 has been observed to participate in a specific interaction that facilitates binding and imparts significant overall kinase selectivity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> However, the cocrystal structure of <b>4</b> did not indicate an interaction of this nature; instead, this dramatic effect was attributed to the introduction of a potential severe steric interaction (∼3 kcal/mol for planar vs skewed conformation for related diphenylamines)<a onclick="showRef(event, 'cit14c'); return false;" href="javascript:void(0);" class="ref cit14c">(14c)</a> between the pyridine C5–H and the benzenesulfonamide C2–H (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). As a consequence, pyridine <b>17</b> is unable to adhere to the highly preferred coplanar binding conformation (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) that is adopted by <b>3</b> leading to reduced activity. Similarly, it is proposed that compound <b>18</b>, the 2,4-diaminopyrimidine counterpart of <b>3</b>, exhibits a reduced potency arising from this conformational bias (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). However, this pyrimidine exhibits a heightened (∼8-fold) affinity for TNNI3K compared to pyridine <b>17</b>, in line with the greater capacity of <b>18</b> to conform to the s-cis orientation required for optimal hinge binding (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref10 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref14">(10,14)</a> Specifically, the N3 of <b>18</b> alleviates the steric interaction (∼2 kcal/mol for s-cis vs s-trans for related anilinopyrimidines)<a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">(14b)</a> between the C3–H of pyridine <b>17</b> and the C6 aryl resulting in an improved bidentate hinge binding interaction with TNNI3K. In fact, the reduced inhibition of TNNI3K observed for 2,4-diaminopyrimidine <b>18</b> compared to 4,6-diaminopyrimdine <b>3</b> represents a departure from the norm, as most kinases prefer 2,4-diaminopyrimidines because of this innate ability to adopt the s-cis configuration.<a onclick="showRef(event, 'ref9 ref10 ref15'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref15">(9,10,15)</a> As a result, in contrast to <b>3</b>, 2,4-diaminopyrimdine <b>18</b> is a promiscuous kinase inhibitor that exhibits substantial activity against many (15/21) of the kinases examined.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> These observations also explain the reduction of TNNI3K affinity associated with ortho-substituted C6 aryls (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <b>7</b>–<b>9</b>) wherein the preferred s-cis configuration is further compromised. Incorporating these SAR and structure informed conformational considerations into compound design led to preparation of triazine <b>19</b>, which simultaneously relieves the steric penalties observed in the 2,4- and 4,6-diaminopyrimdine frameworks upon enzyme binding. Consequently, <b>19</b> exhibits comparable or increased affinity over <b>3</b> (1.6-fold) and <b>18</b> (32-fold), and the kinase selectivity associated with these conformational preferences is restored (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Two-dimensional representation of the preferred TNNI3K binding mode for various heterocyclic cores.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An alternative but equally effective approach to favor the optimal TNNI3K binding mode within the 4,6-diaminopyrimidine system was realized in the design of compounds <b>21</b> and <b>22</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), which incorporates a 2-pyridyl substituent in place of the C6 aniline of <b>3</b>. Inclusion of the pyridyl nitrogen reinforces the requisite s-cis conformation by removing the steric interaction with C5–H of the pyrimidine and simultaneously serves to destabilize the alternative s-trans orientation by introducing a lone pair–lone pair repulsion.<a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">(14b)</a> As such, enhanced potency (2.5-fold) is achieved within pyridyl pyrimidine analog <b>21</b> compared to the analogous phenyl triazine <b>20</b>. Comparison of the potency of the phenyl vs 2-pyridyl analog pairs <b>13</b>/<b>21</b> and <b>4</b>/<b>22</b> confirms the conformational hypothesis and defines the magnitude (∼4–5-fold) of the conformational bias and resultant enhanced hinge binding capacity imparted by the pyridyl nitrogen. Independent of our efforts, an analogous 2-pyridyl unit has been employed in the design of Lck inhibitors based on a similar conformational rationale.<a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">(14b)</a> However, as direct phenyl analogs of the 2-pyridyl substituents were not reported in that study, the experiments disclosed herein confirm the value of the 2-pyridyl design, provide the magnitude of the effect experimentally (0.8 kcal/mol using Δ<i>G</i><sub>1</sub> – Δ<i>G</i><sub>2</sub> = RT ln(<i>K</i><sub>1</sub>/<i>K</i><sub>2</sub>) where <i>K</i> is approximated by IC<sub>50</sub> values of <b>13</b> and <b>21</b> or <b>4</b> and <b>22</b>), and distinguish the contribution of the pyridyl N toward stabilizing the s-cis conformation from other binding benefits arising from the incorporation of C6-aryl amines (e.g., <b>3</b>, IC<sub>50</sub> = 32 nM) instead of C6-alkyl amines (e.g., <b>5</b>, IC<sub>50</sub> = 800 nM). As anticipated, pyridines <b>21</b> and <b>22</b> maintain the good overall kinase selectivity profile of the parent system (>10-fold selectivity vs >90% of kinases tested)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and represent optimal leads for further development.</div><div class="NLM_p last">Overall, the TNNI3K selectivity of 4,6-diaminopyrimidines (e.g., <b>3</b>) can be primarily attributed to their unique ability to adopt a coplanar binding conformation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). This allows the compounds to engage the hinge region H-bond interactions while simultaneously positioning the sulfonamide to hydrogen bond with the gatekeeper threonine (unique to 19% of the kinome) and form polar contacts within the backpocket (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). As within other reports of favored binding by 4,6-diaminopyrimidines the N3 nitrogen has a pivotal role in the attainment of this preferential binding, and as such the 4,6-diaminopyrimdine scaffold may be considered a privileged structure for obtaining selectivity against the kinome.<a onclick="showRef(event, 'ref10 cit14b'); return false;" href="javascript:void(0);" class="ref ref10 cit14b">(10,14b)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> EGFR Selectivity</h3><div class="NLM_p">Although parent compound <b>3</b> generally demonstrated an excellent kinase selectivity profile, a potential liability for the series is its potent inhibition of epidermal growth factor receptor (EGFR) kinase. Although a valid antioncogenic target, inhibition of EGFR has been associated with cardiac dysfunction.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The presence of such an off-target activity would also confound interpretation of target validation studies for TNNI3K. Therefore, it was deemed necessary to attenuate this off-target activity to progress the 4,6-diaminopyrimdines. This undesired activity is consistent with findings that a related 4,6-diaminopyrimidine template can bind preferentially to EGFR.<a onclick="showRef(event, 'cit10a'); return false;" href="javascript:void(0);" class="ref cit10a">(10a)</a> Encouragingly, initial SAR efforts demonstrated that replacement of the 3-methyl substituent of <b>3</b> with a larger group such as the isopropyl of <b>23</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) resulted in a 7-fold reduction of EGFR inhibition with minimal impact on TNNI3K affinity. Further increasing the steric demand of this substituent, as highlighted by <i>t</i>-butyl analog <b>24</b>, provided an inhibitor that was equipotent at TNNI3K and EGFR. Bis-sulphonamide compound <b>25</b> represented a key advance, as it led to an inversion of TNNI3K-EGFR preference compared to parent compound <b>3</b>. SAR indicated that this selectivity gain was not governed by electronics given that analog <b>26</b>, containing the strongly electron withdrawing nitro group, displayed comparable EGFR inhibition to <b>3</b>. To fully interpret this steric-driven effect on EGFR activity, compound <b>3</b> was docked into a crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I23">4I23</a>) of EGFR (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Although both enzymes contain a threonine gatekeeper, EGFR has a smaller back pocket than TNNI3K as a result of two point changes between the active sites (Ala605 to Thr854 and Leu513 to Met766). Thus, it is hypothesized that there is insufficient space within EGFR to tolerate the sulfonamide projecting into its back pocket. These observations suggest that within EGFR the 4,6-diaminopyrimidines reside in a flipped binding mode wherein the smaller C6-aniline group occupies the back pocket (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). In this binding proposal, which mirrors that put forward by Gray for related 4,6-diaminopyrimidine EGFR inhibitors, the pyrimidine N1 participates in a hydrogen bond with the gatekeeper Thr790 leading to its uniquely potent activity at EGFR.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Optimization of Selectivity for TNNI3K vs EGFR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0009.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">TNNI3K IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">EGFR IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">selectivity (fold)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="char" char=".">400</td><td class="colsep0 rowsep0" align="char" char=".">400</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NHMe</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">1600</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">nd<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">2000</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">8000</td><td class="colsep0 rowsep0" align="char" char=".">2000</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Selectivity = EGFR IC<sub>50</sub>/TNNI3K IC<sub>50</sub>.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">nd, not determined.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Cmpd <b>26</b> showed modest activity (IC<sub>50</sub> = 500 nM) in a TNNI3K cellular assay.</p></div></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of <b>3</b> bound to TNNI3K (A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J">6B5J</a>) and EGFR (B, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I23">4I23</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further evidence for this alternative binding mode is exemplified by the relative insensitivity of EGFR activity to the methylation of the C6 linked NH (<b>27</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In contrast, TNNI3K activity is vastly reduced by the removal of this hinge binding NH. Conversely, alkylation of the C4 NH (<b>28</b>), which represents the hinge binding NH within EGFR, results in serious attenuation of activity at this kinase. Interestingly, this methylation is also detrimental to TNNI3K affinity because <b>28</b> is prevented from assuming the crucial coplanar binding conformation as this would introduce at least one severe H/H overlapping interaction between the N-Me and its neighboring aryl hydrogens.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p last">As a consequence of this alternative binding mode in EGFR, divergent SAR is also observed with C6-phenyl analog <b>13</b> (EGFR IC<sub>50</sub> = 13 nM) and its C6-pyridyl derivative <b>21</b> (EGFR IC<sub>50</sub> = 630 nM, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), indicating the pyridyl nitrogen is not well tolerated in the lipophilic back pocket of EGFR. As a result, <b>21</b> exhibits significant selectivity (32-fold) for TNNI3K over EGFR.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Pharmacokinetic Properties</h3><div class="NLM_p">The initial 4,6-diaminopyrimidine inhibitor <b>3</b> showed a poor pharmacokinetic profile with high clearance and low oral bioavailability in the rat (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). To reduce the metabolic liability of <b>3</b>, the 3-methyl group was replaced with a halogen to give analogs <b>10</b> and <b>29</b>, which offered a modest improvement in clearance. Relocating the halogen substituent to the 4-position of the C6 aryl proved beneficial with analog <b>13</b> providing a further 2-fold reduction in clearance versus <b>10</b> and <b>29</b>. These results suggest oxidation of the aniline ring may be a primary metabolic pathway for <b>3</b> that can be blocked through appropriate substitution. Compound <b>13</b> also offered enhanced oral bioavailability over <b>3</b>, which may result from reduced first-pass clearance. Importantly, TNNI3K inhibitor <b>21</b>, which had been optimized for potency by inclusion of the 2-pyridyl moiety, maintained the attractive PK profile of its phenyl analog <b>13</b>, indicating the 4-Cl-2-pyridyl aniline is an optimal C6-moiety.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetics of Initial 4,6-Diaminopyrimidines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0010.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">rat Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">rat PO DNAUC (h·kg/L)</th><th class="colsep0 rowsep0" align="center" char=".">oral <i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">TNNI3K IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">0.037</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">0.064</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">3-Br</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">0.71</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="char" char=".">65</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr></tbody></table></div></div><div class="NLM_p">Next, we turned our attention to exploiting other positions within the molecule to further enhance the inhibitory activity and PK profile of the series. Based on the X-ray crystal structure of <b>4</b> bound to TNNI3K (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), we selected to probe the C4 position of the benzenesulfonamide, as C4-substituents were expected to project favorably into a relatively open area within the TNNI3K binding pocket. The initial analogs (<b>30</b>–<b>36</b>, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) indicated that substitutions at the C4 position greatly influenced TNNI3K activity, but modeling of the substituents in the TNNI3K active site revealed that steric effects could not account for the observed SAR. In our recent publication, the varying effects of these C4-substituents on TNNI3K binding were rationalized based on three separate phenomena: (1) electronic modulation of the sulfonamide H-bond donor interaction with TNNI3K (cf. <b>31</b>, <b>35</b>), (2) intramolecular hydrogen bonding between C4-substituents and the neighboring aniline NH (cf. <b>32</b>, <b>33</b>), and (3) stereoelectronic effects of mono- versus disubstituted <i>ortho</i>-anilines (cf. <b>35</b>, <b>36</b>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> As a result of these effects, highly electron donating substituents exhibit poor potency (e.g., <b>35</b>) by disrupting hydrogen bonding between the inhibitor and TNNI3K, whereas groups that lack an ability to form an internal hydrogen bond with the <i>ortho</i>-aniline NH are also moderately potent (e.g., <b>30</b>, <b>31</b>, <b>32</b>, <b>34</b>). However, the mildly electron donating MeO substituent (<b>33</b>), which can engage in an internal H-bond with the <i>ortho</i>-aniline NH, exhibited good TNNI3K activity (IC<sub>50</sub> = 50 nM) and retained the favorable PK properties of the unsubstituted parent <b>13</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Optimization of the C4-Substituent</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0011.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">rat Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">rat PO DNAUC (h·kg/L)</th><th class="colsep0 rowsep0" align="center" char=".">oral F (%)</th><th class="colsep0 rowsep0" align="center" char=".">TNNI3K IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">0.71</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">nd<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">0.69</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">SMe</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">NHMe</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">2500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">0.096</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">9.9</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">≤10<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">0.91</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="char" char=".">nd<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char=".">≤10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">nd, not determined.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Compound IC<sub>50</sub> values less than 10 nM could not be accurately obtained due to titration of TNNI3K in the enzyme assay.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Cmpd <b>39</b> showed enhanced activity (IC<sub>50</sub> = 63 nM) over <b>38</b> (IC<sub>50</sub> = 320 nM) in a TNNI3K cellular assay.</p></div></div></div><div class="NLM_p">This result prompted a survey of additional C4-ether analogs (<b>37</b>–<b>41</b>), which revealed that compounds bearing ethers with reduced electron-donating ability (e.g., <b>40</b>–<b>41</b>) or electron-withdrawing ability (e.g., <b>38</b>-<b>39</b>) displayed enhanced activity at TNNI3K while maintaining excellent PK properties. These results also served to further verify the value of the C6 aryl pyridyl nitrogen as this modification consistently provided elevated inhibitory activity against TNNI3K in conjunction with reduced clearance across each of the matched pairs (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>; <b>33</b>/<b>37</b>, <b>38</b>/<b>39</b> and <b>40</b>/<b>41</b>).</div><div class="NLM_p">While optimizing the pharmacokinetic properties of the TNNI3K inhibitors, we found TPSA to be an important determinant of oral bioavailability in the series (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) as compounds exhibiting TPSA ≥ 123 Å<sup>2</sup> were consistently observed to show low oral exposure (<i>F</i> < 30% for 28 of 28 tested) in rats. By contrast, compounds with TPSA < 123 Å<sup>2</sup> showed a reasonable likelihood for high oral bioavailability (<i>F</i> > 30% for 69 of 128 tested), and those compounds displaying poor oral exposure within this class typically exhibited very low aqueous solubility or contained a charged functional group, which may negatively impact their passive permeability. This finding is consistent with the historical use of TPSA and PSA<sub>d</sub> in drug design, and it is noteworthy that TPSA was found to be a superior predictor of oral bioavailability within this series when compared to any other calculated property (e.g., cLogP, %PSA, HBA, HBD), measured property (e.g., artificial membrane permeability, ChromLogD), or a multiparameter permeability model.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This highlights the remarkable ability of the simple TPSA calculation to capture the physical processes (e.g., desolvation) involved in passive membrane permeability and its utility for guiding lead optimization when competing effects (e.g., internal H-bonds, varying charge states) do not obscure its predictive relationship with oral bioavailability.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of oral bioavailability (<i>F</i>) vs TPSA for benzenesulfonamide TNNI3K inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> B-Raf Selectivity</h3><div class="NLM_p">The 4,6-diaminopyrimidine <b>37</b> is a highly potent analog that showed promising PK and notably also maintains the broad spectrum kinase selectivity of the series, with >50-fold selectivity against 27 of 29 (93%) kinases assessed. However, <b>37</b> displays potent activity against B-Raf (IC<sub>50</sub> = 20 nM), a kinase that shares 82% sequence similarity with TNNI3K among its ATP-binding site residues, and elimination of this activity was considered critical since inhibition of Raf kinases has been linked to effects in heart failure models.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> A comparison of <b>37</b> modeled into X-ray crystal structures of TNNI3K and B-Raf (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) reveals a key residue difference between the two kinase active sites. In TNNI3K, Leu595 resides below the 4,6-diaminopyrimidine inhibitor, whereas B-Raf contains Phe582 in the corresponding position. We have previously introduced selectivity for TNNI3K over B-Raf by exploiting the electrostatic differences between these two residues in a related series of TNNI3K inhibitors.<a onclick="showRef(event, 'ref17 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref20">(17,20)</a> To optimize the 4,6-diaminopyrimidine inhibitors we sought a complementary approach that would introduce selectivity for TNNI3K based on the observed steric differences between TNNI3K and B-Raf. We noted the proximity of the 4-OMe group of <b>37</b> to Leu595 of TNNI3K and the Phe582 residue of B-Raf (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) and hypothesized that larger 4-substituents might be accommodated by TNNI3K while introducing a steric clash with the larger B-Raf Phe582 residue. Additional residues near the 4-OMe group of <b>37</b> are conserved between TNNI3K (Gly470, Ser471, Asn593) and B-Raf (Gly463, Ser464, Asn580), but Ser464 in B-Raf occupies an alternate position relative to Ser471 in TNNI3K that further constrains the size of the B-Raf pocket relative to TNNI3K (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Models of <b>37</b> in TNNI3K (A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J">6B5J</a>) and B-Raf (B, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YHT">4YHT</a>) and <b>43</b> in TNNI3K (C, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J">6B5J</a>) and B-Raf (D, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YHT">4YHT</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Larger 4-substituents that remain in the plane of the aryl ring did not impart selectivity as compounds such as <b>41</b> exhibited potent B-Raf activity (IC<sub>50</sub> = 13 nM). Thus, we synthesized and evaluated a series of 4-sulfonyl analogs (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) of varying sizes, anticipating that these groups would project out of the plane of the aryl rings and project toward Leu595 and Ser471 of TNNI3K and clash with Phe582 and Ser464 of B-Raf (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Other critical features of the sulfone moiety that pointed to its selection as an ideal 4-substituent included its electron-withdrawing nature and ability to form an internal H-bond with the neighboring aniline NH, both of which are required for optimal TNNI3K binding (<i>vide supra</i>).<a onclick="showRef(event, 'ref17 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref21">(17,21)</a> An initial methyl sulfone analog <b>42</b> retained good potency at TNNI3K and high oral exposure in rats while reducing B-Raf activity by 10-fold. Expanding the size of the sulfonyl group further attenuated B-Raf binding in a stepwise fashion (<b>43</b>–<b>45</b>) with no detrimental impact on TNNI3K affinity, such that the <i>tert</i>-butyl sulfone (<b>45</b>) exhibited ≥200-fold selectivity for TNNI3K over B-Raf. This significant size-dependent enhancement in selectivity corroborates our model showing that TNNI3K contains a larger pocket in this region compared to B-Raf (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). In addition, the model of <b>43</b> bound to B-Raf suggests that one of its sulfonyl oxygens is in close contact with the backbone carbonyl of Ser464, likely creating an electrostatic repulsion that further contributes to the loss in potency for B-Raf. The oral exposure of the <i>i</i>-Pr (<b>44</b>) and <i>t</i>-Bu (<b>45</b>) analogs was reduced compared to <b>42</b>, and therefore, the ethyl sulfone <b>43</b> was deemed to have the optimal balance of selectivity and PK properties for use as an <i>in vivo</i> tool in heart failure models.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. 4-Sulfonylbenzenesulfonamide SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0012.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">TNNI3K IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">B-Raf IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">selectivity (fold)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">rat PO DNAUC (h·kg/L)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">≤10<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">≥2</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">0.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="char" char=".">≤10</td><td class="colsep0 rowsep0" align="char" char=".">250</td><td class="colsep0 rowsep0" align="char" char=".">≥25</td><td class="colsep0 rowsep0" align="char" char=".">0.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>iPr</td><td class="colsep0 rowsep0" align="char" char=".">≤10</td><td class="colsep0 rowsep0" align="char" char=".">500</td><td class="colsep0 rowsep0" align="char" char=".">≥50</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>tBu</td><td class="colsep0 rowsep0" align="char" char=".">≤10</td><td class="colsep0 rowsep0" align="char" char=".">2000</td><td class="colsep0 rowsep0" align="char" char=".">≥200</td><td class="colsep0 rowsep0" align="char" char=".">0.076</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Raf activity was evaluated using the B-Raf (V600E) mutant kinase.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Selectivity = B-Raf IC<sub>50</sub>/TNNI3K IC<sub>50</sub>.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Compound IC<sub>50</sub> values less than 10 nM could not be accurately obtained due to titration of TNNI3K in the enzyme assay.</p></div></div></div><div class="NLM_p last">Compound <b>43</b> (GSK854)<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> exhibits substantial selectivity against B-Raf (>25-fold) and EGFR (IC<sub>50</sub> > 25 μM), excellent broad spectrum kinase selectivity with >100-fold selectivity over 96% of kinases tested (≤50% inhibition @ 1 μM for 282 of 294 kinases, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), high activity in a TNNI3K cellular assay (IC<sub>50</sub> = 8 nM), good pharmacokinetics in rats (Cl = 14 mL/min/kg, Vdss = 1.9 L/kg, <i>t</i><sub>1/2</sub> = 2.3 h, <i>F</i> = 48%), and useful exposures in mice (100 mg/kg/d dietary dose gives blood concentration = 0.4–1.6 μM total, 14–56 nM free and heart concentration = 1.1 μM total, mouse PPB F<sub>u</sub> = 3.5%) and thus has been employed in rodent models and cellular assays to delineate the cardiac biology of TNNI3K.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Notably, mice treated with <b>43</b> for 6 weeks following a myocardial infarction exhibited reduced left ventricular dysfunction and remodeling compared to vehicle controls, and these effects were linked to reduced ROS and reduced p38 MAP kinase activation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">4,6-Diaminopyrimidine TNNI3K inhibitors were synthesized through sequential, acid-mediated (HCl or AgOTf) substitutions<a onclick="showRef(event, 'ref10 ref11 ref17'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref17">(10,11,17)</a> of 4,6-dichloropyrimidine (<b>46</b>) with appropriately adorned anilines (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, Method A), which were either commercially available or synthesized as described previously.<a onclick="showRef(event, 'ref12 ref22'); return false;" href="javascript:void(0);" class="ref ref12 ref22">(12,22)</a> Typically, microwave irradiation was employed to accelerate reaction rates on small scale, while conventional heating conditions were used for multigram preparations.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Pyridine (<b>17</b>), 2,4-diaminopyrimidine (<b>18</b>), and triazine (<b>19</b>, <b>20</b>) variants were synthesized in an analogous fashion from 2,4-dichloropyridine, 2,4-dichloropyrimidine, or 2,4,6-trichloro-1,3,5-triazine, respectively. Incorporation of 2-aminopyridine substituents was accomplished through Pd-catalyzed cross coupling with the monochloride intermediate <b>48</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, Method B).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a></div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Structure-based design led to the discovery of a series of 4,6-diaminopyrimidines that function as highly specific TNNI3K inhibitors that are valuable probes for understanding the biology of TNNI3K. Further scrutiny of the binding mode of these 4,6-diaminopyrimidines and the SAR of alternative heterocycles demonstrated that the 4,6-diaminopyrimidine scaffold uniquely produces potent and selective inhibitors as a result of its intrinsic conformational preferences. Application of this analysis to analog design produced further enhancements in TNNI3K affinity. Concurrent interpretation of additional SAR uncovered simple and predictable strategies to weaken activity at EGFR and B-Raf, two homologous kinases for which the 4,6-diaminopyrimidines also serve as a privileged structure, albeit by virtue of a variant mechanism and binding mode for EGFR. The pharmacokinetics of the 4,6-diaminopyrimidines was also optimized, which culminated in the discovery of <b>43</b>, a preferred TNNI3K inhibitor tool compound and lead for discovery of new medicines.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Experimental</h3><div class="NLM_p">Compounds were evaluated for activity against TNNI3K and B-Raf (V600E) as previously described.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> For the TNNI3K enzyme assay, compound IC<sub>50</sub> values less than 10 nM could not be accurately obtained due to titration of TNNI3K in the assay. TNNI3K cellular assays, rat pharmacokinetics, and X-ray crystallography studies were conducted as previously described.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> All studies were conducted in accordance with the GSK Policy on the Care, Welfare, and Treatment of Laboratory Animals and were reviewed by the Institutional Animal Care and Use Committee either at GSK or by the ethical review process at the institution where the work was performed. The purity of each inhibitor was determined to be >95% on an Agilent 1100 HPLC equipped with a Sunfire C18 5.0 μm column (3.0 mm × 50 mm) using a gradient of 10% to 100% MeCN/H<sub>2</sub>O/0.05% TFA at 1 mL/min flow rate with detection at 220 and 254 nm. Mass determinations were conducted using an Agilent 6110 Quadrupole MS with positive ESI. Preparative HPLC was conducted on a Waters 2525 system at a flow rate of 50 mL/min with 254 nm detection using either a Sunfire C18 OBD 5 μm column (30 × 150 mm) with a gradient of MeCN/H<sub>2</sub>O/0.1% TFA or an Xbridge C18 OBD 5 μm column (30 × 150 mm) with a gradient of MeCN/aq NH<sub>4</sub>OH pH 10. Flash column chromatography was conducted on silica gel eluting with EtOAc–hexanes or MeOH–CH<sub>2</sub>Cl<sub>2</sub> mixtures or with a sequence of CH<sub>2</sub>Cl<sub>2</sub>, Et<sub>2</sub>O, EtOAc, and acetone. Compounds were synthesized using procedures that followed reported protocols,<a onclick="showRef(event, 'ref17 ref22'); return false;" href="javascript:void(0);" class="ref ref17 ref22">(17,22)</a> and specific experimental details have been published previously for compounds <b>1</b>, <b>2</b>, <b>13</b>, <b>30–36</b>, <b>38</b>, and <b>40</b>.<a onclick="showRef(event, 'ref12 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref17">(12,17)</a> Reagents and building blocks were purchased and used as is or synthesized following reported procedures.<a onclick="showRef(event, 'ref12 ref22'); return false;" href="javascript:void(0);" class="ref ref12 ref22">(12,22)</a></div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Method A</h4><div id="sec5_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> General Coupling Method for Anilines and Chloro-pyrimidines</h5><div class="NLM_p last">A mixture of a chloro-heterocycle and the required aniline (1.3 equiv) in <i>i</i>-PrOH or NMP (2 mL) was treated with 1 M aqueous HCl (1 equiv) and subjected to microwave irradiation (150 °C) for 15–60 min before being cooled to room temperature. Analytically pure solids were obtained after purification by reverse-phase HPLC (<b>4, 6</b>, <b>7</b>, <b>8</b>, <b>10</b>, <b>11</b>, <b>12</b>, <b>16</b>, <b>23</b>, <b>24</b>, <b>25</b>, <b>26</b>, <b>27</b>, and <b>28</b>), flash column chromatography (<b>3</b> and <b>9</b>), or by collecting the precipitate by filtration (<b>5</b>, <b>14</b>, and <b>15</b>).</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Method B</h4><div id="sec5_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> General Coupling Method for 2-Aminopyridines and Chloro-pyrimidines</h5><div class="NLM_p last">A mixture of a chloro-heterocycle, the required aniline (1.3 equiv), Pd<sub>2</sub>(dba)<sub>3</sub> (0.02 equiv), Xantphos (0.04 equiv), and K<sub>3</sub>PO<sub>4</sub> in 1,4-dioxane (1.3 mL) was subjected to microwave irradiation (150 °C) for 30–90 min before being cooled to room temperature. Analytically pure solids were obtained after purification by reverse-phase HPLC (<b>21</b>, <b>22</b>, <b>37</b>, <b>39</b>, <b>41</b>, <b>42</b>, <b>44</b>, and <b>45</b>).</div></div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-Methyl-3-({6-[(3-methylphenyl)amino]-4-pyrimidinyl}amino)benzenesulfonamide Trifluoroacetate (<b>3</b>)</h4><div class="NLM_p last">Compound <b>3</b> was prepared from 6-chloro-<i>N</i>-(3-methylphenyl)-4-pyrimidinamine and 3-amino-<i>N</i>-methylbenzenesulfonamide using Method A as a cream solid in 15% yield (89 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.75 (s, 1H), 9.43 (br. s., 1H), 8.37 (s, 1H), 8.02–8.11 (m, 1H), 7.87 (dd, <i>J</i> = 1.51, 8.03 Hz, 1H), 7.54 (t, <i>J</i> = 7.91 Hz, 1H), 7.46 (q, <i>J</i> = 4.85 Hz, 1H), 7.38 (d, <i>J</i> = 7.78 Hz, 1H), 7.29–7.35 (m, 2H), 7.20–7.27 (m, 1H), 6.90 (d, <i>J</i> = 7.28 Hz, 1H), 6.18 (s, 1H), 2.44 (d, <i>J</i> = 4.77 Hz, 3H), 2.31 (s, 3H). MS (<i>m</i>/<i>z</i>) 370.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-Methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}-4-pyrimidinyl)amino]benzenesulfonamide Trifluoroacetate (<b>4</b>)</h4><div class="NLM_p last">Compound <b>4</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzene-sulfonamide and 4-(trifluoromethyl)aniline using Method A as a white solid in 21% yield (52 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.71 (s, 1H), 9.67 (s, 1H), 8.42 (s, 1H), 8.11 (t, <i>J</i> = 1.88 Hz, 1H), 7.93 (dd, <i>J</i> = 1.51, 8.28 Hz, 1H), 7.86 (d, <i>J</i> = 8.78 Hz, 2H), 7.65 (d, <i>J</i> = 8.78 Hz, 2H), 7.53 (t, <i>J</i> = 8.03 Hz, 1H), 7.45 (q, <i>J</i> = 5.02 Hz, 1H), 7.35 (d, <i>J</i> = 7.78 Hz, 1H), 6.27 (s, 1H), 2.45 (d, <i>J</i> = 5.02 Hz, 3H). MS (<i>m</i>/<i>z</i>) 423.9 (M + H<sup>+</sup>).</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-Methyl-3-{[6-(methylamino)-4-pyrimidinyl]amino}benzenesulfonamide Hydrochloride (<b>5</b>)</h4><div class="NLM_p last">Compound <b>5</b> was prepared from 6-chloro-<i>N</i>-methyl-4-pyrimidinamine and 3-amino-<i>N</i>-methylbenzenesulfonamide using Method A as a white solid in 57% yield (106 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.61 (br. s., 1H), 8.82 (br. s., 1H), 8.44 (s, 1H), 7.95 (br. s., 1H), 7.75 (br. s., 1H), 7.55–7.67 (m, 2H), 7.52 (d, <i>J</i> = 7.28 Hz, 1H), 6.08 (br. s., 1H), 2.88 (br. s., 3H), 2.45 (d, <i>J</i> = 4.77 Hz, 3H). MS (<i>m</i>/<i>z</i>) 294.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-Methyl-3-{[6-(phenylamino)-4-pyrimidinyl]amino}benzenesulfonamide Trifluoroacetate (<b>6</b>)</h4><div class="NLM_p last">Compound <b>6</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and aniline using Method A as a white solid in 35% yield (84 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.75 (br. s., 1H), 9.49 (br. s., 1H), 8.38 (s, 1H), 8.07 (br. s., 1H), 7.87 (d, <i>J</i> = 8.03 Hz, 1H), 7.53 (d, <i>J</i> = 6.78 Hz, 3H), 7.46 (d, <i>J</i> = 4.27 Hz, 1H), 7.29–7.41 (m, 3H), 7.02–7.16 (m, 1H), 6.99 (s, 1H), 6.20 (s, 1H), 2.44 (d, <i>J</i> = 4.27 Hz, 3H). MS (<i>m</i>/<i>z</i>) 356.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 3-({6-[(2-Fluorophenyl)amino]-4-pyrimidinyl}amino)-<i>N</i>-methylbenzenesulfonamide Trifluoroacetate (<b>7</b>)</h4><div class="NLM_p last">Compound <b>7</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 2-fluoroaniline using Method A as a yellow solid in 26% yield (33 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.71 (s, 1H), 9.21 (s, 1H), 8.33 (s, 1H), 8.08 (s, 1H), 7.83–7.89 (m, 1H), 7.71–7.78 (m, 1H), 7.49–7.56 (m, 1H), 7.45 (q, <i>J</i> = 4.85 Hz, 1H), 7.36 (d, <i>J</i> = 7.78 Hz, 1H), 7.27–7.34 (m, 1H), 7.17–7.25 (m, 2H), 6.12 (s, 1H), 2.44 (d, <i>J</i> = 5.02 Hz, 3H). MS (<i>m</i>/<i>z</i>) 374.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-Methyl-3-({6-[(2-methylphenyl)amino]-4-pyrimidinyl}amino)benzenesulfonamide (<b>8</b>)</h4><div class="NLM_p last">Compound <b>8</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 2-methylaniline using Method A as a white solid in 19% yield (52 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85 (br. s., 1H), 9.21 (br. s., 1H), 8.34 (s, 1H), 8.03 (br. s., 1H), 7.80 (d, <i>J</i> = 8.03 Hz, 1H), 7.50–7.57 (m, 1H), 7.42–7.49 (m, 1H), 7.40 (d, <i>J</i> = 7.53 Hz, 1H), 7.19–7.37 (m, 4H), 5.82 (s, 1H), 2.43 (d, <i>J</i> = 4.77 Hz, 3H), 2.23 (s, 3H). MS (<i>m</i>/<i>z</i>) 370.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-Methyl-3-[(6-{[2-(methyloxy)phenyl]amino}-4-pyrimidinyl)amino]benzenesulfonamide (<b>9</b>)</h4><div class="NLM_p last">Compound <b>9</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 2-methoxyaniline using Method A in 85% yield (345 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.46 (s, 1H), 8.45 (s, 1H), 8.26 (s, 1H), 8.10 (s, 1H), 7.88 (d, <i>J</i> = 8.28 Hz, 1H), 7.67 (d, <i>J</i> = 7.53 Hz, 1H), 7.49 (t, <i>J</i> = 7.91 Hz, 1H), 7.38–7.44 (m, 1H), 7.30 (d, <i>J</i> = 7.78 Hz, 1H), 7.04–7.16 (m, 2H), 6.91–7.00 (m, 1H), 6.07 (s, 1H), 3.83 (s, 3H), 2.44 (d, <i>J</i> = 5.02 Hz, 3H). MS (<i>m</i>/<i>z</i>) 386.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 3-({6-[(3-Chlorophenyl)amino]-4-pyrimidinyl}amino)-<i>N</i>-methylbenzenesulfonamide Trifluoroacetate (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> was prepared from 6-chloro-<i>N</i>-(3-chlorophenyl)-4-pyrimidinamine and 3-amino-<i>N</i>-methylbenzenesulfonamide using Method A as a white solid in 38% yield (126 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.68 (s, 1H), 9.54 (s, 1H), 8.41 (s, 1H), 8.09 (t, <i>J</i> = 1.88 Hz, 1H), 7.90–7.94 (m, 1H), 7.88 (t, <i>J</i> = 2.01 Hz, 1H), 7.53 (t, <i>J</i> = 7.91 Hz, 1H), 7.41–7.49 (m, 2H), 7.29–7.39 (m, 2H), 7.03 (dd, <i>J</i> = 1.25, 8.03 Hz, 1H), 6.21 (s, 1H), 2.45 (d, <i>J</i> = 4.77 Hz, 3H). MS (<i>m</i>/<i>z</i>) 390.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-Methyl-3-[(6-{[3-(methyloxy)phenyl]amino}-4-pyrimidinyl)amino]benzenesulfonamide Trifluoroacetate (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 3-(methyloxy)aniline using Method A as a pale yellow solid in 32% yield (70 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.77 (s, 1H), 9.49 (br. s., 1H), 8.38 (s, 1H), 8.06 (s, 1H), 7.88 (d, <i>J</i> = 8.28 Hz, 1H), 7.54 (t, <i>J</i> = 7.91 Hz, 1H), 7.46 (q, <i>J</i> = 4.68 Hz, 1H), 7.38 (d, <i>J</i> = 7.78 Hz, 1H), 7.21–7.29 (m, 1H), 7.18 (s, 1H), 7.09 (d, <i>J</i> = 8.03 Hz, 1H), 6.65 (dd, <i>J</i> = 2.01, 8.03 Hz, 1H), 6.22 (s, 1H), 3.76 (s, 3H), 2.44 (d, <i>J</i> = 4.77 Hz, 3H). MS (<i>m</i>/<i>z</i>) 386.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-Methyl-3-[(6-{[3-(methylsulfonyl)phenyl]amino}-4-pyrimidinyl)amino]benzenesulfonamide Trifluoroacetate (<b>12</b>)</h4><div class="NLM_p last">Compound <b>12</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 3-(methylsulfonyl)aniline using Method A as a white solid in 27% yield (62 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.79 (s, 1H), 9.74 (s, 1H), 8.43 (s, 1H), 8.21 (s, 1H), 8.08 (s, 1H), 7.99 (d, <i>J</i> = 7.78 Hz, 1H), 7.93 (d, <i>J</i> = 8.03 Hz, 1H), 7.49–7.63 (m, 3H), 7.43–7.49 (m, 1H), 7.37 (d, <i>J</i> = 7.78 Hz, 1H), 6.24 (s, 1H), 3.22 (s, 3H), 2.45 (d, <i>J</i> = 4.52 Hz, 3H). MS (<i>m</i>/<i>z</i>) 434.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-Methyl-3-({6-[(4-methylphenyl)amino]-4-pyrimidinyl}amino)benzenesulfonamide Hydrochloride (<b>14</b>)</h4><div class="NLM_p last">Compound <b>14</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 4-methylaniline using Method A as a white solid in 15% yield (7.8 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.49 (s, 1H), 9.13 (s, 1H), 8.30 (s, 1H), 8.07–8.14 (m, 1H), 7.85–7.92 (m, 1H), 7.50 (t, <i>J</i> = 8.03 Hz, 1H), 7.37–7.46 (m, 3H), 7.31 (d, <i>J</i> = 7.78 Hz, 1H), 7.13 (d, <i>J</i> = 8.28 Hz, 2H), 6.15 (s, 1H), 2.44 (d, <i>J</i> = 5.02 Hz, 3H), 2.27 (s, 3H). MS (<i>m</i>/<i>z</i>) 370.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-Methyl-3-[(6-{[4-(methyloxy)phenyl]amino}-4-pyrimidinyl)amino]benzenesulfonamide Hydrochloride (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 4-(methyloxy)aniline using Method A as an off-white solid in 50% yield (100 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.28 (br. s., 1H), 9.96 (br. s., 1H), 8.42 (s, 1H), 7.99 (s, 1H), 7.77 (d, <i>J</i> = 8.03 Hz, 1H), 7.51–7.62 (m, 2H), 7.47 (d, <i>J</i> = 7.78 Hz, 1H), 7.35 (d, <i>J</i> = 8.78 Hz, 2H), 7.01 (d, <i>J</i> = 8.78 Hz, 2H), 6.12 (s, 1H), 2.43 (d, <i>J</i> = 4.77 Hz, 3H). MS (<i>m</i>/<i>z</i>) 386.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-Methyl-3-[(6-{[4-(methylsulfonyl)phenyl]amino}-4-pyrimidinyl)amino]benzenesulfonamide Trifluoroacetate (<b>16</b>)</h4><div class="NLM_p last">Compound <b>16</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 4-(methylsulfonyl)aniline using Method A as a white solid in 69% yield (143 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85 (s, 1H), 9.72 (s, 1H), 8.45 (s, 1H), 8.09–8.12 (m, 1H), 7.93 (dd, <i>J</i> = 1.76, 8.03 Hz, 1H), 7.80–7.91 (m, 4H), 7.54 (t, <i>J</i> = 7.91 Hz, 1H), 7.45 (q, <i>J</i> = 5.02 Hz, 1H), 7.37 (d, <i>J</i> = 7.78 Hz, 1H), 6.30 (s, 1H), 3.16 (s, 3H), 2.45 (d, <i>J</i> = 5.02 Hz, 3H). MS (<i>m</i>/<i>z</i>) 434.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-Methyl-3-((2-(<i>m</i>-tolylamino)pyridin-4-yl)amino)benzenesulfonamide Trifluoroacetate (<b>17</b>)</h4><div class="NLM_p">A mixture of 2,4-dichloropyridine (50 mg, 0.34 mmol) and 3-amino-<i>N</i>-methylbenzenesulfonamide (63 mg, 0.34 mmol) in <i>i</i>-PrOH (2 mL) was treated with 1 M aqueous HCl (0.34 mL, 0.34 mmol) and stirred at 80 °C for 60 h before being cooled to room temperature. The mixture was subjected to reverse phase HPLC to give 3-((2-chloropyridin-4-yl)amino)-<i>N</i>-methylbenzenesulfonamide as a white solid (59 mg, 42% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.47 (s, 1H), 8.08 (d, <i>J</i> = 5.52 Hz, 1H), 7.58–7.63 (m, 1H), 7.44–7.58 (m, 4H), 6.91–6.98 (m, 2H), 2.45 (d, <i>J</i> = 4.77 Hz, 3H). MS (<i>m</i>/<i>z</i>) 298.0 (M + H<sup>+</sup>).</div><div class="NLM_p last">A mixture of 3-((2-chloropyridin-4-yl)amino)-<i>N</i>-methylbenzenesulfonamide (30 mg, 0.07 mmol) and <i>m</i>-toluidine (0.03 mL, 0.28 mmol) in <i>i</i>-PrOH (2 mL) was treated with 1 M aqueous HCl (0.1 mL, 0.1 mmol) and subjected to microwave irradiation (150 °C) for 60 min before being cooled to room temperature and subjected to reverse phase HPLC to give <b>17</b> as a white solid (16 mg, 45% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.40 (br. s., 1H), 10.10 (br. s., 1H), 9.85 (br. s., 1H), 7.77 (d, <i>J</i> = 7.28 Hz, 1H), 7.65–7.72 (m, 1H), 7.52–7.63 (m, 4H), 7.30–7.38 (m, 1H), 7.05–7.15 (m, 3H), 6.59 (dd, <i>J</i> = 2.26, 7.28 Hz, 1H), 6.40 (d, <i>J</i> = 2.26 Hz, 1H), 2.42 (d, <i>J</i> = 4.77 Hz, 3H), 2.34 (s, 3H). MS (<i>m</i>/<i>z</i>) 369.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-Methyl-3-((2-(m-tolylamino)pyrimidin-4-yl)amino)benzenesulfonamide Trifluoroacetate (<b>18</b>)</h4><div class="NLM_p">A mixture of 2,4-dichloropyrimidine (160 mg, 1.1 mmol) and 3-amino-<i>N</i>-methylbenzenesulfonamide (100 mg, 0.5 mmol) in <i>i</i>-PrOH (4 mL) was treated with Na<sub>2</sub>CO<sub>3</sub> (171 mg, 1.6 mmol) and stirred at 80 °C for 60 h before being cooled to room temperature and filtered. The filtrate was concentrated and subjected to flash column chromatography (50–75% EtOAc-hexanes) to give 3-((2-chloropyrimidin-4-yl)amino)-<i>N</i>-methylbenzenesulfonamide as a pale yellow solid (133 mg, 60% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.47 10.36 (br. s., 1H), 8.24 (d, <i>J</i> = 5.77 Hz, 1H), 8.07 (s, 1H), 7.85–7.94 (m, 1H), 7.61 (t, <i>J</i> = 8.03 Hz, 1H), 7.47 (d, <i>J</i> = 8.28 Hz, 2H), 6.81 (d, <i>J</i> = 5.77 Hz, 1H), 2.48 (s, 3H). MS (<i>m</i>/<i>z</i>) 299.0 (M + H<sup>+</sup>).</div><div class="NLM_p last">A mixture of 3-((2-chloropyrimidin-4-yl)amino)-<i>N</i>-methylbenzenesulfonamide (60 mg, 0.2 mmol) and <i>m</i>-toluidine (0.043 mL, 0.4 mmol) was treated with 1 M aqueous HCl (0.2 mL, 0.2 mmol) and stirred at 80 °C for 60 min before being cooled to room temperature, concentrated, and subjected to reverse phase HPLC to give <b>18</b> as a white solid (70 mg, 71% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.53 (br. s., 1H), 9.97 (br. s., 1H), 8.26 (d, <i>J</i> = 7.28 Hz, 1H), 8.02 (d, <i>J</i> = 6.78 Hz, 1H), 7.74 (s, 1H), 7.48–7.58 (m, 3H), 7.31–7.42 (m, 2H), 7.22–7.30 (m, 1H), 6.97 (d, <i>J</i> = 7.28 Hz, 1H), 6.38 (d, <i>J</i> = 6.78 Hz, 1H), 2.43 (d, <i>J</i> = 5.02 Hz, 3H), 2.29 (s, 3H). MS (<i>m</i>/<i>z</i>) 370.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-Methyl-3-({4-[(3-methylphenyl)amino]-1,3,5-triazin-2-yl}amino)benzenesulfonamide (<b>19</b>)</h4><div class="NLM_p">A mixture of 2,4,6-trichloro-1,3,5-triazine (800 mg, 4.3 mmol) in AcOH (13 mL) at 15 °C was treated with a solution of 3-amino-<i>N</i>-methylbenzenesulfonamide (808 mg, 4.3 mmol) in AcOH (1.6 mL) and H<sub>2</sub>O (6.8 mL) dropwise over 15 min. The mixture was stirred an additional 10 min before being diluted with saturated aqueous NaCl. The precipitate was collected by filtration, washed with H<sub>2</sub>O and Et<sub>2</sub>O, and dried to give 3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-<i>N</i>-methylbenzenesulfonamide as an off-white solid (1.05 g, 69% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.35–11.47 (m, 1H), 8.07–8.15 (m, 1H), 7.84 (d, <i>J</i> = 7.53 Hz, 1H), 7.60–7.69 (m, 1H), 7.50–7.60 (m, 2H), 2.44–2.49 (m, 3H). MS (<i>m</i>/<i>z</i>) 334.0 (M + H<sup>+</sup>).</div><div class="NLM_p">A mixture of 3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-<i>N</i>-methylbenzenesulfonamide (160 mg, 0.48 mmol) in AcOH (4 mL) and H<sub>2</sub>O (1 mL) was treated with 3-methylaniline (56 mg, 0.53 mmol) and NaOAc (47 mg, 0.58 mmol) and stirred at room temperature overnight. The mixture was diluted with saturated aqueous NaCl, and the precipitate was collected by filtration and washed twice with H<sub>2</sub>O. The filtered solid was dissolved in Et<sub>2</sub>O and the solution concentrated to give 3-({4-chloro-6-[(3-methylphenyl)amino]-1,3,5-triazin-2-yl}amino)-<i>N</i>-methylbenzenesulfonamide as a white solid (166 mg, 86% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.53 (br. s., 1H), 10.30 (br. s., 1H), 8.12 (br. s., 1H), 7.96 (br. s., 1H), 7.78 (br. s., 1H), 7.52–7.65 (m, 1H), 7.48 (d, <i>J</i> = 7.53 Hz, 4H), 7.24 (t, <i>J</i> = 7.78 Hz, 1H), 6.92 (d, <i>J</i> = 7.28 Hz, 1H), 2.44 (br. s., 3H), 2.29 (br. s., 3H). MS (<i>m</i>/<i>z</i>) 405.0 (M + H<sup>+</sup>).</div><div class="NLM_p last">A mixture of 3-({4-chloro-6-[(3-methylphenyl)amino]-1,3,5-triazin-2-yl}amino)-<i>N</i>-methylbenzenesulfonamide (166 mg, 0.41 mmol) in EtOH (1 mL) was treated with ammonium formate (129 mg, 2.1 mmol) and 10% palladium on carbon (44 mg, 0,04 mmol) and stirred at 80 °C for 1 h before being cooled and filtered through Celite and washed with EtOH and then DMSO. The filtrate was subjected to reverse phase HPLC to give <b>19</b> as a white solid (60 mg, 38%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.07 (br. s., 1H), 9.80 (br. s., 1H), 8.40 (s, 1H), 8.18 (br. s. 1H), 7.50–7.61 (m, 3H), 7.38–7.50 (m, 2H), 7.22 (t, <i>J</i> = 7.91 Hz, 1H), 6.88 (d, <i>J</i> = 7.53 Hz, 1H), 2.44 (d, <i>J</i> = 5.02 Hz, 3H), 2.30 (s, 3H). MS (<i>m</i>/<i>z</i>) 405.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-({4-[(4-Chlorophenyl)amino]-1,3,5-triazin-2-yl}amino)-<i>N</i>-methylbenzenesulfonamide (<b>20</b>)</h4><div class="NLM_p">A mixture of 3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-<i>N</i>-methylbenzenesulfonamide (160 mg, 0.48 mmol) in AcOH (4 mL) and H<sub>2</sub>O (1 mL) was treated with 4-chloroaniline (73 mg, 0.58 mmol) and NaOAc (47 mg, 0.58 mmol) and stirred at room temperature overnight. The mixture was diluted with saturated aqueous NaCl, and the precipitate was collected by filtration and washed with water. The filtered solid was dissolved in Et<sub>2</sub>O, and the solution was concentrated to give 3-({4-chloro-6-[(4-chlorophenyl)amino]-1,3,5-triazin-2-yl}amino)-<i>N</i>-methylbenzenesulfonamide as a white solid (230 mg, 100% yield). MS (<i>m</i>/<i>z</i>) 425.0 (M + H<sup>+</sup>).</div><div class="NLM_p last">A mixture of 3-({4-chloro-6-[(4-chlorophenyl)amino]-1,3,5-triazin-2-yl}amino)-<i>N</i>-methylbenzenesulfonamide (230 mg, 0.49 mmol) in EtOH (1.2 mL) was treated with ammonium formate (153 mg, 2.4 mmol) and 10% palladium on carbon (52 mg, 0.05 mmol) and stirred at 60 °C for 30 min before being cooled to room temperature. The mixture was diluted with DMSO (15 mL) and filtered through Celite, and the filtrate was subjected to reverse HPLC to give <b>20</b> as a pale pink solid (39 mg, 19% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.13 (br. s., 1H), 10.00 (br. s., 1H), 8.43 (br. s., 1H), 8.08 (br. s., 2H), 7.79 (br. s., 2H), 7.57 (t, <i>J</i> = 7.91 Hz, 1H), 7.41–7.52 (m, 2H), 7.38 (d, <i>J</i> = 8.53 Hz, 1H), 2.44 (d, <i>J</i> = 4.52, 3H). MS (<i>m</i>/<i>z</i>) 391.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-({6-[(5-Chloro-2-pyridinyl)amino]-4-pyrimidinyl}amino)-<i>N</i>-methylbenzenesulfonamide Trifluoroacetate (<b>21</b>)</h4><div class="NLM_p last">Compound <b>21</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 5-chloro-2-pyridinamine using Method B as a pale yellow solid in 6% yield (22 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32 (br. s., 1H), 9.97 (br. s., 1H), 8.44 (s, 1H), 8.31 (d, <i>J</i> = 2.51 Hz, 1H), 8.18 (s, 1H), 7.88–7.94 (m, 1H), 7.85 (dd, <i>J</i> = 2.64, 8.91 Hz, 1H), 7.51–7.59 (m, 2H), 7.46 (q, <i>J</i> = 4.85 Hz, 1H), 7.38 (d, <i>J</i> = 7.78 Hz, 1H), 7.24 (s, 1H), 2.45 (d, <i>J</i> = 5.02 Hz, 3H). MS (<i>m</i>/<i>z</i>) 390.9 (M + H<sup>+</sup>).</div></div><div id="sec5_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-Methyl-3-[(6-{[5-(trifluoromethyl)-2-pyridinyl]amino}-4-pyrimidinyl)amino]benzenesulfonamide Trifluoroacetate (<b>22</b>)</h4><div class="NLM_p last">Compound <b>22</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 5-(trifluoromethyl)-2-pyridinamine using Method B as a pale yellow solid in 17% yield (69 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.57 (br. s., 1H), 9.98 (s, 1H), 8.62 (s, 1H), 8.48 (s, 1H), 8.20 (s, 1H), 8.05–8.12 (m, 1H), 7.93 (d, <i>J</i> = 8.03 Hz, 1H), 7.72 (d, <i>J</i> = 8.78 Hz, 1H), 7.55 (t, <i>J</i> = 8.03 Hz, 1H), 7.46 (q, <i>J</i> = 4.60 Hz, 1H), 7.35–7.42 (m, 2H), 2.46 (d, <i>J</i> = 4.77 Hz, 3H). MS (<i>m</i>/<i>z</i>) 424.9 (M + H<sup>+</sup>).</div></div><div id="sec5_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-Methyl-3-[(6-{[3-(1-methylethyl)phenyl]amino}-4-pyrimidinyl)amino]benzenesulfonamide (<b>23</b>)</h4><div class="NLM_p last">Compound <b>23</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 3-(1-methylethyl)aniline using Method A as an off-white solid in 12% yield (25 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.49 (br. s., 1H), 9.15 (br. s., 1H), 8.31 (s, 1H), 8.08 (s, 1H), 7.90 (d, <i>J</i> = 7.32 Hz, 1H), 7.46–7.53 (m, 1H), 7.44 (d, <i>J</i> = 7.81 Hz, 1H), 7.39 (q, <i>J</i> = 4.80 Hz, 1H), 7.29–7.34 (m, 2H), 7.22 (t, <i>J</i> = 7.81 Hz, 1H), 6.89 (d, <i>J</i> = 7.57 Hz, 1H), 6.18 (s, 1H), 2.86 (dt, <i>J</i> = 6.93, 13.73 Hz, 1H), 2.44 (d, <i>J</i> = 5.13 Hz, 3H), 1.22 (s, 3H), 1.20 (s, 3H). MS (<i>m</i>/<i>z</i>) 398.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-[(6-{[3-(1,1-Dimethylethyl)phenyl]amino}-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide Trifluoroacetate (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 3-(1,1-dimethylethyl)aniline using Method A as a white solid in 53% yield (148 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.72 (br. s., 1H), 9.42 (br. s., 1H), 8.36 (s, 1H), 8.03 (s, 1H), 7.86 (d, <i>J</i> = 8.06 Hz, 1H), 7.53 (t, <i>J</i> = 7.93 Hz, 1H), 7.35–7.46 (m, 4H), 7.28 (t, <i>J</i> = 7.81 Hz, 1H), 7.11 (d, <i>J</i> = 7.81 Hz, 1H), 6.16 (s, 1H), 2.44 (d, <i>J</i> = 4.88 Hz, 3H), 1.29 (s, 9H). MS (<i>m</i>/<i>z</i>) 412.2 (M + H<sup>+</sup>).</div></div><div id="sec5_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3,3′-(4,6-Pyrimidinediyldiimino)bis(<i>N</i>-methylbenzenesulfonamide) Trifluoroacetate (<b>25</b>)</h4><div class="NLM_p last">Compound <b>25</b> was prepared from 4,6-dichloropyrimidine (1 equiv) and 3-amino-<i>N</i>-methylbenzenesulfonamide (2 equiv) using Method A as a white solid in 41% yield (81 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.75 (s, 2H), 8.41 (s, 1H), 8.08 (s, 2H), 7.92 (d, <i>J</i> = 7.78 Hz, 2H), 7.54 (t, <i>J</i> = 7.91 Hz, 2H), 7.46 (q, <i>J</i> = 4.85 Hz, 2H), 7.37 (d, <i>J</i> = 7.78 Hz, 2H), 6.24 (s, 1H), 2.45 (d, <i>J</i> = 4.52 Hz, 6H). MS (<i>m</i>/<i>z</i>) 449.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-Methyl-3-({6-[(3-nitrophenyl)amino]-4-pyrimidinyl}amino)benzenesulfonamide Trifluoroacetate (<b>26</b>)</h4><div class="NLM_p last">Compound <b>26</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and 3-nitroaniline using Method A as a yellow solid in 40% yield (102 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.87 (br. s., 1H), 9.74 (br. s., 1H), 8.71 (br. s., 1H), 8.45 (br. s., 1H), 8.08 (br. s., 1H), 7.99 (d, <i>J</i> = 7.53 Hz, 1H), 7.93 (d, <i>J</i> = 7.53 Hz, 1H), 7.81 (d, <i>J</i> = 7.78 Hz, 1H), 7.49–7.63 (m, 2H), 7.41–7.49 (m, 1H), 7.36 (d, <i>J</i> = 7.28 Hz, 1H), 6.25 (br. s., 1H), 2.44 (d, <i>J</i> = 2.51 Hz, 3H). MS (<i>m</i>/<i>z</i>) 401.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-Methyl-3-({6-[methyl(3-methylphenyl)amino]-4-pyrimidinyl}amino)benzenesulfonamide (<b>27</b>)</h4><div class="NLM_p last">Compound <b>27</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide and methyl(3-methylphenyl)amine using Method A as a pale brown solid in 48% yield (60 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.58 (br. s., 1H), 8.38 (s, 1H), 8.07 (br. s., 1H), 7.77 (d, <i>J</i> = 7.28 Hz, 1H), 7.36–7.54 (m, 3H), 7.33 (d, <i>J</i> = 7.28 Hz, 1H), 7.10–7.24 (m, 3H), 5.74 (s, 1H), 3.41 (s, 3H), 2.42 (d, <i>J</i> = 4.77 Hz, 3H), 2.37 (s, 3H). MS (<i>m</i>/<i>z</i>) 384.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-Methyl-3-(methyl{6-[(3-methylphenyl)amino]-4-pyrimidinyl}amino)benzenesulfonamide (<b>28</b>)</h4><div class="NLM_p last">Compound <b>28</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)(methyl)amino]-<i>N</i>-methylbenzenesulfonamide and 3-methylaniline using Method A as a white solid in 23% yield (37 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.46 (br. s., 1H), 8.34 (s, 1H), 7.61–7.81 (m, 4H), 7.55 (q, <i>J</i> = 4.77 Hz, 1H), 7.12–7.34 (m, 3H), 6.85 (d, <i>J</i> = 7.03 Hz, 1H), 5.79 (s, 1H), 3.44 (s, 3H), 2.44 (d, <i>J</i> = 5.02 Hz, 3H), 2.26 (s, 3H). MS (<i>m</i>/<i>z</i>) 384.1 (M + H<sup>+</sup>).</div></div><div id="sec5_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-({6-[(3-Bromophenyl)amino]-4-pyrimidinyl}amino)-<i>N</i>-methylbenzenesulfonamide (<b>29</b>)</h4><div class="NLM_p last">A mixture of 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methylbenzenesulfonamide (15 g, 50 mmol) and 3-bromoaniline (7.8 g, 43 mmol) in isoamylalcohol (10 mL) was treated with HCl (3 mL of a 2 M solution, 6 mmol) and stirred at 131 °C for 6 h. The mixture was cooled and quenched with aqueous NH<sub>4</sub>OH and stirred for 30 min. The precipitate that formed was collected by filtration, washed with hexanes, and dried to give <b>29</b> as a yellow solid (17.5 g, 93% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.67 (br. s., 1H), 9.54 (br. s., 1H), 8.39 (s, 1H), 8.11 (br. s., 1H), 8.03 (br. s., 1H), 7.93 (d, <i>J</i> = 7.53 Hz, 1H), 7.41–7.58 (m, 3H), 7.34 (d, <i>J</i> = 7.53 Hz, 1H), 7.25 (t, <i>J</i> = 7.91 Hz, 1H), 7.13 (d, <i>J</i> = 7.28 Hz, 1H), 6.25 (s, 1H), 2.45 (d, <i>J</i> = 4.52 Hz, 3H), MS (<i>m</i>/<i>z</i>) 436.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 3-({6-[(5-Chloro-2-pyridinyl)amino]-4-pyrimidinyl}amino)-<i>N</i>-methyl-4-(methyloxy)-benzenesulfonamide Trifluoroacetate (<b>37</b>)</h4><div class="NLM_p last">Compound <b>37</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methyl-4-(methyloxy)benzenesulfonamide and 5-chloro-2-pyridinamine using Method B as a pale yellow solid in 4% yield (22 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.31 (br. s., 1H), 9.15 (br. s., 1H), 8.38 (s, 1H), 8.29–8.31 (m, 1H), 8.26–8.28 (m, 1H), 7.85 (dd, <i>J</i> = 9.03, 2.76 Hz, 1H), 7.49–7.56 (m, 2H), 7.30–7.34 (m, 1H), 7.27–7.30 (m, 1H), 7.18 (br. s., 1H), 3.93 (s, 3H), 2.43 (d, <i>J</i> = 5.02 Hz, 3H). MS (<i>m</i>/<i>z</i>) 421.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 3-({6-[(5-Chloro-2-pyridinyl)amino]-4-pyrimidinyl}amino)-<i>N</i>-methyl-4-[(trifluoromethyl)oxy]benzenesulfonamide Trifluoroacetate (<b>39</b>)</h4><div class="NLM_p last">Compound <b>39</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methyl-4-[(trifluoromethyl)oxy]benzenesulfonamide and 5-chloro-2-pyridinamine using Method B as a pale brown solid in 25% yield (123 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.31 (br. s., 1H), 9.62 (s, 1H), 8.44 (d, <i>J</i> = 2.01 Hz, 1H), 8.37 (s, 1H), 8.31 (d, <i>J</i> = 2.26 Hz, 1H), 7.85 (dd, <i>J</i> = 8.91, 2.64 Hz, 1H), 7.54–7.68 (m, 4H), 7.33 (s, 1 H), 2.49 (d, <i>J</i> = 4.77 Hz, 3H). MS (<i>m</i>/<i>z</i>) 475.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 3-({6-[(5-Chloro-2-pyridinyl)amino]-4-pyrimidinyl}amino)-<i>N</i>-methyl-4-[(2,2,2-trifluoroethyl)oxy]benzenesulfonamide Trifluoroacetate (<b>41</b>)</h4><div class="NLM_p last">Compound <b>41</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methyl-4-[(2,2,2-trifluoroethyl)oxy]benzenesulfonamide and 5-chloro-2-pyridinamine using Method B as a pale yellow solid in 12% yield (49 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.49 (br. s., 1H), 9.47 (br. s., 1H), 8.38 (s, 1H), 8.31 (d, <i>J</i> = 2.51 Hz, 1H), 8.01 (d, <i>J</i> = 2.01 Hz, 1H), 7.87 (dd, <i>J</i> = 8.91, 2.64 Hz, 1H), 7.62 (dd, <i>J</i> = 8.66, 2.13 Hz, 1H), 7.49 (d, <i>J</i> = 8.78 Hz, 1H), 7.42–7.47 (m, 2H), 7.05 (br. s., 1H), 4.92 (q, <i>J</i> = 8.78 Hz, 2H), 2.44 (d, <i>J</i> = 5.02 Hz, 3H). MS (<i>m</i>/<i>z</i>) 489.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 3-({6-[(5-Chloro-2-pyridinyl)amino]-4-pyrimidinyl}amino)-<i>N</i>-methyl-4-(methylsulfonyl)benzenesulfonamide (<b>42</b>)</h4><div class="NLM_p last">Compound <b>42</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methyl-4-(methylsulfonyl)benzenesulfonamide and 5-chloro-2-pyridinamine using Method B as an off-white solid in 11% yield (36 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.26 (s, 1H), 9.08–9.10 (m, 1H), 8.45–8.48 (m, 1H), 8.38–8.40 (m, 1H), 8.31–8.34 (m, 1H), 8.12 (d, <i>J</i> = 8.28 Hz, 1H), 7.84 (dd, <i>J</i> = 2.76, 9.03 Hz, 1H), 7.80 (q, <i>J</i> = 4.52 Hz, 1H), 7.68 (dd, <i>J</i> = 1.76, 8.28 Hz, 1H), 7.61 (d, <i>J</i> = 9.03 Hz, 1H), 7.42 (s, 1H), 3.33 (s, 3H), 2.50 (d, 3H, obscured by solvent). MS (<i>m</i>/<i>z</i>) 469.0 (M + H<sup>+</sup>).</div></div><div id="sec5_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3-({6-[(5-chloro-2-pyridinyl)amino]-4-pyrimidinyl}amino)-4-(ethylsulfonyl)-<i>N</i>-methylbenzenesulfonamide <i>p</i>-Toluenesulfonate Monohydrate (<b>43</b>)</h4><div class="NLM_p last">A mixture of 3-[(6-chloro-4-pyrimidinyl)amino]-4-(ethylsulfonyl)-<i>N</i>-methylbenzenesulfonamide (1.5 g, 3.84 mmol), 5-chloro-2-pyridinamine (0.99 g, 7.68 mmol), Cs<sub>2</sub>CO<sub>3</sub> (3.75 g, 11.5 mmol), BINAP (0.096 g, 0.154 mmol), and Pd(OAc)<sub>2</sub> (0.034 g, 0.154 mmol) in 1,4-dioxane (6.4 mL) was treated with a few drops of DMF (to solubilize the reagents) and subjected to microwave irradiation (150 °C) for 30 min before being cooled to room temperature and filtered. This procedure was repeated nine times, and the filtrates from all reactions were combined and concentrated. The residue was suspended in CH<sub>2</sub>Cl<sub>2</sub>, and the resulting solid was collected by filtration, triturated in MeOH (3 × 50 mL), triturated in acetone (3 × 50 mL), and then collected and dried to give <b>43</b> as a crystalline free base (7.8 g, 42% yield). The resulting crystalline free base product was converted to the <i>p</i>-TsOH salt as this produced an amorphous form that maximized oral bioavailability for <i>in vivo</i> studies. Thus, 2 g of crystalline free base was suspended in ∼50 mL of MeCN/MeOH (2:1) and treated with <i>p</i>-TsOH-H<sub>2</sub>O (796 mg, 1 equiv), and the resulting solution was heated at 60 °C for 15 min to give a clear solution. The solution was concentrated, the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, and the resulting solution was concentrated to give the amorphous salt. This process was repeated in multiple 1–2 g batches for the remaining material, and the batches were combined and mixed by mortar and pestle to give the <i>p</i>-TsOH salt of <b>43</b> as a pale yellow solid (8.16 g, 77%): <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.67 (br. s., 1H, C6-aniline-NH), 9.58 (br. s., 1H, C4-aniline-NH), 8.47 (s, 1H, pyrimidine C2–H), 8.29–8.38 (m, 2H, pyridine C6–H, benzenesulfonamide C2–H), 8.14 (d, <i>J</i> = 8.31 Hz, 1H, benzenesulfonamide C5–H), 7.91 (dd, <i>J</i> = 2.32, 8.93 Hz, 1H, pyridine C4–H), 7.77–7.85 (m, 2H, sulfonamide-NH, benzenesulfonamide C6–H), 7.45–7.53 (m, 3H, pyridine C3–H, <i>p</i>-TsOH–C2-H/C6-H), 7.23 (br. s., 1H, pyrimidine C5–H), 7.12 (d, <i>J</i> = 7.83 Hz, 2H. <i>p</i>-TsOH–C3-H/C5-H), 3.41 (q, <i>J</i> = 7.34 Hz, 2H, SO<sub>2</sub><i>CH</i><sub>2</sub>CH<sub>3</sub>), 2.49–2.51 (m, 3H, SO<sub>2</sub>NH<i>CH</i><sub>3</sub>), 2.30 (s, 3H, p-TsOH-<i>CH</i><sub>3</sub>), 1.11 (t, <i>J</i> = 7.34 Hz, 3H, SO<sub>2</sub>CH<sub>2</sub><i>CH</i><sub>3</sub>). <sup>13</sup>C NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 155.5 (pyrimidine-C2), 152.73 (pyridine-C2), 146.60 (<i>p</i>-TsOH-C1), 146.24 (pyridine-C6), 145.89 (benzenesulfonamide-C3), 139.00 (benzenesulfonamide-C1), 138.60 (pyridine-C4), 138.45 (<i>p</i>-TsOH-C4), 132.70 (benzenesulfonamide-C5), 128.92 (<i>p</i>-TsOH-C3/C5), 126.36 (<i>p</i>-TsOH-C2/C6), 125.5 (benzenesulfonamide-C2), 124.67 (pyridine-C5), 124.0 (benzenesulfonamide-C6), 115.49 (pyridine-C3), 92.0 (pyrimidine-C5), 49.77 (SO<sub>2</sub><i>CH</i><sub>2</sub>CH<sub>3</sub>), 29.57 (SO<sub>2</sub>NH<i>CH</i><sub>3</sub>), 21.66 (p-TsOH-<i>CH</i><sub>3</sub>), 7.74 (SO<sub>2</sub>CH<sub>2</sub><i>CH</i><sub>3</sub>). <sup>1</sup>H and <sup>13</sup>C NMR resonances were assigned based on gCOSY45, gHMQC, gHMBC, and <sup>13</sup>C gaspe spectra. Anal. Calcd (C<sub>18</sub>H<sub>19</sub>ClN<sub>6</sub>O<sub>4</sub>S<sub>2</sub>–C<sub>7</sub>H<sub>8</sub>O<sub>3</sub>S–H<sub>2</sub>O): C, 44.61; H, 4.34; N, 12.48. Found: C, 44.75; H, 4.06; N. 12.35. HRMS (C<sub>18</sub>H<sub>19</sub>ClN<sub>6</sub>O<sub>4</sub>S<sub>2</sub>) [M + H]<sup>+</sup> found <i>m</i>/<i>z</i> 483.0676, calcd 483.0676.</div></div><div id="sec5_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-[6-(5-Chloro-pyridin-2-ylamino)-pyrimidin-4-ylamino]-<i>N</i>-methyl-4-(propane-2-sulfonyl)-benzenesulfonamide (<b>44</b>)</h4><div class="NLM_p last">Compound <b>44</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-<i>N</i>-methyl-4-[(1-methylethyl)sulfonyl]benzenesulfonamide and 5-chloro-2-pyridinamine using Method B as a white solid in 40% yield (49 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.49 (br. s., 1H), 9.36 (br. s., 1H), 8.41 (s, 1H), 8.39 (d, <i>J</i> = 1.54 Hz, 1H), 8.30 (d, <i>J</i> = 2.65 Hz, 1H), 8.06 (d, <i>J</i> = 8.38 Hz, 1H), 7.84 (dd, <i>J</i> = 2.65, 8.82 Hz, 1H), 7.78 (q, 1H), 7.69 (dd, <i>J</i> = 1.65, 8.27 Hz, 1H), 7.52 (d, <i>J</i> = 8.82 Hz, 1H), 7.28 (s, 1H), 3.45–3.54 (m, 1H), 2.47 (d, 3H, obscured by solvent), 1.14 (d, <i>J</i> = 6.62 Hz, 6H). MS (<i>m</i>/<i>z</i>) 496.9 (M + H<sup>+</sup>).</div></div><div id="sec5_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-(<i>tert</i>-Butylsulfonyl)-3-(6-(5-chloropyridin-2-ylamino)pyrimidin-4-ylamino)-<i>N</i>-methylbenzenesulfonamide Trifluoroacetate (<b>45</b>)</h4><div class="NLM_p last">Compound <b>45</b> was prepared from 3-[(6-chloro-4-pyrimidinyl)amino]-4-[(1,1-dimethylethyl)sulfonyl]-<i>N</i>-methylbenzenesulfonamide and 5-chloro-2-pyridinamine using Method B as a pale yellow solid in 50% yield (61 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.27 (s, 1H), 9.28 (s, 1H), 8.61 (d, <i>J</i> = 1.54 Hz, 1H), 8.40 (s, 1H), 8.32 (d, <i>J</i> = 2.43 Hz, 1H), 7.98 (d, <i>J</i> = 8.38 Hz, 1H), 7.76–7.83 (m, 2H), 7.55–7.60 (m, 2H), 7.40 (s, 1H), 2.47 (d, 3H, obscured by solvent), 1.22 (s, 9H). MS (<i>m</i>/<i>z</i>) 511.2 (M + H<sup>+</sup>).</div></div></div><div id="sec5_3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Computational Modeling</h3><div class="NLM_p">The crystal structure of <b>4</b> bound to TNNI3K (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J">6B5J</a>) reported in this article was used to model the binding of compounds <b>3</b>, <b>37</b>, and <b>43</b> to TNNI3K. The crystal structure PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I23">4I23</a> was used to model the binding of <b>3</b> to EGFR, and the crystal structure PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YHT">4YHT</a> was used to model the binding of <b>37</b> and <b>43</b> to B-raf. All computational modeling was performed using Maestro from Schrödinger Release 2017–1 (Schrödinger, LLC, New York, 2017). Protein structures were prepared using the Protein Preparation Wizard using default parameters. Protons were added, water orientations were sampled, and hydrogen bond assignments were optimized. Final hydrogen orientations were optimized by performing a restrained minimization with heavy atoms kept fixed.</div><div class="NLM_p">Receptor grids to be used as inputs for Glide were generated around the crystallized ligands in the respective protein structures. Hydrogen bond constraints were defined for the backbone carbonyl and NH of the hinge residue in TNNI3K (Ile542), EGFR (Met793), and B-raf (Cys531). The crystallographic water molecule that is observed to make hydrogen bond interactions with the sulfonyl oxygen of the crystallized ligand and the protein in the back pocket of TNNI3K and B-raf was included in the receptor grids for those targets.</div><div class="NLM_p">Glide XP was used to dock the ligands into the respective structures using default parameters with the exception that enhanced planarity of conjugated pi groups was enforced. The hydrogen bonding constraints to the hinge residues described above were used to guide the automatic selection of poses. Postdocking minimization was performed with strain correction terms applied. Glide XP scores and visual inspection were used to select reported poses for <b>3</b>, <b>37</b>, and <b>43</b> bound to TNNI3K and <b>37</b> and <b>43</b> bound to B-raf.</div><div class="NLM_p">Given that compound <b>3</b> is relatively different from the compound crystallized to EGFR and those crystallized to TNNI3K and B-raf, the resultant Glide XP poses of <b>3</b> bound to EGFR were further optimized with Prime MM-GBSA using the VSGB solvation model and OPLS3 force field. Ligand poses from Glide XP and receptor residues within 5 Å of these poses were minimized to relieve steric clashes. Prime MM-GBSA scores and visual inspection were used to select the final pose of <b>3</b> bound to EGFR.</div><div class="NLM_p last">All structure figures were generated with PyMOL version 1.8.6.0 (Schrödinger, LLC, New York, 2017).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00125" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00125" class="ext-link">10.1021/acs.jmedchem.8b00125</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Kinase selectivity results for <b>3</b>, <b>33</b>, and <b>43</b>, table of statistics for X-ray crystal structures and tabulated data used to generate <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Coordinates for docking models of compound <b>3</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_002.pdb" class="ext-link">PDB</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_003.pdb" class="ext-link">PDB</a>), compound <b>37</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_004.pdb" class="ext-link">PDB</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_005.pdb" class="ext-link">PDB</a>), and compound <b>43</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_006.pdb" class="ext-link">PDB</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_007.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">SMILES representation of compounds with key data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_008.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_001.pdf">jm8b00125_si_001.pdf (750.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_002.pdb">jm8b00125_si_002.pdb (165.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_003.pdb">jm8b00125_si_003.pdb (196.63 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_004.pdb">jm8b00125_si_004.pdb (166.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_005.pdb">jm8b00125_si_005.pdb (168.28 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_006.pdb">jm8b00125_si_006.pdb (166.36 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_007.pdb">jm8b00125_si_007.pdb (168.52 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_008.csv">jm8b00125_si_008.csv (2.68 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J">6B5J</a> (TNNI3K-<b>4</b>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00125" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian G. Lawhorn</span> - <span class="hlFld-Affiliation affiliation">Heart Failure Discovery Performance Unit and , GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4618-5314" title="Orcid link">http://orcid.org/0000-0003-4618-5314</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#94f6e6fdf5fabaa6baf8f5e3fcfbe6fad4f3e7ffbaf7fbf9"><span class="__cf_email__" data-cfemail="f496869d959adac6da9895839c9b869ab493879fda979b99">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanne Philp</span> - <span class="hlFld-Affiliation affiliation">Heart Failure Discovery Performance Unit and , GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan P. Graves</span> - <span class="hlFld-Affiliation affiliation">Platform Technology
and Sciences and , GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Shewchuk</span> - <span class="hlFld-Affiliation affiliation">Platform Technology
and Sciences and , GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katrina L. Rivera</span> - <span class="hlFld-Affiliation affiliation">Heart Failure Discovery Performance Unit and , GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Larry J. Jolivette</span> - <span class="hlFld-Affiliation affiliation">Heart Failure Discovery Performance Unit and , GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis A. Holt</span> - <span class="hlFld-Affiliation affiliation">Heart Failure Discovery Performance Unit and , GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory J. Gatto</span> - <span class="hlFld-Affiliation affiliation">Heart Failure Discovery Performance Unit and , GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lara S. Kallander</span> - <span class="hlFld-Affiliation affiliation">Heart Failure Discovery Performance Unit and , GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Authors affiliated with GlaxoSmithKline have received compensation in the form of salary and stock.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4951-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67472" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67472" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge Steve Zhao and Claire Jarvis for synthesis of <b>9</b>, <b>31</b>, and <b>32</b> and Nathan Gaul, Evanson Agyeman, Peter Caprioli, Michael Shaber, Joi Brown, Brian Dombroski, Mehul Patel, and Laurie Carson for conducting the TNNI3K and B-Raf assays.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">TNNI3K</td><td class="NLM_def"><p class="first last">troponin I-interacting kinase</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">DNAUC</td><td class="NLM_def"><p class="first last">dose-normalized area under the curve</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">iv clearance</p></td></tr><tr><td class="NLM_term">F</td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">Vdss</td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">μwave</td><td class="NLM_def"><p class="first last">microwave</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">Fu</td><td class="NLM_def"><p class="first last">fraction unbound as percent</p></td></tr><tr><td class="NLM_term">Xantphos</td><td class="NLM_def"><p class="first last">4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene</p></td></tr><tr><td class="NLM_term">dba</td><td class="NLM_def"><p class="first last">dibenzylideneacetone</p></td></tr><tr><td class="NLM_term">BINAP</td><td class="NLM_def"><p class="first last">2,2′-Bis(diphenylphosphino)-1,1′-binaphthyl</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J. F.</span></span> <span> </span><span class="NLM_article-title">Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I</span>. <i>J. Mol. Med. (Heidelberg, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1007/s00109-003-0427-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1007%2Fs00109-003-0427-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=12721663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVSltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2003&pages=297-304&author=Y.+Zhaoauthor=X.+M.+Mengauthor=Y.+J.+Weiauthor=X.+W.+Zhaoauthor=D.+Q.+Liuauthor=H.+Q.+Caoauthor=C.+C.+Liewauthor=J.+F.+Ding&title=Cloning+and+characterization+of+a+novel+cardiac-specific+kinase+that+interacts+specifically+with+cardiac+troponin+I&doi=10.1007%2Fs00109-003-0427-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I</span></div><div class="casAuthors">Zhao, Yong; Meng, Xian-Min; Wei, Ying-Jie; Zhao, Xiu-Wen; Liu, Dong-Qing; Cao, Hui-Qing; Liew, Choong-Chin; Ding, Jin-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">297-304</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Cardiac-restricted genes play important roles in cardiovascular system.  In an effort to identify such novel genes we identified a novel cardiac-specific kinase gene TNNI3K localized on 1p31.1 based on bioinformatics analyses.  Sequence anal. suggested that TNNI3K is a distant family member of integrin-linked kinase.  Northern blot and 76-tissue array analyses showed that TNNI3K is highly expressed in heart, but is undetectable in other tissues.  Immunohistochem. anal. predominantly localized TNNI3K in the nucleus of cardiac myocytes.  In vitro kinase assay showed that TNNI3K is a functional kinase.  The yeast two-hybrid system showed that TNNI3K could directly interact with cardiac troponin I, results that were further confirmed by coimmunopptn. in vivo.  Our data suggest that TNNI3K is a cardiac-specific kinase and play important roles in cardiac system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk9NEF_6MNsLVg90H21EOLACvtfcHk0lj7RWJViYTfRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVSltrg%253D&md5=06ab8b91ae88c4facda43e99a91db288</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs00109-003-0427-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-003-0427-x%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DX.%2BM.%26aulast%3DWei%26aufirst%3DY.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%2BW.%26aulast%3DLiu%26aufirst%3DD.%2BQ.%26aulast%3DCao%26aufirst%3DH.%2BQ.%26aulast%3DLiew%26aufirst%3DC.%2BC.%26aulast%3DDing%26aufirst%3DJ.%2BF.%26atitle%3DCloning%2520and%2520characterization%2520of%2520a%2520novel%2520cardiac-specific%2520kinase%2520that%2520interacts%2520specifically%2520with%2520cardiac%2520troponin%2520I%26jtitle%3DJ.%2520Mol.%2520Med.%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2003%26volume%3D81%26spage%3D297%26epage%3D304%26doi%3D10.1007%2Fs00109-003-0427-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Force, T.</span></span> <span> </span><span class="NLM_article-title">Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease</span>. <i>Circ. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1514</span>– <span class="NLM_lpage">1519</span>, <span class="refDoi"> DOI: 10.1253/circj.CJ-14-0543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1253%2Fcircj.CJ-14-0543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=24899531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlClsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2014&pages=1514-1519&author=H.+Lalauthor=F.+Ahmadauthor=S.+Parikhauthor=T.+Force&title=Troponin+I-interacting+protein+kinase%3A+a+novel+cardiac-specific+kinase%2C+emerging+as+a+molecular+target+for+the+treatment+of+cardiac+disease&doi=10.1253%2Fcircj.CJ-14-0543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease</span></div><div class="casAuthors">Lal, Hind; Ahmad, Firdos; Parikh, Shan; Force, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1514-1519</span>CODEN:
                <span class="NLM_cas:coden">CJIOBY</span>;
        ISSN:<span class="NLM_cas:issn">1346-9843</span>.
    
            (<span class="NLM_cas:orgname">Japanese Circulation Society</span>)
        </div><div class="casAbstract">A review.  Coronary artery disease is the leading cause of death and disability worldwide.  In patients with acute coronary syndromes, timely and effective myocardial reperfusion by percutaneous coronary intervention is the primary treatment of choice to minimize the ischemic injury and limit the size of the myocardial infarction (MI).  However, reperfusion can itself promote cardiomyocyte death, which leads to cardiac dysfunction via reperfusion injury.  The mol. mechanisms of ischemia-reperfusion (IR) injury are not completely understood and new drug targets are needed.  Recently, we reported that cardiac troponin I-interacting protein kinase (TNNI3K), a cardiomyocyte-specific kinase, promotes IR injury via profound oxidative stress, thereby promoting cardiomyocyte death.  By using novel genetic animal models and newly developed small-mol. TNNI3K inhibitors, we demonstrated that TNNI3K-mediated IR injury occurs through impaired mitochondrial function and is in part dependent on p38 MAPK.  Here we discuss the emerging role of TNNI3K as a promising new drug target to limit IR-induced myocardial injury.  We will also examine the underlying mechanisms that drive the profoundly reduced infarct size in mice in which TNNI3K is specifically deleted in cardiomyocytes.  Because TNNI3K is a cardiac-specific kinase, it could be an ideal mol. target, as inhibiting it would have little or no effect on other organ systems, a serious problem assocd. with the use of kinase inhibitors targeting kinases that are more widely expressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN5Bkqoa_-_bVg90H21EOLACvtfcHk0lgho0XzkOARWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlClsL3N&md5=b54f2c64110df79e4c992b111d43d3ce</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1253%2Fcircj.CJ-14-0543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1253%252Fcircj.CJ-14-0543%26sid%3Dliteratum%253Aachs%26aulast%3DLal%26aufirst%3DH.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DParikh%26aufirst%3DS.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DTroponin%2520I-interacting%2520protein%2520kinase%253A%2520a%2520novel%2520cardiac-specific%2520kinase%252C%2520emerging%2520as%2520a%2520molecular%2520target%2520for%2520the%2520treatment%2520of%2520cardiac%2520disease%26jtitle%3DCirc.%2520J.%26date%3D2014%26volume%3D78%26spage%3D1514%26epage%3D1519%26doi%3D10.1253%2Fcircj.CJ-14-0543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodder, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezzina, C. R.</span></span> <span> </span><span class="NLM_article-title">TNNI3K in cardiovascular disease and prospects for therapy</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.yjmcc.2015.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.yjmcc.2015.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=25787061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1artbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2015&pages=167-173&author=A.+Milanoauthor=E.+M.+Lodderauthor=C.+R.+Bezzina&title=TNNI3K+in+cardiovascular+disease+and+prospects+for+therapy&doi=10.1016%2Fj.yjmcc.2015.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">TNNI3K in cardiovascular disease and prospects for therapy</span></div><div class="casAuthors">Milano, Annalisa; Lodder, Elisabeth. M.; Bezzina, Connie. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">167-173</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cardiovascular diseases are an important cause of morbidity and mortality worldwide and the global burden of these diseases continues to grow.  Therefore new therapies are urgently needed.  The role of protein kinases in disease, including cardiac disease, is long recognized, making kinases important therapeutic targets.  We here review the knowledge gathered in the last decade about troponin I-interacting kinase (TNNI3K), a kinase with cardiac-restricted expression that has been implicated in various cardiac phenotypes and diseases including heart failure, cardiomyopathy, ischemia/reperfusion injury and conduction of the cardiac elec. impulse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC_UKVV9Il77Vg90H21EOLACvtfcHk0lgho0XzkOARWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1artbc%253D&md5=c3f321c61c9d2714238c58dfa8c1443d</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2015.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2015.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DMilano%26aufirst%3DA.%26aulast%3DLodder%26aufirst%3DE.%2BM.%26aulast%3DBezzina%26aufirst%3DC.%2BR.%26atitle%3DTNNI3K%2520in%2520cardiovascular%2520disease%2520and%2520prospects%2520for%2520therapy%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2015%26volume%3D82%26spage%3D167%26epage%3D173%26doi%3D10.1016%2Fj.yjmcc.2015.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadnott, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchuk, D. A.</span></span> <span> </span><span class="NLM_article-title"><i>Tnni3k</i> modifies disease progression in murine models of cardiomyopathy</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1000647</span>, <span class="refDoi"> DOI: 10.1371/journal.pgen.1000647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1371%2Fjournal.pgen.1000647" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000647&author=F.+C.+Wheelerauthor=H.+Tangauthor=O.+A.+Marksauthor=T.+N.+Hadnottauthor=P.+L.+Chuauthor=L.+Maoauthor=H.+A.+Rockmanauthor=D.+A.+Marchuk&title=Tnni3k+modifies+disease+progression+in+murine+models+of+cardiomyopathy&doi=10.1371%2Fjournal.pgen.1000647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1000647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1000647%26sid%3Dliteratum%253Aachs%26aulast%3DWheeler%26aufirst%3DF.%2BC.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DMarks%26aufirst%3DO.%2BA.%26aulast%3DHadnott%26aufirst%3DT.%2BN.%26aulast%3DChu%26aufirst%3DP.%2BL.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DMarchuk%26aufirst%3DD.%2BA.%26atitle%3DTnni3k%2520modifies%2520disease%2520progression%2520in%2520murine%2520models%2520of%2520cardiomyopathy%26jtitle%3DPLoS%2520Genet.%26date%3D2009%26volume%3D5%26spage%3De1000647%26doi%3D10.1371%2Fjournal.pgen.1000647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchuk, D. A.</span></span> <span> </span><span class="NLM_article-title">Overexpression of TNNI3K, a cardiac-specific MAPKKK, promotes cardiac dysfunction</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1016/j.yjmcc.2012.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.yjmcc.2012.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=23085512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsleisb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=101-111&author=H.+Tangauthor=K.+Xiaoauthor=L.+Maoauthor=H.+A.+Rockmanauthor=D.+A.+Marchuk&title=Overexpression+of+TNNI3K%2C+a+cardiac-specific+MAPKKK%2C+promotes+cardiac+dysfunction&doi=10.1016%2Fj.yjmcc.2012.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of TNNI3K, a cardiac-specific MAPKKK, promotes cardiac dysfunction</span></div><div class="casAuthors">Tang, Hao; Xiao, Kunhong; Mao, Lan; Rockman, Howard A.; Marchuk, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-111</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cardiac troponin I-interacting kinase (TNNI3K) is a cardiac-specific kinase whose biol. function remains largely unknown.  We have recently shown that TNNI3K expression greatly accelerates cardiac dysfunction in mouse models of cardiomyopathy, indicating an important role in modulating disease progression.  To further investigate TNNI3K kinase activity in vivo, we have generated transgenic mice expressing both wild-type and kinase-dead versions of the human TNNI3K protein.  Importantly, we show that the increased TNNI3K kinase activity induces mouse cardiac remodeling, and its kinase activity promotes accelerated disease progression in a left-ventricular pressure overload model of mouse cardiomyopathy.  Using an in vitro kinase assay and proteomics anal., we show that TNNI3K is a dual-function kinase with Tyr and Ser/Thr kinase activity.  TNNI3K expression induces a series of cellular and mol. changes, including a redn. of sarcomere length and changes in titin isoform compn., which are indicative of cardiac remodeling.  Using antisera to TNNI3K, we show that TNNI3K protein is located at the sarcomere Z disk.  These combined data suggest that TNNI3K mediates cell signaling to modulate cardiac response to stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouIq5fuR9dGrVg90H21EOLACvtfcHk0lgho0XzkOARWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsleisb7I&md5=718845de3ce0b0a8d59ac6506e62290e</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2012.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2012.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DK.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DMarchuk%26aufirst%3DD.%2BA.%26atitle%3DOverexpression%2520of%2520TNNI3K%252C%2520a%2520cardiac-specific%2520MAPKKK%252C%2520promotes%2520cardiac%2520dysfunction%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2013%26volume%3D54%26spage%3D101%26epage%3D111%26doi%3D10.1016%2Fj.yjmcc.2012.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchuk, D. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the cardiomyocyte-specific troponin I-interacting kinase limits oxidative stress, injury, and adverse remodeling due to ischemic heart disease</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">938</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.113.303238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1161%2FCIRCRESAHA.113.303238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=938-940&author=D.+M.+Abrahamauthor=D.+A.+Marchuk&title=Inhibition+of+the+cardiomyocyte-specific+troponin+I-interacting+kinase+limits+oxidative+stress%2C+injury%2C+and+adverse+remodeling+due+to+ischemic+heart+disease&doi=10.1161%2FCIRCRESAHA.113.303238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.113.303238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.113.303238%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DD.%2BM.%26aulast%3DMarchuk%26aufirst%3DD.%2BA.%26atitle%3DInhibition%2520of%2520the%2520cardiomyocyte-specific%2520troponin%2520I-interacting%2520kinase%2520limits%2520oxidative%2520stress%252C%2520injury%252C%2520and%2520adverse%2520remodeling%2520due%2520to%2520ischemic%2520heart%2520disease%26jtitle%3DCirc.%2520Res.%26date%3D2014%26volume%3D114%26spage%3D938%26epage%3D940%26doi%3D10.1161%2FCIRCRESAHA.113.303238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vagnozzi, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, G. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallilankaraman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, V. L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madesh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Force, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the cardiomyocyte-specific TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">207ra141</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3006479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1126%2Fscitranslmed.3006479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=24132636" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=207ra141&author=R.+J.+Vagnozziauthor=G.+J.+Gattoauthor=L.+S.+Kallanderauthor=N.+E.+Hoffmanauthor=K.+Mallilankaramanauthor=V.+L.+T.+Ballardauthor=B.+G.+Lawhornauthor=P.+Stoyauthor=J.+Philpauthor=A.+P.+Gravesauthor=Y.+Naitoauthor=J.+J.+Leporeauthor=E.+Gaoauthor=M.+Madeshauthor=T.+Force&title=Inhibition+of+the+cardiomyocyte-specific+TNNI3K+limits+oxidative+stress%2C+injury%2C+and+adverse+remodeling+in+the+ischemic+heart&doi=10.1126%2Fscitranslmed.3006479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3006479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3006479%26sid%3Dliteratum%253Aachs%26aulast%3DVagnozzi%26aufirst%3DR.%2BJ.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DKallander%26aufirst%3DL.%2BS.%26aulast%3DHoffman%26aufirst%3DN.%2BE.%26aulast%3DMallilankaraman%26aufirst%3DK.%26aulast%3DBallard%26aufirst%3DV.%2BL.%2BT.%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DStoy%26aufirst%3DP.%26aulast%3DPhilp%26aufirst%3DJ.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DNaito%26aufirst%3DY.%26aulast%3DLepore%26aufirst%3DJ.%2BJ.%26aulast%3DGao%26aufirst%3DE.%26aulast%3DMadesh%26aufirst%3DM.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520the%2520cardiomyocyte-specific%2520TNNI3K%2520limits%2520oxidative%2520stress%252C%2520injury%252C%2520and%2520adverse%2520remodeling%2520in%2520the%2520ischemic%2520heart%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D207ra141%26doi%3D10.1126%2Fscitranslmed.3006479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mudd, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span> <span> </span><span class="NLM_article-title">Tackling heart failure in the twenty-first century</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>451</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">928</span>, <span class="refDoi"> DOI: 10.1038/nature06798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1038%2Fnature06798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=18288181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD1cXit1ynsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2008&pages=919-928&author=J.+O.+Muddauthor=D.+A.+Kass&title=Tackling+heart+failure+in+the+twenty-first+century&doi=10.1038%2Fnature06798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tackling heart failure in the twenty-first century</span></div><div class="casAuthors">Mudd, James O.; Kass, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">451</span>
        (<span class="NLM_cas:issue">7181</span>),
    <span class="NLM_cas:pages">919-928</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Heart failure, or congestive heart failure, is a condition in which the heart cannot supply the body's tissues with enough blood.  The result is a cascade of changes that lead to severe fatigue, breathlessness and, ultimately, death.  In the past quarter century, much progress has been made in understanding the mol. and cellular processes that contribute to heart failure, leading to the development of effective therapies.  Despite this, chronic heart failure remains a major cause of illness and death.  And because the condition becomes more common with increasing age, the no. of affected individuals is rising with the rapidly aging global population.  New treatments that target disease mechanisms at the cellular and whole-organ level are needed to halt and reverse the devastating consequences of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWp3zLwVK0GbVg90H21EOLACvtfcHk0lite2K9k_4d8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXit1ynsb0%253D&md5=73e8de69e1b3126a9efb721b90884fa4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature06798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06798%26sid%3Dliteratum%253Aachs%26aulast%3DMudd%26aufirst%3DJ.%2BO.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DTackling%2520heart%2520failure%2520in%2520the%2520twenty-first%2520century%26jtitle%3DNature%26date%3D2008%26volume%3D451%26spage%3D919%26epage%3D928%26doi%3D10.1038%2Fnature06798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krum, H.</span></span> <span> </span><span class="NLM_article-title">Drug discovery for heart failure: a new era or the end of the pipeline?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1038/nrd2219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1038%2Fnrd2219" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=127-139&author=D.+M.+Kayeauthor=H.+Krum&title=Drug+discovery+for+heart+failure%3A+a+new+era+or+the+end+of+the+pipeline%3F&doi=10.1038%2Fnrd2219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd2219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2219%26sid%3Dliteratum%253Aachs%26aulast%3DKaye%26aufirst%3DD.%2BM.%26aulast%3DKrum%26aufirst%3DH.%26atitle%3DDrug%2520discovery%2520for%2520heart%2520failure%253A%2520a%2520new%2520era%2520or%2520the%2520end%2520of%2520the%2520pipeline%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D127%26epage%3D139%26doi%3D10.1038%2Fnrd2219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boloor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis-Ward, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epperly, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkle, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, R. N.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knick, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudeman, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczyk, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truesdale, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-[[4-[(2,3-dimethyl-2<i>H</i>-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4632</span>– <span class="NLM_lpage">4640</span>, <span class="refDoi"> DOI: 10.1021/jm800566m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800566m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVGrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4632-4640&author=P.+A.+Harrisauthor=A.+Boloorauthor=M.+Cheungauthor=R.+Kumarauthor=R.+M.+Crosbyauthor=R.+G.+Davis-Wardauthor=A.+H.+Epperlyauthor=K.+W.+Hinkleauthor=R.+N.+Hunterauthor=J.+H.+Johnsonauthor=V.+B.+Knickauthor=C.+P.+Laudemanauthor=D.+K.+Luttrellauthor=R.+A.+Mookauthor=R.+T.+Nolteauthor=S.+K.+Rudolphauthor=J.+R.+Szewczykauthor=A.+T.+Truesdaleauthor=J.+M.+Vealauthor=L.+Wangauthor=J.+A.+Stafford&title=Discovery+of+5-%5B%5B4-%5B%282%2C3-dimethyl-2H-indazol-6-yl%29methylamino%5D-2-pyrimidinyl%5Damino%5D-2-methyl-benzenesulfonamide+%28pazopanib%29%2C+a+novel+and+potent+vascular+endothelial+growth+factor+receptor+inhibitor&doi=10.1021%2Fjm800566m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor</span></div><div class="casAuthors">Harris, Philip A.; Boloor, Amogh; Cheung, Mui; Kumar, Rakesh; Crosby, Renae M.; Davis-Ward, Ronda G.; Epperly, Andrea H.; Hinkle, Kevin W.; Hunter, Robert N., III; Johnson, Jennifer H.; Knick, Victoria B.; Laudeman, Christopher P.; Luttrell, Deirdre K.; Mook, Robert A.; Nolte, Robert T.; Rudolph, Sharon K.; Szewczyk, Jerzy R.; Truesdale, Anne T.; Veal, James M.; Wang, Liping; Stafford, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4632-4640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the vascular endothelial growth factor (VEGF) signaling pathway has emerged as one of the most promising new approaches for cancer therapy.  We describe herein the key steps starting from an initial screening hit leading to the discovery of pazopanib, N4-(2,3-dimethyl-2H-indazol-6-yl)-N4-methyl-N2-(4-methyl-3-sulfonamidophenyl)-2,4-pyrimidinediamine, a potent pan-VEGF receptor (VEGFR) inhibitor under clin. development for renal-cell cancer and other solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIb4UT-IbEi7Vg90H21EOLACvtfcHk0lgyAl0iKlLDdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVGrtL4%253D&md5=a8737a6e003a3f6002575b4b96712fc9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm800566m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800566m%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBoloor%26aufirst%3DA.%26aulast%3DCheung%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DDavis-Ward%26aufirst%3DR.%2BG.%26aulast%3DEpperly%26aufirst%3DA.%2BH.%26aulast%3DHinkle%26aufirst%3DK.%2BW.%26aulast%3DHunter%26aufirst%3DR.%2BN.%26aulast%3DJohnson%26aufirst%3DJ.%2BH.%26aulast%3DKnick%26aufirst%3DV.%2BB.%26aulast%3DLaudeman%26aufirst%3DC.%2BP.%26aulast%3DLuttrell%26aufirst%3DD.%2BK.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DRudolph%26aufirst%3DS.%2BK.%26aulast%3DSzewczyk%26aufirst%3DJ.%2BR.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%25205-%255B%255B4-%255B%25282%252C3-dimethyl-2H-indazol-6-yl%2529methylamino%255D-2-pyrimidinyl%255Damino%255D-2-methyl-benzenesulfonamide%2520%2528pazopanib%2529%252C%2520a%2520novel%2520and%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4632%26epage%3D4640%26doi%3D10.1021%2Fjm800566m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ung, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulford, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Autry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berliner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzzio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaGreca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marr, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1935</span>– <span class="NLM_lpage">1944</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-5155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1158%2F0008-5472.CAN-07-5155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=18339875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFOhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1935-1944&author=W.+G.+Robertsauthor=E.+Ungauthor=P.+Whalenauthor=B.+Cooperauthor=C.+Hulfordauthor=C.+Autryauthor=D.+Richterauthor=E.+Emersonauthor=J.+Linauthor=J.+Kathauthor=K.+Colemanauthor=L.+Yaoauthor=L.+Martinez-Alsinaauthor=M.+Lorenzenauthor=M.+Berlinerauthor=M.+Luzzioauthor=N.+Patelauthor=E.+Schmittauthor=S.+LaGrecaauthor=J.+Janiauthor=M.+Wesselauthor=E.+Marrauthor=M.+Grifforauthor=F.+Vajdos&title=Antitumor+activity+and+pharmacology+of+a+selective+focal+adhesion+kinase+inhibitor%2C+PF-562%2C271&doi=10.1158%2F0008-5472.CAN-07-5155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271</span></div><div class="casAuthors">Roberts, Walter Gregory; Ung, Ethan; Whalen, Pamela; Cooper, Beth; Hulford, Catherine; Autry, Christofer; Richter, Daniel; Emerson, Earling; Lin, Jing; Kath, John; Coleman, Kevin; Yao, Lili; Martinez-Alsina, Luis; Lorenzen, Marianne; Berliner, Martin; Luzzio, Michael; Patel, Nandini; Schmitt, Erika; LaGreca, Susan; Jani, Jitesh; Wessel, Matt; Marr, Eric; Griffor, Matt; Vajdos, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1935-1944</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cancer cells are characterized by the ability to grow in an anchorage-independent manner.  The activity of the nonreceptor tyrosine kinase, focal adhesion kinase (FAK), is thought to contribute to this phenotype.  FAK localizes in focal adhesion plaques and has a role as a scaffolding and signaling protein for other adhesion mols.  Recent studies show a strong correlation between increased FAK expression and phosphorylation status and the invasive phenotype of aggressive human tumors.  PF-562,271 is a potent, ATP-competitive, reversible inhibitor of FAK and Pyk2 catalytic activity with a IC50 of 1.5 and 14 nmol/L, resp.  Addnl., PF-562,271 displayed robust inhibition in an inducible cell-based assay measuring phospho-FAK with an IC50 of 5 nmol/L.  PF-562,271 was evaluated against multiple kinases and displays >100x selectivity against a long list of nontarget kinases.  PF-562,271 inhibits FAK phosphorylation in vivo in a dose-dependent fashion (calcd. EC50 of 93 ng/mL, total) after p.o. administration to tumor-bearing mice.  In vivo inhibition of FAK phosphorylation (>50%) was sustained for >4 h with a single p.o. dose of 33 mg/kg.  Antitumor efficacy and regressions were obsd. in multiple human s.c. xenograft models.  No wt. loss, morbidity, or mortality were obsd. in any in vivo expt.  Tumor growth inhibition was dose and drug exposure dependent.  Taken together, these data show that kinase inhibition with an ATP-competitive small mol. inhibitor of FAK decreases the phospho-status in vivo, resulting in robust antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofV3TtMU2E07Vg90H21EOLACvtfcHk0lgyAl0iKlLDdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFOhtrw%253D&md5=a5dad7cd49e32a9904de14fb34939be5</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-5155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-5155%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DUng%26aufirst%3DE.%26aulast%3DWhalen%26aufirst%3DP.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DHulford%26aufirst%3DC.%26aulast%3DAutry%26aufirst%3DC.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DEmerson%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DKath%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DLorenzen%26aufirst%3DM.%26aulast%3DBerliner%26aufirst%3DM.%26aulast%3DLuzzio%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DSchmitt%26aufirst%3DE.%26aulast%3DLaGreca%26aufirst%3DS.%26aulast%3DJani%26aufirst%3DJ.%26aulast%3DWessel%26aufirst%3DM.%26aulast%3DMarr%26aufirst%3DE.%26aulast%3DGriffor%26aufirst%3DM.%26aulast%3DVajdos%26aufirst%3DF.%26atitle%3DAntitumor%2520activity%2520and%2520pharmacology%2520of%2520a%2520selective%2520focal%2520adhesion%2520kinase%2520inhibitor%252C%2520PF-562%252C271%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1935%26epage%3D1944%26doi%3D10.1158%2F0008-5472.CAN-07-5155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack-Davis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilghman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, W. G.</span></span> <span> </span><span class="NLM_article-title">Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-07-2220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1158%2F1078-0432.CCR-07-2220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=18245520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFyksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=627-232&author=J.+T.+Parsonsauthor=J.+Slack-Davisauthor=R.+Tilghmanauthor=W.+G.+Roberts&title=Focal+adhesion+kinase%3A+targeting+adhesion+signaling+pathways+for+therapeutic+intervention&doi=10.1158%2F1078-0432.CCR-07-2220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention</span></div><div class="casAuthors">Parsons, J. Thomas; Slack-Davis, Jill; Tilghman, Robert; Roberts, W. Gregory</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">627-632</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The tumor microenvironment plays a central role in cancer progression and metastasis.  Within this environment, cancer cells respond to a host of signals including growth factors and chemotactic factors, as well as signals from adjacent cells, cells in the surrounding stroma, and signals from the extracellular matrix.  Targeting the pathways that mediate many of these signals has been a major goal in the effort to develop therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrevWVNxaWCL7Vg90H21EOLACvtfcHk0lgyAl0iKlLDdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFyksbw%253D&md5=0e9b84c9216582b035ed9abd98b42cda</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-2220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-2220%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26aulast%3DSlack-Davis%26aufirst%3DJ.%26aulast%3DTilghman%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26atitle%3DFocal%2520adhesion%2520kinase%253A%2520targeting%2520adhesion%2520signaling%2520pathways%2520for%2520therapeutic%2520intervention%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D627%26epage%3D232%26doi%3D10.1158%2F1078-0432.CCR-07-2220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Beattie, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breault, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellston, R. P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewsbury, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naven, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minshull, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauptit, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J. E.</span></span> <span> </span><span class="NLM_article-title">Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: identification and optimization of substituted 4,6-bis anilino pyrimidines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2955</span>– <span class="NLM_lpage">2960</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00202-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2FS0960-894X%2803%2900202-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2955-2960&author=J.+F.+Beattieauthor=G.+A.+Breaultauthor=R.+P.+A.+Ellstonauthor=S.+Greenauthor=P.+J.+Jewsburyauthor=C.+J.+Midgleyauthor=R.+T.+Navenauthor=C.+A.+Minshullauthor=R.+A.+Pauptitauthor=J.+A.+Tuckerauthor=J.+E.+Pease&title=Cyclin-dependent+kinase+4+inhibitors+as+a+treatment+for+cancer.+Part+1%3A+identification+and+optimization+of+substituted+4%2C6-bis+anilino+pyrimidines&doi=10.1016%2FS0960-894X%2803%2900202-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900202-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900202-6%26sid%3Dliteratum%253Aachs%26aulast%3DBeattie%26aufirst%3DJ.%2BF.%26aulast%3DBreault%26aufirst%3DG.%2BA.%26aulast%3DEllston%26aufirst%3DR.%2BP.%2BA.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMidgley%26aufirst%3DC.%2BJ.%26aulast%3DNaven%26aufirst%3DR.%2BT.%26aulast%3DMinshull%26aufirst%3DC.%2BA.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26atitle%3DCyclin-dependent%2520kinase%25204%2520inhibitors%2520as%2520a%2520treatment%2520for%2520cancer.%2520Part%25201%253A%2520identification%2520and%2520optimization%2520of%2520substituted%25204%252C6-bis%2520anilino%2520pyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2955%26epage%3D2960%26doi%3D10.1016%2FS0960-894X%2803%2900202-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Breault, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellston, R. P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewsbury, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauptit, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minshull, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J. E.</span></span> <span> </span><span class="NLM_article-title">Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimization of substituted 2,4-bis anilino pyrimidines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2961</span>– <span class="NLM_lpage">2966</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00203-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2FS0960-894X%2803%2900203-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2961-2966&author=G.+A.+Breaultauthor=R.+P.+A.+Ellstonauthor=S.+Greenauthor=S.+R.+Jamesauthor=P.+J.+Jewsburyauthor=C.+J.+Midgleyauthor=R.+A.+Pauptitauthor=C.+A.+Minshullauthor=J.+A.+Tuckerauthor=J.+E.+Pease&title=Cyclin-dependent+kinase+4+inhibitors+as+a+treatment+for+cancer.+Part+2%3A+identification+and+optimization+of+substituted+2%2C4-bis+anilino+pyrimidines&doi=10.1016%2FS0960-894X%2803%2900203-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900203-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900203-8%26sid%3Dliteratum%253Aachs%26aulast%3DBreault%26aufirst%3DG.%2BA.%26aulast%3DEllston%26aufirst%3DR.%2BP.%2BA.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DS.%2BR.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMidgley%26aufirst%3DC.%2BJ.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DMinshull%26aufirst%3DC.%2BA.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26atitle%3DCyclin-dependent%2520kinase%25204%2520inhibitors%2520as%2520a%2520treatment%2520for%2520cancer.%2520Part%25202%253A%2520identification%2520and%2520optimization%2520of%2520substituted%25202%252C4-bis%2520anilino%2520pyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2961%26epage%3D2966%26doi%3D10.1016%2FS0960-894X%2803%2900203-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joazeiro, C. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of EGFR selective 4,6-disubstituted pyrimidines from a combinatorial kinase-directed heterocycle library</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">2182</span>– <span class="NLM_lpage">2183</span>, <span class="refDoi"> DOI: 10.1021/ja0567485</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0567485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=2182-2183&author=Q.+Zhangauthor=Y.+Liuauthor=F.+Gaoauthor=Q.+Dingauthor=C.+Choauthor=W.+Hurauthor=Y.+Jinauthor=T.+Unoauthor=C.+A.+P.+Joazeiroauthor=N.+Gray&title=Discovery+of+EGFR+selective+4%2C6-disubstituted+pyrimidines+from+a+combinatorial+kinase-directed+heterocycle+library&doi=10.1021%2Fja0567485"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fja0567485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0567485%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DCho%26aufirst%3DC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DUno%26aufirst%3DT.%26aulast%3DJoazeiro%26aufirst%3DC.%2BA.%2BP.%26aulast%3DGray%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520EGFR%2520selective%25204%252C6-disubstituted%2520pyrimidines%2520from%2520a%2520combinatorial%2520kinase-directed%2520heterocycle%2520library%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D2182%26epage%3D2183%26doi%3D10.1021%2Fja0567485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adrian, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojciechowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan-Jacob, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Expanding the diversity of allosteric Bcr-Abl inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6934</span>– <span class="NLM_lpage">6946</span>, <span class="refDoi"> DOI: 10.1021/jm100555f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100555f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6934-6946&author=X.+Dengauthor=B.+Okramauthor=Q.+Dingauthor=J.+Zhangauthor=Y.+Choiauthor=F.+J.+Adrianauthor=A.+Wojciechowskiauthor=G.+Zhangauthor=J.+Cheauthor=B.+Bursulayaauthor=S.+W.+Cowan-Jacobauthor=G.+Rummelauthor=T.+Simauthor=N.+S.+Gray&title=Expanding+the+diversity+of+allosteric+Bcr-Abl+inhibitors&doi=10.1021%2Fjm100555f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm100555f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100555f%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DOkram%26aufirst%3DB.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DAdrian%26aufirst%3DF.%2BJ.%26aulast%3DWojciechowski%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DExpanding%2520the%2520diversity%2520of%2520allosteric%2520Bcr-Abl%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6934%26epage%3D6946%26doi%3D10.1021%2Fjm100555f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dancik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinecker, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span> <span> </span><span class="NLM_article-title">Small-molecule screening identifies inhibition of salt-inducible kinses as therapeutic strategy to enhance immunoregulatory functions of dendritic cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12468</span>– <span class="NLM_lpage">12473</span>, <span class="refDoi"> DOI: 10.1073/pnas.1412308111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1073%2Fpnas.1412308111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12468-12473&author=T.+B.+Sundbergauthor=H.+W.+Choiauthor=J.-H.+Songauthor=C.+N.+Russellauthor=M.+M.+Hussainauthor=D.+B.+Grahamauthor=B.+Khorauthor=J.+Gagnonauthor=D.+J.+O%E2%80%99Connellauthor=K.+Narayanauthor=V.+Dancikauthor=J.+R.+Perezauthor=H.-C.+Reineckerauthor=N.+S.+Grayauthor=S.+L.+Schreiberauthor=R.+J.+Xavierauthor=A.+F.+Shamji&title=Small-molecule+screening+identifies+inhibition+of+salt-inducible+kinses+as+therapeutic+strategy+to+enhance+immunoregulatory+functions+of+dendritic+cells&doi=10.1073%2Fpnas.1412308111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1412308111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1412308111%26sid%3Dliteratum%253Aachs%26aulast%3DSundberg%26aufirst%3DT.%2BB.%26aulast%3DChoi%26aufirst%3DH.%2BW.%26aulast%3DSong%26aufirst%3DJ.-H.%26aulast%3DRussell%26aufirst%3DC.%2BN.%26aulast%3DHussain%26aufirst%3DM.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BB.%26aulast%3DKhor%26aufirst%3DB.%26aulast%3DGagnon%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DD.%2BJ.%26aulast%3DNarayan%26aufirst%3DK.%26aulast%3DDancik%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DJ.%2BR.%26aulast%3DReinecker%26aufirst%3DH.-C.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26atitle%3DSmall-molecule%2520screening%2520identifies%2520inhibition%2520of%2520salt-inducible%2520kinses%2520as%2520therapeutic%2520strategy%2520to%2520enhance%2520immunoregulatory%2520functions%2520of%2520dendritic%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D12468%26epage%3D12473%26doi%3D10.1073%2Fpnas.1412308111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latorre, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span> <span> </span><span class="NLM_article-title">Development of chemical probes for investigation of salt-inducible kinase function in vivo</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2105</span>– <span class="NLM_lpage">2111</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00217</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00217" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFaku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2105-2111&author=T.+B.+Sundbergauthor=Y.+Liangauthor=H.+Wuauthor=H.+G.+Choiauthor=N.+D.+Kimauthor=T.+Simauthor=L.+Johannessenauthor=A.+Petroneauthor=B.+Khorauthor=D.+B.+Grahamauthor=I.+J.+Latorreauthor=A.+J.+Phillipsauthor=S.+L.+Schreiberauthor=J.+Perezauthor=A.+F.+Shamjiauthor=N.+S.+Grayauthor=R.+J.+Xavier&title=Development+of+chemical+probes+for+investigation+of+salt-inducible+kinase+function+in+vivo&doi=10.1021%2Facschembio.6b00217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo</span></div><div class="casAuthors">Sundberg, Thomas B.; Liang, Yanke; Wu, Huixian; Choi, Hwan Geun; Kim, Nam Doo; Sim, Taebo; Johannessen, Liv; Petrone, Adam; Khor, Bernard; Graham, Daniel B.; Latorre, Isabel J.; Phillips, Andrew J.; Schreiber, Stuart L.; Perez, Jose; Shamji, Alykhan F.; Gray, Nathanael S.; Xavier, Ramnik J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2105-2111</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Salt-inducible kinases (SIKs) are promising therapeutic targets for modulating cytokine responses during innate immune activation.  The study of SIK inhibition in animal models of disease has been limited by the lack of selective small-mol. probes suitable for modulating SIK function in vivo.  We used the pan-SIK inhibitor HG-9-91-01 as a starting point to develop improved analogs, yielding a novel probe 5 (YKL-05-099) that displays increased selectivity for SIKs vs. other kinases and enhanced pharmacokinetic properties.  Well-tolerated doses of YKL-05-099 achieve free serum concns. above its IC50 for SIK2 inhibition for >16 h and reduce phosphorylation of a known SIK substrate in vivo.  While in vivo active doses of YKL-05-099 recapitulate the effects of SIK inhibition on inflammatory cytokine responses, they did not induce metabolic abnormalities obsd. in Sik2 knockout mice.  These results identify YKL-05-099 as a useful probe to investigate SIK function in vivo and further support the development of SIK inhibitors for treatment of inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyaf4sRvYdDrVg90H21EOLACvtfcHk0ljh-NvA2sQLWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFaku70%253D&md5=fa634038675ff3ab8198ebd3c223e36b</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00217%26sid%3Dliteratum%253Aachs%26aulast%3DSundberg%26aufirst%3DT.%2BB.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DJohannessen%26aufirst%3DL.%26aulast%3DPetrone%26aufirst%3DA.%26aulast%3DKhor%26aufirst%3DB.%26aulast%3DGraham%26aufirst%3DD.%2BB.%26aulast%3DLatorre%26aufirst%3DI.%2BJ.%26aulast%3DPhillips%26aufirst%3DA.%2BJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DPerez%26aufirst%3DJ.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26atitle%3DDevelopment%2520of%2520chemical%2520probes%2520for%2520investigation%2520of%2520salt-inducible%2520kinase%2520function%2520in%2520vivo%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D2105%26epage%3D2111%26doi%3D10.1021%2Facschembio.6b00217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fries, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottom, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweitzer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, G. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span></span> <span> </span><span class="NLM_article-title">Identification of purines and 7-deazapurines as potent and selective type I inhibitors of troponin I-interacting kinase (TNNI3K)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7431</span>– <span class="NLM_lpage">7448</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00931</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00931" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7431-7448&author=B.+G.+Lawhornauthor=J.+Philpauthor=S.+Zhaoauthor=C.+Louerauthor=M.+Hammondauthor=M.+Cheungauthor=H.+Friesauthor=A.+P.+Gravesauthor=L.+Shewchukauthor=L.+Wangauthor=J.+E.+Cottomauthor=H.+Qiauthor=H.+Zhaoauthor=R.+Totoritisauthor=G.+Zhangauthor=B.+Schwartzauthor=H.+Liauthor=S.+Sweitzerauthor=D.+A.+Holtauthor=G.+J.+Gattoauthor=L.+S.+Kallander&title=Identification+of+purines+and+7-deazapurines+as+potent+and+selective+type+I+inhibitors+of+troponin+I-interacting+kinase+%28TNNI3K%29&doi=10.1021%2Facs.jmedchem.5b00931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Purines and 7-Deazapurines as Potent and Selective Type I Inhibitors of Troponin I-Interacting Kinase (TNNI3K)</span></div><div class="casAuthors">Lawhorn, Brian G.; Philp, Joanne; Zhao, Yongdong; Louer, Christopher; Hammond, Marlys; Cheung, Mui; Fries, Harvey; Graves, Alan P.; Shewchuk, Lisa; Wang, Liping; Cottom, Joshua E.; Qi, Hongwei; Zhao, Huizhen; Totoritis, Rachel; Zhang, Guofeng; Schwartz, Benjamin; Li, Hu; Sweitzer, Sharon; Holt, Dennis A.; Gatto, Gregory J., Jr.; Kallander, Lara S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7431-7448</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of cardiac troponin I-interacting kinase (TNNI3K) inhibitors arising from 3-((9H-purin-6-yl)amino)-N-methyl-benzenesulfonamide (1) is disclosed along with fundamental structure-function relationships that delineate the role of each element of 1 for TNNI3K recognition.  An X-ray structure of 1 bound to TNNI3K confirmed its Type I binding mode and is used to rationalize the structure-activity relationship and employed to design potent, selective, and orally bioavailable TNNI3K inhibitors.  Identification of the 7-deazapurine heterocycle as a superior template (vs purine) and its elaboration by introduction of C4-benzenesulfonamide and C7- and C8-7-deazapurine substituents produced compds. with substantial improvements in potency (>1000-fold), general kinase selectivity (10-fold improvement), and pharmacokinetic properties (>10-fold increase in poDNAUC).  Optimal members of the series have properties suitable for use in in vitro and in vivo expts. aimed at elucidating the role of TNNI3K in cardiac biol. and serve as leads for developing novel heart failure medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRFuxLWuXyP7Vg90H21EOLACvtfcHk0ljh-NvA2sQLWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7rN&md5=d4a66f1ee1b5d62a5443225aca9bcb12</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00931%26sid%3Dliteratum%253Aachs%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DPhilp%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLouer%26aufirst%3DC.%26aulast%3DHammond%26aufirst%3DM.%26aulast%3DCheung%26aufirst%3DM.%26aulast%3DFries%26aufirst%3DH.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCottom%26aufirst%3DJ.%2BE.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DTotoritis%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DKallander%26aufirst%3DL.%2BS.%26atitle%3DIdentification%2520of%2520purines%2520and%25207-deazapurines%2520as%2520potent%2520and%2520selective%2520type%2520I%2520inhibitors%2520of%2520troponin%2520I-interacting%2520kinase%2520%2528TNNI3K%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7431%26epage%3D7448%26doi%3D10.1021%2Facs.jmedchem.5b00931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">Compound IC<sub>50</sub> values were determined in a panel of internal kinase assays at GSK at a highest tested concentration of 10 μM. The composition of the kinase panel was fluid over the course of the project so that compounds were evaluated against an overlapping, but nonidentical number and set of kinases. This data provides a rough approximation of general kinome selectivity for a given compound. For early compounds, a 10-fold selectivity margin was chosen to allow an equitable comparison of general kinase selectivity for weakly active compounds (IC<sub>50</sub> ≈ 1 μM) where no greater than 10-fold selectivity could be assessed given the 10 μM highest test concentration. Selected compounds (<b>3</b>, <b>33</b>, and <b>43</b>) were evaluated in a broader kinase panel and show favorable selectivity using a more stringent 100-fold selectivity measure (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tari, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensen, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nix, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McRee, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, R. V.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the inhibition of Aurora A kinase by a novel class of high affinity disubstituted pyrimidine inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.10.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.bmcl.2006.10.086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=688-691&author=L.+W.+Tariauthor=I.+D.+Hoffmanauthor=D.+C.+Bensenauthor=M.+J.+Hunterauthor=J.+Nixauthor=K.+J.+Nelsonauthor=D.+E.+McReeauthor=R.+V.+Swanson&title=Structural+basis+for+the+inhibition+of+Aurora+A+kinase+by+a+novel+class+of+high+affinity+disubstituted+pyrimidine+inhibitors&doi=10.1016%2Fj.bmcl.2006.10.086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.10.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.10.086%26sid%3Dliteratum%253Aachs%26aulast%3DTari%26aufirst%3DL.%2BW.%26aulast%3DHoffman%26aufirst%3DI.%2BD.%26aulast%3DBensen%26aufirst%3DD.%2BC.%26aulast%3DHunter%26aufirst%3DM.%2BJ.%26aulast%3DNix%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DK.%2BJ.%26aulast%3DMcRee%26aufirst%3DD.%2BE.%26aulast%3DSwanson%26aufirst%3DR.%2BV.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520Aurora%2520A%2520kinase%2520by%2520a%2520novel%2520class%2520of%2520high%2520affinity%2520disubstituted%2520pyrimidine%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D688%26epage%3D691%26doi%3D10.1016%2Fj.bmcl.2006.10.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandberg, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spalding, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iskandar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanewsky, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyrimidine benzimidazoles as Lck inhibitors: Part I</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5618</span>– <span class="NLM_lpage">5621</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.08.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.bmcl.2008.08.104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5618-5621&author=G.+Zhangauthor=P.+Renauthor=N.+S.+Grayauthor=T.+Simauthor=Y.+Liuauthor=X.+Wangauthor=J.+Cheauthor=S.-S.+Tianauthor=M.+L.+Sandbergauthor=T.+A.+Spaldingauthor=R.+Romeoauthor=M.+Iskandarauthor=D.+Chowauthor=H.+M.+Seidelauthor=D.+S.+Karanewskyauthor=Y.+He&title=Discovery+of+pyrimidine+benzimidazoles+as+Lck+inhibitors%3A+Part+I&doi=10.1016%2Fj.bmcl.2008.08.104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.08.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.08.104%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DS.-S.%26aulast%3DSandberg%26aufirst%3DM.%2BL.%26aulast%3DSpalding%26aufirst%3DT.%2BA.%26aulast%3DRomeo%26aufirst%3DR.%26aulast%3DIskandar%26aufirst%3DM.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DKaranewsky%26aufirst%3DD.%2BS.%26aulast%3DHe%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520pyrimidine%2520benzimidazoles%2520as%2520Lck%2520inhibitors%253A%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5618%26epage%3D5621%26doi%3D10.1016%2Fj.bmcl.2008.08.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamabe, T.</span></span> <span> </span><span class="NLM_article-title">Ab initio MO study of diphenyl derivatives: diphenylamine, diphenylaminium, diphenylaminyl and diphenylnitroxide</span>. <i>Chem. Phys. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/0009-2614(94)00416-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2F0009-2614%2894%2900416-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=1994&pages=27-34&author=A.+Itoauthor=K.+Otaauthor=K.+Yoshizawaauthor=K.+Tanakaauthor=T.+Yamabe&title=Ab+initio+MO+study+of+diphenyl+derivatives%3A+diphenylamine%2C+diphenylaminium%2C+diphenylaminyl+and+diphenylnitroxide&doi=10.1016%2F0009-2614%2894%2900416-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1016%2F0009-2614%2894%2900416-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-2614%252894%252900416-1%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DA.%26aulast%3DOta%26aufirst%3DK.%26aulast%3DYoshizawa%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYamabe%26aufirst%3DT.%26atitle%3DAb%2520initio%2520MO%2520study%2520of%2520diphenyl%2520derivatives%253A%2520diphenylamine%252C%2520diphenylaminium%252C%2520diphenylaminyl%2520and%2520diphenylnitroxide%26jtitle%3DChem.%2520Phys.%2520Lett.%26date%3D1994%26volume%3D223%26spage%3D27%26epage%3D34%26doi%3D10.1016%2F0009-2614%2894%2900416-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Manley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balitza, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coll, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFall, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodman, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, K. A.</span></span> <span> </span><span class="NLM_article-title">2,4-disubstituted pyrimidines: A novel class of KDR kinase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1677</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00244-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2FS0960-894X%2803%2900244-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1673-1677&author=P.+J.+Manleyauthor=A.+E.+Balitzaauthor=M.+T.+Bilodeauauthor=K.+E.+Collauthor=G.+D.+Hartmanauthor=R.+C.+McFallauthor=K.+W.+Rickertauthor=L.+D.+Rodmanauthor=K.+A.+Thomas&title=2%2C4-disubstituted+pyrimidines%3A+A+novel+class+of+KDR+kinase+inhibitors&doi=10.1016%2FS0960-894X%2803%2900244-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900244-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900244-0%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BJ.%26aulast%3DBalitza%26aufirst%3DA.%2BE.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DColl%26aufirst%3DK.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DMcFall%26aufirst%3DR.%2BC.%26aulast%3DRickert%26aufirst%3DK.%2BW.%26aulast%3DRodman%26aufirst%3DL.%2BD.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26atitle%3D2%252C4-disubstituted%2520pyrimidines%253A%2520A%2520novel%2520class%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1673%26epage%3D1677%26doi%3D10.1016%2FS0960-894X%2803%2900244-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortlock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the tyrosine kinase EphB4. Part 1: structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2776</span>– <span class="NLM_lpage">2780</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.bmcl.2008.04.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2776-2780&author=C.+Bardelleauthor=D.+Crossauthor=S.+Davenportauthor=J.+G.+Kettleauthor=E.+J.+Koauthor=A.+D.+Leachauthor=A.+Mortlockauthor=J.+Readauthor=N.+J.+Robertsauthor=P.+Robinsauthor=E.+J.+Williams&title=Inhibitors+of+the+tyrosine+kinase+EphB4.+Part+1%3A+structure-based+design+and+optimization+of+a+series+of+2%2C4-bis-anilinopyrimidines&doi=10.1016%2Fj.bmcl.2008.04.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DBardelle%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DD.%26aulast%3DDavenport%26aufirst%3DS.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DKo%26aufirst%3DE.%2BJ.%26aulast%3DLeach%26aufirst%3DA.%2BD.%26aulast%3DMortlock%26aufirst%3DA.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DN.%2BJ.%26aulast%3DRobins%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DE.%2BJ.%26atitle%3DInhibitors%2520of%2520the%2520tyrosine%2520kinase%2520EphB4.%2520Part%25201%253A%2520structure-based%2520design%2520and%2520optimization%2520of%2520a%2520series%2520of%25202%252C4-bis-anilinopyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2776%26epage%3D2780%26doi%3D10.1016%2Fj.bmcl.2008.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Force, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Etten, R. A.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1038/nrc2106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1038%2Fnrc2106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=17457301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=332-344&author=T.+Forceauthor=D.+S.+Krauseauthor=R.+A.+Van+Etten&title=Molecular+mechanisms+of+cardiotoxicity+of+tyrosine+kinase+inhibition&doi=10.1038%2Fnrc2106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition</span></div><div class="casAuthors">Force, Thomas; Krause, Daniela S.; Van Etten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">332-344</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer therapy has progressed remarkably in recent years.  In no area has this been more apparent than in the development of 'targeted therapies', particularly those using drugs that inhibit the activity of certain tyrosine kinases, activating mutations or amplifications of which are causal, or strongly contributory, to tumorigenesis.  However, some of these therapies have been assocd. with toxicity to the heart.  Here we summarize what is known about the cardiotoxicity of cancer drugs that target tyrosine kinases.  We focus on basic mechanisms through which interruption of specific signalling pathways leads to cardiomyocyte dysfunction and/or death, and contrast this with therapeutic responses in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIyJIGdG9hv7Vg90H21EOLACvtfcHk0liFZHQJz4S9Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7w%253D&md5=b574f420e2a09de9bae3aa2313e76c3e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrc2106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2106%26sid%3Dliteratum%253Aachs%26aulast%3DForce%26aufirst%3DT.%26aulast%3DKrause%26aufirst%3DD.%2BS.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26atitle%3DMolecular%2520mechanisms%2520of%2520cardiotoxicity%2520of%2520tyrosine%2520kinase%2520inhibition%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D332%26epage%3D344%26doi%3D10.1038%2Fnrc2106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, G. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span></span> <span> </span><span class="NLM_article-title">Substituent effects on drug-receptor H-bond interactions: correlations useful for the design of kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10629</span>– <span class="NLM_lpage">10641</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01342</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01342" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVymtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10629-10641&author=B.+G.+Lawhornauthor=J.+Philpauthor=A.+P.+Gravesauthor=D.+A.+Holtauthor=G.+J.+Gattoauthor=L.+S.+Kallander&title=Substituent+effects+on+drug-receptor+H-bond+interactions%3A+correlations+useful+for+the+design+of+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.6b01342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Substituent Effects on Drug-Receptor H-bond Interactions: Correlations Useful for the Design of Kinase Inhibitors</span></div><div class="casAuthors">Lawhorn, Brian G.; Philp, Joanne; Graves, Alan P.; Holt, Dennis A.; Gatto, Gregory J.; Kallander, Lara S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10629-10641</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Investigation of troponin I-interacting kinase (TNNI3K) as a potential target for the treatment of heart failure has produced a series of substituted N-methyl-3-(pyrimidin-4-ylamino)benzenesulfonamide inhibitors that display excellent potency and selectivity against a broad spectrum of protein kinases.  Crystal structures of prototypical members bound to the ATP-binding site of TNNI3K reveal two anchoring hydrogen bond contacts: (1) from the hinge region amide N-H to the pyrimidine nitrogen and (2) from the sulfonamide N-H to the gatekeeper threonine.  Evaluation of various para-substituted benzenesulfonamides defined a substituent effect on binding affinity resulting from modulation of the sulfonamide H-bond donor strength.  An opposite electronic effect emerged for the hinge NH-pyrimidine H-bond interaction, which is further illuminated in the correlation of calcd. H-bond acceptor strength and TNNI3K affinity for a variety of hinge binding heterocycles.  These fundamental correlations on drug-receptor H-bond interactions may be generally useful tools for the optimization of potency and selectivity in the design of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjFZcXi9ebFrVg90H21EOLACvtfcHk0lg7uNgJ7-8lSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVymtbbI&md5=af40d68aeac88239b629b21cb3f218d7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01342%26sid%3Dliteratum%253Aachs%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DPhilp%26aufirst%3DJ.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DKallander%26aufirst%3DL.%2BS.%26atitle%3DSubstituent%2520effects%2520on%2520drug-receptor%2520H-bond%2520interactions%253A%2520correlations%2520useful%2520for%2520the%2520design%2520of%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10629%26epage%3D10641%26doi%3D10.1021%2Facs.jmedchem.6b01342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selzer, P.</span></span> <span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3714</span>– <span class="NLM_lpage">3717</span>, <span class="refDoi"> DOI: 10.1021/jm000942e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties&doi=10.1021%2Fjm000942e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lg7uNgJ7-8lSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717%26doi%3D10.1021%2Fjm000942e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Palm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">Polar molecular surface properties predict the intestinal absorption of drugs in humans</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1023/A:1012188625088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1023%2FA%3A1012188625088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=9165525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=568-571&author=K.+Palmauthor=P.+Stenbergauthor=K.+Luthmanauthor=P.+Artursson&title=Polar+molecular+surface+properties+predict+the+intestinal+absorption+of+drugs+in+humans&doi=10.1023%2FA%3A1012188625088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Polar molecular surface properties predict the intestinal absorption of drugs in humans</span></div><div class="casAuthors">Palm, Katrin; Stenberg, Patric; Luthman, Kristina; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">568-571</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">A theor. method was devised for prediction of drug absorption after oral administration to humans.  Twenty structurally diverse model drugs, ranging from 0.3 to 100% absorbed, were investigated.  The compds. also displayed diversity in physicochem. properties such as lipophilicity, hydrogen bonding potential and mol. size.  The dynamic mol. surface properties of the compds. were calcd., taking into account their 3-dimensional shape and flexibility.  An excellent sigmoidal relationship was established between the absorbed fraction after oral administration to humans (FA) and the dynamic polar mol. surface area (PSAd) (r2 = 0.94).  The relationship was stronger than those obtained for more established predictors of drug absorption.  Drugs that are completely absorbed (FA > 90%) had a PSAd ≤ 60 Å2 while drugs that are < 10% absorbed had a PSAd ≥ 140 Å2.  PSAd can be used to differentiate poorly absorbed drugs at an early stage of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPW66hupHIyLVg90H21EOLACvtfcHk0lh3gJ97GSQ4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlSksrk%253D&md5=1394f0d1059e7d99ee02be977b92da8b</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1023%2FA%3A1012188625088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1012188625088%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%26aufirst%3DK.%26aulast%3DStenberg%26aufirst%3DP.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DPolar%2520molecular%2520surface%2520properties%2520predict%2520the%2520intestinal%2520absorption%2520of%2520drugs%2520in%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1997%26volume%3D14%26spage%3D568%26epage%3D571%26doi%3D10.1023%2FA%3A1012188625088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kelder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grootenhuis, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayada, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbressine, L. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploemen, J.-P.</span></span> <span> </span><span class="NLM_article-title">Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1514</span>– <span class="NLM_lpage">1519</span>, <span class="refDoi"> DOI: 10.1023/A:1015040217741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1023%2FA%3A1015040217741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10554091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=1514-1519&author=J.+Kelderauthor=D.+J.+Grootenhuisauthor=D.+M.+Bayadaauthor=L.+P.+C.+Delbressineauthor=J.-P.+Ploemen&title=Polar+molecular+surface+as+a+dominating+determinant+for+oral+absorption+and+brain+penetration+of+drugs&doi=10.1023%2FA%3A1015040217741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs</span></div><div class="casAuthors">Kelder, Jan; Grootenhuis, Peter D. J.; Bayada, Denis M.; Delbressine, Leon P. C.; Ploemen, Jan-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1514-1519</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Purpose: To study oral absorption and brain penetration as a function of polar mol. surface area.  Methods: Measured brain penetration data of 45 drug mols. were investigated.  The dynamic polar surface areas were calcd. and correlated with the brain penetration data.  Also the static polar surface areas of 776 orally administered CNS drugs that have reached at least Phase II efficacy studies were calcd.  The same was done for a series of 1590 orally administered non-CNS drugs that have reached at least Phase II efficacy studies.  Results: A linear relationship between brain penetration and dynamic polar surface area (A2) was found (n = 45, R = 0.917, F1,43 = 229).  Brain penetration decreases with increasing polar surface area.  A clear difference between the distribution of the polar surface area of the 776 CNS and 1590 non-CNS drugs was found.  It was deduced that orally active drugs that are transported passively by the transcellular route should not exceed a polar surface area of about 120 A2.  They can be tailored to brain penetration by decreasing the polar surface to <60-70 A2.  This conclusion is supported by the inverse linear relationship between exptl. brain penetration data and the dynamic polar surface area of 45 drug mols.  Conclusions: The polar mol. surface area is a dominating determinant for oral absorption and brain penetration of drugs that are transported by the transcellular route.  This property should be considered in the early phase of drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmc3v7TzWM4LVg90H21EOLACvtfcHk0lh3gJ97GSQ4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D&md5=868fe1e9491dd3b8b92b326d28ee48f9</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015040217741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015040217741%26sid%3Dliteratum%253Aachs%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DGrootenhuis%26aufirst%3DD.%2BJ.%26aulast%3DBayada%26aufirst%3DD.%2BM.%26aulast%3DDelbressine%26aufirst%3DL.%2BP.%2BC.%26aulast%3DPloemen%26aufirst%3DJ.-P.%26atitle%3DPolar%2520molecular%2520surface%2520as%2520a%2520dominating%2520determinant%2520for%2520oral%2520absorption%2520and%2520brain%2520penetration%2520of%2520drugs%26jtitle%3DPharm.%2520Res.%26date%3D1999%26volume%3D16%26spage%3D1514%26epage%3D1519%26doi%3D10.1023%2FA%3A1015040217741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treskov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinheimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muslin, A. J.</span></span> <span> </span><span class="NLM_article-title">Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.0000138190.50127.6A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1161%2F01.CIR.0000138190.50127.6A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2004&pages=718-723&author=L.+S.+Harrisauthor=S.+Zhangauthor=I.+Treskovauthor=A.+Kovacsauthor=C.+Weinheimerauthor=A.+J.+Muslin&title=Raf-1+kinase+is+required+for+cardiac+hypertrophy+and+cardiomyocyte+survival+in+response+to+pressure+overload&doi=10.1161%2F01.CIR.0000138190.50127.6A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000138190.50127.6A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000138190.50127.6A%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DL.%2BS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DTreskov%26aufirst%3DI.%26aulast%3DKovacs%26aufirst%3DA.%26aulast%3DWeinheimer%26aufirst%3DC.%26aulast%3DMuslin%26aufirst%3DA.%2BJ.%26atitle%3DRaf-1%2520kinase%2520is%2520required%2520for%2520cardiac%2520hypertrophy%2520and%2520cardiomyocyte%2520survival%2520in%2520response%2520to%2520pressure%2520overload%26jtitle%3DCirculation%26date%3D2004%26volume%3D110%26spage%3D718%26epage%3D723%26doi%3D10.1161%2F01.CIR.0000138190.50127.6A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Muslin, A. J.</span></span> <span> </span><span class="NLM_article-title">Role of Raf proteins in cardiac hypertrophy and cardiomyocyte survival</span>. <i>Trends Cardiovasc. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.tcm.2005.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.tcm.2005.06.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=225-229&author=A.+J.+Muslin&title=Role+of+Raf+proteins+in+cardiac+hypertrophy+and+cardiomyocyte+survival&doi=10.1016%2Fj.tcm.2005.06.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.tcm.2005.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcm.2005.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DMuslin%26aufirst%3DA.%2BJ.%26atitle%3DRole%2520of%2520Raf%2520proteins%2520in%2520cardiac%2520hypertrophy%2520and%2520cardiomyocyte%2520survival%26jtitle%3DTrends%2520Cardiovasc.%2520Med.%26date%3D2005%26volume%3D15%26spage%3D225%26epage%3D229%26doi%3D10.1016%2Fj.tcm.2005.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, G. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span></span> <span> </span><span class="NLM_article-title">GSK114: a selective inhibitor for identifying the biological role of TNNI3K</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3355</span>– <span class="NLM_lpage">3358</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.bmcl.2016.05.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3355-3358&author=B.+G.+Lawhornauthor=J.+Philpauthor=A.+P.+Gravesauthor=L.+Shewchukauthor=D.+A.+Holtauthor=G.+J.+Gattoauthor=L.+S.+Kallander&title=GSK114%3A+a+selective+inhibitor+for+identifying+the+biological+role+of+TNNI3K&doi=10.1016%2Fj.bmcl.2016.05.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DPhilp%26aufirst%3DJ.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DKallander%26aufirst%3DL.%2BS.%26atitle%3DGSK114%253A%2520a%2520selective%2520inhibitor%2520for%2520identifying%2520the%2520biological%2520role%2520of%2520TNNI3K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3355%26epage%3D3358%26doi%3D10.1016%2Fj.bmcl.2016.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">The calculated TPSA (143 Å<sup>2</sup>) of the 4-sulfone analogs exceeds the limit required for oral bioavailability within the series. However, these analogs were expected to retain oral bioavailability (as observed) based on their presumed internal H-bond with the neighboring aniline NH, which is unaccounted for in the TPSA calculation, leading to an overestimated value of PSA.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, M.</span>; <span class="NLM_string-name">Kallander, L. S.</span>; <span class="NLM_string-name">Lawhorn, B. G.</span>; <span class="NLM_string-name">Philp, J.</span>; <span class="NLM_string-name">Sarpong, M. A.</span>; <span class="NLM_string-name">Seefeld, M. A.</span></span> <span> </span><span class="NLM_article-title">Azolopyrimidine Compounds as Kinase Inhibitors and Their Preparations and Use in the Treatment of Diseases and Methods</span>. PCT Int. Appl. <span class="NLM_patent">WO2011149827</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+Hammond&author=L.+S.+Kallander&author=B.+G.+Lawhorn&author=J.+Philp&author=M.+A.+Sarpong&author=M.+A.+Seefeld&title=Azolopyrimidine+Compounds+as+Kinase+Inhibitors+and+Their+Preparations+and+Use+in+the+Treatment+of+Diseases+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DM.%26atitle%3DAzolopyrimidine%2520Compounds%2520as%2520Kinase%2520Inhibitors%2520and%2520Their%2520Preparations%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diseases%2520and%2520Methods%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span>; <span class="NLM_string-name">Lawhorn, B. G.</span>; <span class="NLM_string-name">Philp, J.</span>; <span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">3-[(6-Aminopyrimidin-4-yl)amino]benzenesulfonamide Compounds Useful as TNNI3K Inhibitors, Their Preparation, and Methods of Use in the Treatment of Congestive Heart Failure</span>. PCT Int. Appl. <span class="NLM_patent">WO2011088027</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=L.+S.+Kallander&author=B.+G.+Lawhorn&author=J.+Philp&author=Y.+Zhao&title=3-%5B%286-Aminopyrimidin-4-yl%29amino%5Dbenzenesulfonamide+Compounds+Useful+as+TNNI3K+Inhibitors%2C+Their+Preparation%2C+and+Methods+of+Use+in+the+Treatment+of+Congestive+Heart+Failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKallander%26aufirst%3DL.%2BS.%26atitle%3D3-%255B%25286-Aminopyrimidin-4-yl%2529amino%255Dbenzenesulfonamide%2520Compounds%2520Useful%2520as%2520TNNI3K%2520Inhibitors%252C%2520Their%2520Preparation%252C%2520and%2520Methods%2520of%2520Use%2520in%2520the%2520Treatment%2520of%2520Congestive%2520Heart%2520Failure%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span>; <span class="NLM_string-name">Philp, J.</span></span> <span> </span><span class="NLM_article-title">Compounds for Treating Congestive Heart Failure</span>. PCT Int. Appl. <span class="NLM_patent">WO2011088031</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=L.+S.+Kallander&author=J.+Philp&title=Compounds+for+Treating+Congestive+Heart+Failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKallander%26aufirst%3DL.%2BS.%26atitle%3DCompounds%2520for%2520Treating%2520Congestive%2520Heart%2520Failure%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, C.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backes, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philipp, A.</span></span> <span> </span><span class="NLM_article-title">Efficient microwave-assisted synthesis of highly functionalized pyrimidine derivatives</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">10055</span>– <span class="NLM_lpage">10064</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2006.08.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.tet.2006.08.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=10055-10064&author=C.%0AG.+Hartungauthor=A.+C.+Backesauthor=B.+Felberauthor=A.+Missioauthor=A.+Philipp&title=Efficient+microwave-assisted+synthesis+of+highly+functionalized+pyrimidine+derivatives&doi=10.1016%2Fj.tet.2006.08.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.08.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.08.065%26sid%3Dliteratum%253Aachs%26aulast%3DHartung%26aufirst%3DC.%2BG.%26aulast%3DBackes%26aufirst%3DA.%2BC.%26aulast%3DFelber%26aufirst%3DB.%26aulast%3DMissio%26aufirst%3DA.%26aulast%3DPhilipp%26aufirst%3DA.%26atitle%3DEfficient%2520microwave-assisted%2520synthesis%2520of%2520highly%2520functionalized%2520pyrimidine%2520derivatives%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D10055%26epage%3D10064%26doi%3D10.1016%2Fj.tet.2006.08.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':[],'ref14':['cit14a','cit14b','cit14c'],'ref15':['cit15a','cit15b'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b','cit18c'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':[],'ref22':['cit22a','cit22b','cit22c'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeelan Basha  N</span>, <span class="hlFld-ContribAuthor ">Naganna M.  Goudgaon</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review on pyrimidine analogs-versatile scaffold with medicinal and biological potential. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1246 </em>, 131168. <a href="https://doi.org/10.1016/j.molstruc.2021.131168" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.131168</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.131168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.131168%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DA%252Bcomprehensive%252Breview%252Bon%252Bpyrimidine%252Banalogs-versatile%252Bscaffold%252Bwith%252Bmedicinal%252Band%252Bbiological%252Bpotential%26aulast%3DN%26aufirst%3DJeelan%2BBasha%26date%3D2021%26volume%3D1246%26spage%3D131168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline  Pham</span>, <span class="hlFld-ContribAuthor ">Noelia  Muñoz-Martín</span>, <span class="hlFld-ContribAuthor ">Elisabeth M.  Lodder</span>. </span><span class="cited-content_cbyCitation_article-title">The Diverse Roles of TNNI3K in Cardiac Disease and Potential for Treatment. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (12)
                                     , 6422. <a href="https://doi.org/10.3390/ijms22126422" title="DOI URL">https://doi.org/10.3390/ijms22126422</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22126422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22126422%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DThe%252BDiverse%252BRoles%252Bof%252BTNNI3K%252Bin%252BCardiac%252BDisease%252Band%252BPotential%252Bfor%252BTreatment%26aulast%3DPham%26aufirst%3DCaroline%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D12%26spage%3D6422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhu-Ming  Qian</span>, <span class="hlFld-ContribAuthor ">Kai-Li  Zuo</span>, <span class="hlFld-ContribAuthor ">Zhi  Guan</span>, <span class="hlFld-ContribAuthor ">Yan-Hong  He</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-light-induced sequential sulfonylation/hydroxylation of allylacetamides leading to β-tert-hydroxy sulfones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>83 </em>, 131999. <a href="https://doi.org/10.1016/j.tet.2021.131999" title="DOI URL">https://doi.org/10.1016/j.tet.2021.131999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.131999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.131999%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DVisible-light-induced%252Bsequential%252Bsulfonylation%25252Fhydroxylation%252Bof%252Ballylacetamides%252Bleading%252Bto%252B%2525CE%2525B2-tert-hydroxy%252Bsulfones%26aulast%3DQian%26aufirst%3DZhu-Ming%26date%3D2021%26volume%3D83%26spage%3D131999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ab  Majeed Ganai</span>, <span class="hlFld-ContribAuthor ">Tabasum  Khan Pathan</span>, <span class="hlFld-ContribAuthor ">Girish A.  Hampannavar</span>, <span class="hlFld-ContribAuthor ">Chandrakant  Pawar</span>, <span class="hlFld-ContribAuthor ">Vincent A.  Obakachi</span>, <span class="hlFld-ContribAuthor ">Babita  Kushwaha</span>, <span class="hlFld-ContribAuthor ">Narva  Deshwar Kushwaha</span>, <span class="hlFld-ContribAuthor ">Rajshekhar  Karpoormath</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances on the s‐Triazine Scaffold with Emphasis on Synthesis, Structure‐Activity and Pharmacological Aspects: A Concise Review. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (7)
                                     , 1616-1660. <a href="https://doi.org/10.1002/slct.202004591" title="DOI URL">https://doi.org/10.1002/slct.202004591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202004591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202004591%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DRecent%252BAdvances%252Bon%252Bthe%252Bs%2525E2%252580%252590Triazine%252BScaffold%252Bwith%252BEmphasis%252Bon%252BSynthesis%25252C%252BStructure%2525E2%252580%252590Activity%252Band%252BPharmacological%252BAspects%25253A%252BA%252BConcise%252BReview%26aulast%3DMajeed%2BGanai%26aufirst%3DAb%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D7%26spage%3D1616%26epage%3D1660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peiheng  Gan</span>, <span class="hlFld-ContribAuthor ">Catalin  Baicu</span>, <span class="hlFld-ContribAuthor ">Hirofumi  Watanabe</span>, <span class="hlFld-ContribAuthor ">Kristy  Wang</span>, <span class="hlFld-ContribAuthor ">Ge  Tao</span>, <span class="hlFld-ContribAuthor ">Daniel P  Judge</span>, <span class="hlFld-ContribAuthor ">Michael R  Zile</span>, <span class="hlFld-ContribAuthor ">Takako  Makita</span>, <span class="hlFld-ContribAuthor ">Rupak  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Henry M  Sucov</span>. </span><span class="cited-content_cbyCitation_article-title">The prevalent I686T human variant and loss-of-function mutations in the cardiomyocyte-specific kinase gene TNNI3K cause adverse contractility and concentric remodeling in mice. </span><span class="cited-content_cbyCitation_journal-name">Human Molecular Genetics</span><span> <strong>2021,</strong> <em>29 </em>
                                    (21)
                                     , 3504-3515. <a href="https://doi.org/10.1093/hmg/ddaa234" title="DOI URL">https://doi.org/10.1093/hmg/ddaa234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/hmg/ddaa234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fhmg%2Fddaa234%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Molecular%2520Genetics%26atitle%3DThe%252Bprevalent%252BI686T%252Bhuman%252Bvariant%252Band%252Bloss-of-function%252Bmutations%252Bin%252Bthe%252Bcardiomyocyte-specific%252Bkinase%252Bgene%252BTNNI3K%252Bcause%252Badverse%252Bcontractility%252Band%252Bconcentric%252Bremodeling%252Bin%252Bmice%26aulast%3DGan%26aufirst%3DPeiheng%26date%3D2021%26date%3D2020%26volume%3D29%26issue%3D21%26spage%3D3504%26epage%3D3515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.J. Jenepha  Mary</span>, <span class="hlFld-ContribAuthor ">Mohd Usman Mohd  Siddique</span>, <span class="hlFld-ContribAuthor ">Sayantan  Pradhan</span>, <span class="hlFld-ContribAuthor ">Venkatesan  Jayaprakash</span>, <span class="hlFld-ContribAuthor ">C.  James</span>. </span><span class="cited-content_cbyCitation_article-title">Quantum chemical insight into molecular structure, NBO analysis of the hydrogen-bonded interactions, spectroscopic (FT–IR, FT–Raman), drug likeness and molecular docking of the novel anti COVID-19 molecule 2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluorophenyl)acetamide - dimer. </span><span class="cited-content_cbyCitation_journal-name">Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy</span><span> <strong>2021,</strong> <em>244 </em>, 118825. <a href="https://doi.org/10.1016/j.saa.2020.118825" title="DOI URL">https://doi.org/10.1016/j.saa.2020.118825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.saa.2020.118825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.saa.2020.118825%26sid%3Dliteratum%253Aachs%26jtitle%3DSpectrochimica%2520Acta%2520Part%2520A%253A%2520Molecular%2520and%2520Biomolecular%2520Spectroscopy%26atitle%3DQuantum%252Bchemical%252Binsight%252Binto%252Bmolecular%252Bstructure%25252C%252BNBO%252Banalysis%252Bof%252Bthe%252Bhydrogen-bonded%252Binteractions%25252C%252Bspectroscopic%252B%252528FT%2525E2%252580%252593IR%25252C%252BFT%2525E2%252580%252593Raman%252529%25252C%252Bdrug%252Blikeness%252Band%252Bmolecular%252Bdocking%252Bof%252Bthe%252Bnovel%252Banti%252BCOVID-19%252Bmolecule%252B2-%25255B%2525284%25252C6-diaminopyrimidin-2-yl%252529sulfanyl%25255D-N-%2525284-fluorophenyl%252529acetamide%252B-%252Bdimer%26aulast%3DMary%26aufirst%3DS.J.%2BJenepha%26date%3D2021%26volume%3D244%26spage%3D118825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaydeepsinh  Chavda</span>, <span class="hlFld-ContribAuthor ">Hardik  Bhatt</span>. </span><span class="cited-content_cbyCitation_article-title">Systemic review on B-RafV600E mutation as potential therapeutic target for the treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112675. <a href="https://doi.org/10.1016/j.ejmech.2020.112675" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112675%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSystemic%252Breview%252Bon%252BB-RafV600E%252Bmutation%252Bas%252Bpotential%252Btherapeutic%252Btarget%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%26aulast%3DChavda%26aufirst%3DJaydeepsinh%26date%3D2020%26volume%3D206%26spage%3D112675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Xu</span>, <span class="hlFld-ContribAuthor ">Zhao  Yang</span>, <span class="hlFld-ContribAuthor ">Jiawei  Hua</span>, <span class="hlFld-ContribAuthor ">Yang  Lin</span>, <span class="hlFld-ContribAuthor ">Mixue  Bian</span>, <span class="hlFld-ContribAuthor ">Yuguang  Li</span>, <span class="hlFld-ContribAuthor ">Chengkou  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  He</span>, <span class="hlFld-ContribAuthor ">Zheng  Fang</span>, <span class="hlFld-ContribAuthor ">Kai  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">The continuous-flow electrosynthesis of 4-(sulfonylmethyl)isoquinoline-1,3(2
              H
              ,4
              H
              )-diones from
              N
              -alkyl-
              N
              -methacryloyl benzamides under metal-free and oxidant-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (20)
                                     , 3223-3228. <a href="https://doi.org/10.1039/D0QO00909A" title="DOI URL">https://doi.org/10.1039/D0QO00909A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00909A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00909A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DThe%252Bcontinuous-flow%252Belectrosynthesis%252Bof%252B4-%252528sulfonylmethyl%252529isoquinoline-1%25252C3%2525282%252BH%252B%25252C4%252BH%252B%252529-diones%252Bfrom%252BN%252B-alkyl-%252BN%252B-methacryloyl%252Bbenzamides%252Bunder%252Bmetal-free%252Band%252Boxidant-free%252Bconditions%26aulast%3DXu%26aufirst%3DJia%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D20%26spage%3D3223%26epage%3D3228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haiying  Pang</span>, <span class="hlFld-ContribAuthor ">Ning  Wang</span>, <span class="hlFld-ContribAuthor ">Jinlong  Chai</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Wang</span>, <span class="hlFld-ContribAuthor ">Yuehua  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiang  Bi</span>, <span class="hlFld-ContribAuthor ">Wenbin  Wu</span>, <span class="hlFld-ContribAuthor ">Gu  He</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>197 </em>, 112314. <a href="https://doi.org/10.1016/j.ejmech.2020.112314" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112314%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BTNNI3K%252Binhibitor%252Bsuppresses%252Bpyroptosis%252Band%252Bapoptosis%252Bin%252Bmurine%252Bmyocardial%252Binfarction%252Binjury%26aulast%3DPang%26aufirst%3DHaiying%26date%3D2020%26volume%3D197%26spage%3D112314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kornelia  Czaja</span>, <span class="hlFld-ContribAuthor ">Jacek  Kujawski</span>, <span class="hlFld-ContribAuthor ">Karol  Kamel</span>, <span class="hlFld-ContribAuthor ">Marek K.  Bernard</span>. </span><span class="cited-content_cbyCitation_article-title">Selected arylsulphonyl pyrazole derivatives as potential Chk1 kinase ligands—computational investigations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2020,</strong> <em>26 </em>
                                    (6)
                                     <a href="https://doi.org/10.1007/s00894-020-04407-3" title="DOI URL">https://doi.org/10.1007/s00894-020-04407-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-020-04407-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-020-04407-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DSelected%252Barylsulphonyl%252Bpyrazole%252Bderivatives%252Bas%252Bpotential%252BChk1%252Bkinase%252Bligands%2525E2%252580%252594computational%252Binvestigations%26aulast%3DCzaja%26aufirst%3DKornelia%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R. M.  Asquith</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">Carrow I.  Wells</span>, <span class="hlFld-ContribAuthor ">Graham J.  Tizzard</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>. </span><span class="cited-content_cbyCitation_article-title">New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I–Interacting Kinase (TNNi3K). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (7)
                                     , 1697. <a href="https://doi.org/10.3390/molecules25071697" title="DOI URL">https://doi.org/10.3390/molecules25071697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25071697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25071697%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNew%252BInsights%252Binto%252B4-Anilinoquinazolines%252Bas%252BInhibitors%252Bof%252BCardiac%252BTroponin%252BI%2525E2%252580%252593Interacting%252BKinase%252B%252528TNNi3K%252529%26aulast%3DAsquith%26aufirst%3DChristopher%2BR.%2BM.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D7%26spage%3D1697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-Li  Zuo</span>, <span class="hlFld-ContribAuthor ">Yan-Hong  He</span>, <span class="hlFld-ContribAuthor ">Zhi  Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free Visible-Light Photocatalytic Tandem Radical Addition-Cyclization Strategy for the Synthesis of Sulfonyl-Containing Isoquinolinediones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (5)
                                     , 939-948. <a href="https://doi.org/10.1002/ejoc.201801519" title="DOI URL">https://doi.org/10.1002/ejoc.201801519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201801519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201801519%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Free%252BVisible-Light%252BPhotocatalytic%252BTandem%252BRadical%252BAddition-Cyclization%252BStrategy%252Bfor%252Bthe%252BSynthesis%252Bof%252BSulfonyl-Containing%252BIsoquinolinediones%26aulast%3DZuo%26aufirst%3DKai-Li%26date%3D2019%26date%3D2018%26volume%3D2019%26issue%3D5%26spage%3D939%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cocrystal structures of <b>1</b> (A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YFI">4YFI</a>)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and <b>4</b> (B, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J">6B5J</a>) bound to TNNI3K and (C) a 2D representation of the binding mode of <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Two-dimensional representation of the preferred TNNI3K binding mode for various heterocyclic cores.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of <b>3</b> bound to TNNI3K (A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J">6B5J</a>) and EGFR (B, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I23">4I23</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of oral bioavailability (<i>F</i>) vs TPSA for benzenesulfonamide TNNI3K inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Models of <b>37</b> in TNNI3K (A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J">6B5J</a>) and B-Raf (B, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YHT">4YHT</a>) and <b>43</b> in TNNI3K (C, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J">6B5J</a>) and B-Raf (D, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YHT">4YHT</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/medium/jm-2018-00125z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00125/20180406/images/large/jm-2018-00125z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00125&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J. F.</span></span> <span> </span><span class="NLM_article-title">Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I</span>. <i>J. Mol. Med. (Heidelberg, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1007/s00109-003-0427-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1007%2Fs00109-003-0427-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=12721663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVSltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2003&pages=297-304&author=Y.+Zhaoauthor=X.+M.+Mengauthor=Y.+J.+Weiauthor=X.+W.+Zhaoauthor=D.+Q.+Liuauthor=H.+Q.+Caoauthor=C.+C.+Liewauthor=J.+F.+Ding&title=Cloning+and+characterization+of+a+novel+cardiac-specific+kinase+that+interacts+specifically+with+cardiac+troponin+I&doi=10.1007%2Fs00109-003-0427-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I</span></div><div class="casAuthors">Zhao, Yong; Meng, Xian-Min; Wei, Ying-Jie; Zhao, Xiu-Wen; Liu, Dong-Qing; Cao, Hui-Qing; Liew, Choong-Chin; Ding, Jin-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">297-304</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Cardiac-restricted genes play important roles in cardiovascular system.  In an effort to identify such novel genes we identified a novel cardiac-specific kinase gene TNNI3K localized on 1p31.1 based on bioinformatics analyses.  Sequence anal. suggested that TNNI3K is a distant family member of integrin-linked kinase.  Northern blot and 76-tissue array analyses showed that TNNI3K is highly expressed in heart, but is undetectable in other tissues.  Immunohistochem. anal. predominantly localized TNNI3K in the nucleus of cardiac myocytes.  In vitro kinase assay showed that TNNI3K is a functional kinase.  The yeast two-hybrid system showed that TNNI3K could directly interact with cardiac troponin I, results that were further confirmed by coimmunopptn. in vivo.  Our data suggest that TNNI3K is a cardiac-specific kinase and play important roles in cardiac system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk9NEF_6MNsLVg90H21EOLACvtfcHk0lh3vdNaiz6DuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVSltrg%253D&md5=06ab8b91ae88c4facda43e99a91db288</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs00109-003-0427-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-003-0427-x%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DX.%2BM.%26aulast%3DWei%26aufirst%3DY.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%2BW.%26aulast%3DLiu%26aufirst%3DD.%2BQ.%26aulast%3DCao%26aufirst%3DH.%2BQ.%26aulast%3DLiew%26aufirst%3DC.%2BC.%26aulast%3DDing%26aufirst%3DJ.%2BF.%26atitle%3DCloning%2520and%2520characterization%2520of%2520a%2520novel%2520cardiac-specific%2520kinase%2520that%2520interacts%2520specifically%2520with%2520cardiac%2520troponin%2520I%26jtitle%3DJ.%2520Mol.%2520Med.%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2003%26volume%3D81%26spage%3D297%26epage%3D304%26doi%3D10.1007%2Fs00109-003-0427-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Force, T.</span></span> <span> </span><span class="NLM_article-title">Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease</span>. <i>Circ. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1514</span>– <span class="NLM_lpage">1519</span>, <span class="refDoi"> DOI: 10.1253/circj.CJ-14-0543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1253%2Fcircj.CJ-14-0543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=24899531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlClsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2014&pages=1514-1519&author=H.+Lalauthor=F.+Ahmadauthor=S.+Parikhauthor=T.+Force&title=Troponin+I-interacting+protein+kinase%3A+a+novel+cardiac-specific+kinase%2C+emerging+as+a+molecular+target+for+the+treatment+of+cardiac+disease&doi=10.1253%2Fcircj.CJ-14-0543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease</span></div><div class="casAuthors">Lal, Hind; Ahmad, Firdos; Parikh, Shan; Force, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1514-1519</span>CODEN:
                <span class="NLM_cas:coden">CJIOBY</span>;
        ISSN:<span class="NLM_cas:issn">1346-9843</span>.
    
            (<span class="NLM_cas:orgname">Japanese Circulation Society</span>)
        </div><div class="casAbstract">A review.  Coronary artery disease is the leading cause of death and disability worldwide.  In patients with acute coronary syndromes, timely and effective myocardial reperfusion by percutaneous coronary intervention is the primary treatment of choice to minimize the ischemic injury and limit the size of the myocardial infarction (MI).  However, reperfusion can itself promote cardiomyocyte death, which leads to cardiac dysfunction via reperfusion injury.  The mol. mechanisms of ischemia-reperfusion (IR) injury are not completely understood and new drug targets are needed.  Recently, we reported that cardiac troponin I-interacting protein kinase (TNNI3K), a cardiomyocyte-specific kinase, promotes IR injury via profound oxidative stress, thereby promoting cardiomyocyte death.  By using novel genetic animal models and newly developed small-mol. TNNI3K inhibitors, we demonstrated that TNNI3K-mediated IR injury occurs through impaired mitochondrial function and is in part dependent on p38 MAPK.  Here we discuss the emerging role of TNNI3K as a promising new drug target to limit IR-induced myocardial injury.  We will also examine the underlying mechanisms that drive the profoundly reduced infarct size in mice in which TNNI3K is specifically deleted in cardiomyocytes.  Because TNNI3K is a cardiac-specific kinase, it could be an ideal mol. target, as inhibiting it would have little or no effect on other organ systems, a serious problem assocd. with the use of kinase inhibitors targeting kinases that are more widely expressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN5Bkqoa_-_bVg90H21EOLACvtfcHk0lid-BRnJNcvaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlClsL3N&md5=b54f2c64110df79e4c992b111d43d3ce</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1253%2Fcircj.CJ-14-0543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1253%252Fcircj.CJ-14-0543%26sid%3Dliteratum%253Aachs%26aulast%3DLal%26aufirst%3DH.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DParikh%26aufirst%3DS.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DTroponin%2520I-interacting%2520protein%2520kinase%253A%2520a%2520novel%2520cardiac-specific%2520kinase%252C%2520emerging%2520as%2520a%2520molecular%2520target%2520for%2520the%2520treatment%2520of%2520cardiac%2520disease%26jtitle%3DCirc.%2520J.%26date%3D2014%26volume%3D78%26spage%3D1514%26epage%3D1519%26doi%3D10.1253%2Fcircj.CJ-14-0543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodder, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezzina, C. R.</span></span> <span> </span><span class="NLM_article-title">TNNI3K in cardiovascular disease and prospects for therapy</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.yjmcc.2015.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.yjmcc.2015.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=25787061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1artbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2015&pages=167-173&author=A.+Milanoauthor=E.+M.+Lodderauthor=C.+R.+Bezzina&title=TNNI3K+in+cardiovascular+disease+and+prospects+for+therapy&doi=10.1016%2Fj.yjmcc.2015.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">TNNI3K in cardiovascular disease and prospects for therapy</span></div><div class="casAuthors">Milano, Annalisa; Lodder, Elisabeth. M.; Bezzina, Connie. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">167-173</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cardiovascular diseases are an important cause of morbidity and mortality worldwide and the global burden of these diseases continues to grow.  Therefore new therapies are urgently needed.  The role of protein kinases in disease, including cardiac disease, is long recognized, making kinases important therapeutic targets.  We here review the knowledge gathered in the last decade about troponin I-interacting kinase (TNNI3K), a kinase with cardiac-restricted expression that has been implicated in various cardiac phenotypes and diseases including heart failure, cardiomyopathy, ischemia/reperfusion injury and conduction of the cardiac elec. impulse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC_UKVV9Il77Vg90H21EOLACvtfcHk0lid-BRnJNcvaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1artbc%253D&md5=c3f321c61c9d2714238c58dfa8c1443d</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2015.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2015.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DMilano%26aufirst%3DA.%26aulast%3DLodder%26aufirst%3DE.%2BM.%26aulast%3DBezzina%26aufirst%3DC.%2BR.%26atitle%3DTNNI3K%2520in%2520cardiovascular%2520disease%2520and%2520prospects%2520for%2520therapy%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2015%26volume%3D82%26spage%3D167%26epage%3D173%26doi%3D10.1016%2Fj.yjmcc.2015.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadnott, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchuk, D. A.</span></span> <span> </span><span class="NLM_article-title"><i>Tnni3k</i> modifies disease progression in murine models of cardiomyopathy</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1000647</span>, <span class="refDoi"> DOI: 10.1371/journal.pgen.1000647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1371%2Fjournal.pgen.1000647" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000647&author=F.+C.+Wheelerauthor=H.+Tangauthor=O.+A.+Marksauthor=T.+N.+Hadnottauthor=P.+L.+Chuauthor=L.+Maoauthor=H.+A.+Rockmanauthor=D.+A.+Marchuk&title=Tnni3k+modifies+disease+progression+in+murine+models+of+cardiomyopathy&doi=10.1371%2Fjournal.pgen.1000647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1000647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1000647%26sid%3Dliteratum%253Aachs%26aulast%3DWheeler%26aufirst%3DF.%2BC.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DMarks%26aufirst%3DO.%2BA.%26aulast%3DHadnott%26aufirst%3DT.%2BN.%26aulast%3DChu%26aufirst%3DP.%2BL.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DMarchuk%26aufirst%3DD.%2BA.%26atitle%3DTnni3k%2520modifies%2520disease%2520progression%2520in%2520murine%2520models%2520of%2520cardiomyopathy%26jtitle%3DPLoS%2520Genet.%26date%3D2009%26volume%3D5%26spage%3De1000647%26doi%3D10.1371%2Fjournal.pgen.1000647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchuk, D. A.</span></span> <span> </span><span class="NLM_article-title">Overexpression of TNNI3K, a cardiac-specific MAPKKK, promotes cardiac dysfunction</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1016/j.yjmcc.2012.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.yjmcc.2012.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=23085512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsleisb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=101-111&author=H.+Tangauthor=K.+Xiaoauthor=L.+Maoauthor=H.+A.+Rockmanauthor=D.+A.+Marchuk&title=Overexpression+of+TNNI3K%2C+a+cardiac-specific+MAPKKK%2C+promotes+cardiac+dysfunction&doi=10.1016%2Fj.yjmcc.2012.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of TNNI3K, a cardiac-specific MAPKKK, promotes cardiac dysfunction</span></div><div class="casAuthors">Tang, Hao; Xiao, Kunhong; Mao, Lan; Rockman, Howard A.; Marchuk, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-111</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cardiac troponin I-interacting kinase (TNNI3K) is a cardiac-specific kinase whose biol. function remains largely unknown.  We have recently shown that TNNI3K expression greatly accelerates cardiac dysfunction in mouse models of cardiomyopathy, indicating an important role in modulating disease progression.  To further investigate TNNI3K kinase activity in vivo, we have generated transgenic mice expressing both wild-type and kinase-dead versions of the human TNNI3K protein.  Importantly, we show that the increased TNNI3K kinase activity induces mouse cardiac remodeling, and its kinase activity promotes accelerated disease progression in a left-ventricular pressure overload model of mouse cardiomyopathy.  Using an in vitro kinase assay and proteomics anal., we show that TNNI3K is a dual-function kinase with Tyr and Ser/Thr kinase activity.  TNNI3K expression induces a series of cellular and mol. changes, including a redn. of sarcomere length and changes in titin isoform compn., which are indicative of cardiac remodeling.  Using antisera to TNNI3K, we show that TNNI3K protein is located at the sarcomere Z disk.  These combined data suggest that TNNI3K mediates cell signaling to modulate cardiac response to stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouIq5fuR9dGrVg90H21EOLACvtfcHk0lid-BRnJNcvaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsleisb7I&md5=718845de3ce0b0a8d59ac6506e62290e</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2012.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2012.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DK.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DMarchuk%26aufirst%3DD.%2BA.%26atitle%3DOverexpression%2520of%2520TNNI3K%252C%2520a%2520cardiac-specific%2520MAPKKK%252C%2520promotes%2520cardiac%2520dysfunction%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2013%26volume%3D54%26spage%3D101%26epage%3D111%26doi%3D10.1016%2Fj.yjmcc.2012.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchuk, D. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the cardiomyocyte-specific troponin I-interacting kinase limits oxidative stress, injury, and adverse remodeling due to ischemic heart disease</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">938</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.113.303238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1161%2FCIRCRESAHA.113.303238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=938-940&author=D.+M.+Abrahamauthor=D.+A.+Marchuk&title=Inhibition+of+the+cardiomyocyte-specific+troponin+I-interacting+kinase+limits+oxidative+stress%2C+injury%2C+and+adverse+remodeling+due+to+ischemic+heart+disease&doi=10.1161%2FCIRCRESAHA.113.303238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.113.303238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.113.303238%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DD.%2BM.%26aulast%3DMarchuk%26aufirst%3DD.%2BA.%26atitle%3DInhibition%2520of%2520the%2520cardiomyocyte-specific%2520troponin%2520I-interacting%2520kinase%2520limits%2520oxidative%2520stress%252C%2520injury%252C%2520and%2520adverse%2520remodeling%2520due%2520to%2520ischemic%2520heart%2520disease%26jtitle%3DCirc.%2520Res.%26date%3D2014%26volume%3D114%26spage%3D938%26epage%3D940%26doi%3D10.1161%2FCIRCRESAHA.113.303238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vagnozzi, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, G. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallilankaraman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, V. L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madesh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Force, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the cardiomyocyte-specific TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">207ra141</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3006479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1126%2Fscitranslmed.3006479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=24132636" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=207ra141&author=R.+J.+Vagnozziauthor=G.+J.+Gattoauthor=L.+S.+Kallanderauthor=N.+E.+Hoffmanauthor=K.+Mallilankaramanauthor=V.+L.+T.+Ballardauthor=B.+G.+Lawhornauthor=P.+Stoyauthor=J.+Philpauthor=A.+P.+Gravesauthor=Y.+Naitoauthor=J.+J.+Leporeauthor=E.+Gaoauthor=M.+Madeshauthor=T.+Force&title=Inhibition+of+the+cardiomyocyte-specific+TNNI3K+limits+oxidative+stress%2C+injury%2C+and+adverse+remodeling+in+the+ischemic+heart&doi=10.1126%2Fscitranslmed.3006479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3006479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3006479%26sid%3Dliteratum%253Aachs%26aulast%3DVagnozzi%26aufirst%3DR.%2BJ.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DKallander%26aufirst%3DL.%2BS.%26aulast%3DHoffman%26aufirst%3DN.%2BE.%26aulast%3DMallilankaraman%26aufirst%3DK.%26aulast%3DBallard%26aufirst%3DV.%2BL.%2BT.%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DStoy%26aufirst%3DP.%26aulast%3DPhilp%26aufirst%3DJ.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DNaito%26aufirst%3DY.%26aulast%3DLepore%26aufirst%3DJ.%2BJ.%26aulast%3DGao%26aufirst%3DE.%26aulast%3DMadesh%26aufirst%3DM.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520the%2520cardiomyocyte-specific%2520TNNI3K%2520limits%2520oxidative%2520stress%252C%2520injury%252C%2520and%2520adverse%2520remodeling%2520in%2520the%2520ischemic%2520heart%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D207ra141%26doi%3D10.1126%2Fscitranslmed.3006479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mudd, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span> <span> </span><span class="NLM_article-title">Tackling heart failure in the twenty-first century</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>451</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">928</span>, <span class="refDoi"> DOI: 10.1038/nature06798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1038%2Fnature06798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=18288181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD1cXit1ynsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2008&pages=919-928&author=J.+O.+Muddauthor=D.+A.+Kass&title=Tackling+heart+failure+in+the+twenty-first+century&doi=10.1038%2Fnature06798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tackling heart failure in the twenty-first century</span></div><div class="casAuthors">Mudd, James O.; Kass, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">451</span>
        (<span class="NLM_cas:issue">7181</span>),
    <span class="NLM_cas:pages">919-928</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Heart failure, or congestive heart failure, is a condition in which the heart cannot supply the body's tissues with enough blood.  The result is a cascade of changes that lead to severe fatigue, breathlessness and, ultimately, death.  In the past quarter century, much progress has been made in understanding the mol. and cellular processes that contribute to heart failure, leading to the development of effective therapies.  Despite this, chronic heart failure remains a major cause of illness and death.  And because the condition becomes more common with increasing age, the no. of affected individuals is rising with the rapidly aging global population.  New treatments that target disease mechanisms at the cellular and whole-organ level are needed to halt and reverse the devastating consequences of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWp3zLwVK0GbVg90H21EOLACvtfcHk0li9gDA1VMU5Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXit1ynsb0%253D&md5=73e8de69e1b3126a9efb721b90884fa4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature06798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06798%26sid%3Dliteratum%253Aachs%26aulast%3DMudd%26aufirst%3DJ.%2BO.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DTackling%2520heart%2520failure%2520in%2520the%2520twenty-first%2520century%26jtitle%3DNature%26date%3D2008%26volume%3D451%26spage%3D919%26epage%3D928%26doi%3D10.1038%2Fnature06798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krum, H.</span></span> <span> </span><span class="NLM_article-title">Drug discovery for heart failure: a new era or the end of the pipeline?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1038/nrd2219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1038%2Fnrd2219" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=127-139&author=D.+M.+Kayeauthor=H.+Krum&title=Drug+discovery+for+heart+failure%3A+a+new+era+or+the+end+of+the+pipeline%3F&doi=10.1038%2Fnrd2219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd2219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2219%26sid%3Dliteratum%253Aachs%26aulast%3DKaye%26aufirst%3DD.%2BM.%26aulast%3DKrum%26aufirst%3DH.%26atitle%3DDrug%2520discovery%2520for%2520heart%2520failure%253A%2520a%2520new%2520era%2520or%2520the%2520end%2520of%2520the%2520pipeline%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D127%26epage%3D139%26doi%3D10.1038%2Fnrd2219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boloor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis-Ward, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epperly, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkle, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, R. N.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knick, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudeman, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczyk, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truesdale, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-[[4-[(2,3-dimethyl-2<i>H</i>-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4632</span>– <span class="NLM_lpage">4640</span>, <span class="refDoi"> DOI: 10.1021/jm800566m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800566m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVGrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4632-4640&author=P.+A.+Harrisauthor=A.+Boloorauthor=M.+Cheungauthor=R.+Kumarauthor=R.+M.+Crosbyauthor=R.+G.+Davis-Wardauthor=A.+H.+Epperlyauthor=K.+W.+Hinkleauthor=R.+N.+Hunterauthor=J.+H.+Johnsonauthor=V.+B.+Knickauthor=C.+P.+Laudemanauthor=D.+K.+Luttrellauthor=R.+A.+Mookauthor=R.+T.+Nolteauthor=S.+K.+Rudolphauthor=J.+R.+Szewczykauthor=A.+T.+Truesdaleauthor=J.+M.+Vealauthor=L.+Wangauthor=J.+A.+Stafford&title=Discovery+of+5-%5B%5B4-%5B%282%2C3-dimethyl-2H-indazol-6-yl%29methylamino%5D-2-pyrimidinyl%5Damino%5D-2-methyl-benzenesulfonamide+%28pazopanib%29%2C+a+novel+and+potent+vascular+endothelial+growth+factor+receptor+inhibitor&doi=10.1021%2Fjm800566m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor</span></div><div class="casAuthors">Harris, Philip A.; Boloor, Amogh; Cheung, Mui; Kumar, Rakesh; Crosby, Renae M.; Davis-Ward, Ronda G.; Epperly, Andrea H.; Hinkle, Kevin W.; Hunter, Robert N., III; Johnson, Jennifer H.; Knick, Victoria B.; Laudeman, Christopher P.; Luttrell, Deirdre K.; Mook, Robert A.; Nolte, Robert T.; Rudolph, Sharon K.; Szewczyk, Jerzy R.; Truesdale, Anne T.; Veal, James M.; Wang, Liping; Stafford, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4632-4640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the vascular endothelial growth factor (VEGF) signaling pathway has emerged as one of the most promising new approaches for cancer therapy.  We describe herein the key steps starting from an initial screening hit leading to the discovery of pazopanib, N4-(2,3-dimethyl-2H-indazol-6-yl)-N4-methyl-N2-(4-methyl-3-sulfonamidophenyl)-2,4-pyrimidinediamine, a potent pan-VEGF receptor (VEGFR) inhibitor under clin. development for renal-cell cancer and other solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIb4UT-IbEi7Vg90H21EOLACvtfcHk0lis2sOwlR4-tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVGrtL4%253D&md5=a8737a6e003a3f6002575b4b96712fc9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm800566m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800566m%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBoloor%26aufirst%3DA.%26aulast%3DCheung%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DDavis-Ward%26aufirst%3DR.%2BG.%26aulast%3DEpperly%26aufirst%3DA.%2BH.%26aulast%3DHinkle%26aufirst%3DK.%2BW.%26aulast%3DHunter%26aufirst%3DR.%2BN.%26aulast%3DJohnson%26aufirst%3DJ.%2BH.%26aulast%3DKnick%26aufirst%3DV.%2BB.%26aulast%3DLaudeman%26aufirst%3DC.%2BP.%26aulast%3DLuttrell%26aufirst%3DD.%2BK.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DRudolph%26aufirst%3DS.%2BK.%26aulast%3DSzewczyk%26aufirst%3DJ.%2BR.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%25205-%255B%255B4-%255B%25282%252C3-dimethyl-2H-indazol-6-yl%2529methylamino%255D-2-pyrimidinyl%255Damino%255D-2-methyl-benzenesulfonamide%2520%2528pazopanib%2529%252C%2520a%2520novel%2520and%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4632%26epage%3D4640%26doi%3D10.1021%2Fjm800566m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ung, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulford, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Autry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berliner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzzio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaGreca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marr, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1935</span>– <span class="NLM_lpage">1944</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-5155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1158%2F0008-5472.CAN-07-5155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=18339875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFOhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1935-1944&author=W.+G.+Robertsauthor=E.+Ungauthor=P.+Whalenauthor=B.+Cooperauthor=C.+Hulfordauthor=C.+Autryauthor=D.+Richterauthor=E.+Emersonauthor=J.+Linauthor=J.+Kathauthor=K.+Colemanauthor=L.+Yaoauthor=L.+Martinez-Alsinaauthor=M.+Lorenzenauthor=M.+Berlinerauthor=M.+Luzzioauthor=N.+Patelauthor=E.+Schmittauthor=S.+LaGrecaauthor=J.+Janiauthor=M.+Wesselauthor=E.+Marrauthor=M.+Grifforauthor=F.+Vajdos&title=Antitumor+activity+and+pharmacology+of+a+selective+focal+adhesion+kinase+inhibitor%2C+PF-562%2C271&doi=10.1158%2F0008-5472.CAN-07-5155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271</span></div><div class="casAuthors">Roberts, Walter Gregory; Ung, Ethan; Whalen, Pamela; Cooper, Beth; Hulford, Catherine; Autry, Christofer; Richter, Daniel; Emerson, Earling; Lin, Jing; Kath, John; Coleman, Kevin; Yao, Lili; Martinez-Alsina, Luis; Lorenzen, Marianne; Berliner, Martin; Luzzio, Michael; Patel, Nandini; Schmitt, Erika; LaGreca, Susan; Jani, Jitesh; Wessel, Matt; Marr, Eric; Griffor, Matt; Vajdos, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1935-1944</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cancer cells are characterized by the ability to grow in an anchorage-independent manner.  The activity of the nonreceptor tyrosine kinase, focal adhesion kinase (FAK), is thought to contribute to this phenotype.  FAK localizes in focal adhesion plaques and has a role as a scaffolding and signaling protein for other adhesion mols.  Recent studies show a strong correlation between increased FAK expression and phosphorylation status and the invasive phenotype of aggressive human tumors.  PF-562,271 is a potent, ATP-competitive, reversible inhibitor of FAK and Pyk2 catalytic activity with a IC50 of 1.5 and 14 nmol/L, resp.  Addnl., PF-562,271 displayed robust inhibition in an inducible cell-based assay measuring phospho-FAK with an IC50 of 5 nmol/L.  PF-562,271 was evaluated against multiple kinases and displays >100x selectivity against a long list of nontarget kinases.  PF-562,271 inhibits FAK phosphorylation in vivo in a dose-dependent fashion (calcd. EC50 of 93 ng/mL, total) after p.o. administration to tumor-bearing mice.  In vivo inhibition of FAK phosphorylation (>50%) was sustained for >4 h with a single p.o. dose of 33 mg/kg.  Antitumor efficacy and regressions were obsd. in multiple human s.c. xenograft models.  No wt. loss, morbidity, or mortality were obsd. in any in vivo expt.  Tumor growth inhibition was dose and drug exposure dependent.  Taken together, these data show that kinase inhibition with an ATP-competitive small mol. inhibitor of FAK decreases the phospho-status in vivo, resulting in robust antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofV3TtMU2E07Vg90H21EOLACvtfcHk0lis2sOwlR4-tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFOhtrw%253D&md5=a5dad7cd49e32a9904de14fb34939be5</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-5155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-5155%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DUng%26aufirst%3DE.%26aulast%3DWhalen%26aufirst%3DP.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DHulford%26aufirst%3DC.%26aulast%3DAutry%26aufirst%3DC.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DEmerson%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DKath%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DLorenzen%26aufirst%3DM.%26aulast%3DBerliner%26aufirst%3DM.%26aulast%3DLuzzio%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DSchmitt%26aufirst%3DE.%26aulast%3DLaGreca%26aufirst%3DS.%26aulast%3DJani%26aufirst%3DJ.%26aulast%3DWessel%26aufirst%3DM.%26aulast%3DMarr%26aufirst%3DE.%26aulast%3DGriffor%26aufirst%3DM.%26aulast%3DVajdos%26aufirst%3DF.%26atitle%3DAntitumor%2520activity%2520and%2520pharmacology%2520of%2520a%2520selective%2520focal%2520adhesion%2520kinase%2520inhibitor%252C%2520PF-562%252C271%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1935%26epage%3D1944%26doi%3D10.1158%2F0008-5472.CAN-07-5155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack-Davis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilghman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, W. G.</span></span> <span> </span><span class="NLM_article-title">Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-07-2220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1158%2F1078-0432.CCR-07-2220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=18245520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFyksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=627-232&author=J.+T.+Parsonsauthor=J.+Slack-Davisauthor=R.+Tilghmanauthor=W.+G.+Roberts&title=Focal+adhesion+kinase%3A+targeting+adhesion+signaling+pathways+for+therapeutic+intervention&doi=10.1158%2F1078-0432.CCR-07-2220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention</span></div><div class="casAuthors">Parsons, J. Thomas; Slack-Davis, Jill; Tilghman, Robert; Roberts, W. Gregory</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">627-632</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The tumor microenvironment plays a central role in cancer progression and metastasis.  Within this environment, cancer cells respond to a host of signals including growth factors and chemotactic factors, as well as signals from adjacent cells, cells in the surrounding stroma, and signals from the extracellular matrix.  Targeting the pathways that mediate many of these signals has been a major goal in the effort to develop therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrevWVNxaWCL7Vg90H21EOLACvtfcHk0lis2sOwlR4-tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFyksbw%253D&md5=0e9b84c9216582b035ed9abd98b42cda</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-2220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-2220%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26aulast%3DSlack-Davis%26aufirst%3DJ.%26aulast%3DTilghman%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26atitle%3DFocal%2520adhesion%2520kinase%253A%2520targeting%2520adhesion%2520signaling%2520pathways%2520for%2520therapeutic%2520intervention%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D627%26epage%3D232%26doi%3D10.1158%2F1078-0432.CCR-07-2220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Beattie, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breault, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellston, R. P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewsbury, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naven, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minshull, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauptit, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J. E.</span></span> <span> </span><span class="NLM_article-title">Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: identification and optimization of substituted 4,6-bis anilino pyrimidines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2955</span>– <span class="NLM_lpage">2960</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00202-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2FS0960-894X%2803%2900202-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2955-2960&author=J.+F.+Beattieauthor=G.+A.+Breaultauthor=R.+P.+A.+Ellstonauthor=S.+Greenauthor=P.+J.+Jewsburyauthor=C.+J.+Midgleyauthor=R.+T.+Navenauthor=C.+A.+Minshullauthor=R.+A.+Pauptitauthor=J.+A.+Tuckerauthor=J.+E.+Pease&title=Cyclin-dependent+kinase+4+inhibitors+as+a+treatment+for+cancer.+Part+1%3A+identification+and+optimization+of+substituted+4%2C6-bis+anilino+pyrimidines&doi=10.1016%2FS0960-894X%2803%2900202-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900202-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900202-6%26sid%3Dliteratum%253Aachs%26aulast%3DBeattie%26aufirst%3DJ.%2BF.%26aulast%3DBreault%26aufirst%3DG.%2BA.%26aulast%3DEllston%26aufirst%3DR.%2BP.%2BA.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMidgley%26aufirst%3DC.%2BJ.%26aulast%3DNaven%26aufirst%3DR.%2BT.%26aulast%3DMinshull%26aufirst%3DC.%2BA.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26atitle%3DCyclin-dependent%2520kinase%25204%2520inhibitors%2520as%2520a%2520treatment%2520for%2520cancer.%2520Part%25201%253A%2520identification%2520and%2520optimization%2520of%2520substituted%25204%252C6-bis%2520anilino%2520pyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2955%26epage%3D2960%26doi%3D10.1016%2FS0960-894X%2803%2900202-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Breault, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellston, R. P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewsbury, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauptit, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minshull, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J. E.</span></span> <span> </span><span class="NLM_article-title">Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimization of substituted 2,4-bis anilino pyrimidines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2961</span>– <span class="NLM_lpage">2966</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00203-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2FS0960-894X%2803%2900203-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2961-2966&author=G.+A.+Breaultauthor=R.+P.+A.+Ellstonauthor=S.+Greenauthor=S.+R.+Jamesauthor=P.+J.+Jewsburyauthor=C.+J.+Midgleyauthor=R.+A.+Pauptitauthor=C.+A.+Minshullauthor=J.+A.+Tuckerauthor=J.+E.+Pease&title=Cyclin-dependent+kinase+4+inhibitors+as+a+treatment+for+cancer.+Part+2%3A+identification+and+optimization+of+substituted+2%2C4-bis+anilino+pyrimidines&doi=10.1016%2FS0960-894X%2803%2900203-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900203-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900203-8%26sid%3Dliteratum%253Aachs%26aulast%3DBreault%26aufirst%3DG.%2BA.%26aulast%3DEllston%26aufirst%3DR.%2BP.%2BA.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DS.%2BR.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMidgley%26aufirst%3DC.%2BJ.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DMinshull%26aufirst%3DC.%2BA.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26atitle%3DCyclin-dependent%2520kinase%25204%2520inhibitors%2520as%2520a%2520treatment%2520for%2520cancer.%2520Part%25202%253A%2520identification%2520and%2520optimization%2520of%2520substituted%25202%252C4-bis%2520anilino%2520pyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2961%26epage%3D2966%26doi%3D10.1016%2FS0960-894X%2803%2900203-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joazeiro, C. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of EGFR selective 4,6-disubstituted pyrimidines from a combinatorial kinase-directed heterocycle library</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">2182</span>– <span class="NLM_lpage">2183</span>, <span class="refDoi"> DOI: 10.1021/ja0567485</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0567485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=2182-2183&author=Q.+Zhangauthor=Y.+Liuauthor=F.+Gaoauthor=Q.+Dingauthor=C.+Choauthor=W.+Hurauthor=Y.+Jinauthor=T.+Unoauthor=C.+A.+P.+Joazeiroauthor=N.+Gray&title=Discovery+of+EGFR+selective+4%2C6-disubstituted+pyrimidines+from+a+combinatorial+kinase-directed+heterocycle+library&doi=10.1021%2Fja0567485"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fja0567485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0567485%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DCho%26aufirst%3DC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DUno%26aufirst%3DT.%26aulast%3DJoazeiro%26aufirst%3DC.%2BA.%2BP.%26aulast%3DGray%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520EGFR%2520selective%25204%252C6-disubstituted%2520pyrimidines%2520from%2520a%2520combinatorial%2520kinase-directed%2520heterocycle%2520library%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D2182%26epage%3D2183%26doi%3D10.1021%2Fja0567485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adrian, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojciechowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan-Jacob, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Expanding the diversity of allosteric Bcr-Abl inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6934</span>– <span class="NLM_lpage">6946</span>, <span class="refDoi"> DOI: 10.1021/jm100555f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100555f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6934-6946&author=X.+Dengauthor=B.+Okramauthor=Q.+Dingauthor=J.+Zhangauthor=Y.+Choiauthor=F.+J.+Adrianauthor=A.+Wojciechowskiauthor=G.+Zhangauthor=J.+Cheauthor=B.+Bursulayaauthor=S.+W.+Cowan-Jacobauthor=G.+Rummelauthor=T.+Simauthor=N.+S.+Gray&title=Expanding+the+diversity+of+allosteric+Bcr-Abl+inhibitors&doi=10.1021%2Fjm100555f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm100555f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100555f%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DOkram%26aufirst%3DB.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DAdrian%26aufirst%3DF.%2BJ.%26aulast%3DWojciechowski%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DExpanding%2520the%2520diversity%2520of%2520allosteric%2520Bcr-Abl%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6934%26epage%3D6946%26doi%3D10.1021%2Fjm100555f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dancik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinecker, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span> <span> </span><span class="NLM_article-title">Small-molecule screening identifies inhibition of salt-inducible kinses as therapeutic strategy to enhance immunoregulatory functions of dendritic cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12468</span>– <span class="NLM_lpage">12473</span>, <span class="refDoi"> DOI: 10.1073/pnas.1412308111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1073%2Fpnas.1412308111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12468-12473&author=T.+B.+Sundbergauthor=H.+W.+Choiauthor=J.-H.+Songauthor=C.+N.+Russellauthor=M.+M.+Hussainauthor=D.+B.+Grahamauthor=B.+Khorauthor=J.+Gagnonauthor=D.+J.+O%E2%80%99Connellauthor=K.+Narayanauthor=V.+Dancikauthor=J.+R.+Perezauthor=H.-C.+Reineckerauthor=N.+S.+Grayauthor=S.+L.+Schreiberauthor=R.+J.+Xavierauthor=A.+F.+Shamji&title=Small-molecule+screening+identifies+inhibition+of+salt-inducible+kinses+as+therapeutic+strategy+to+enhance+immunoregulatory+functions+of+dendritic+cells&doi=10.1073%2Fpnas.1412308111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1412308111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1412308111%26sid%3Dliteratum%253Aachs%26aulast%3DSundberg%26aufirst%3DT.%2BB.%26aulast%3DChoi%26aufirst%3DH.%2BW.%26aulast%3DSong%26aufirst%3DJ.-H.%26aulast%3DRussell%26aufirst%3DC.%2BN.%26aulast%3DHussain%26aufirst%3DM.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BB.%26aulast%3DKhor%26aufirst%3DB.%26aulast%3DGagnon%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DD.%2BJ.%26aulast%3DNarayan%26aufirst%3DK.%26aulast%3DDancik%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DJ.%2BR.%26aulast%3DReinecker%26aufirst%3DH.-C.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26atitle%3DSmall-molecule%2520screening%2520identifies%2520inhibition%2520of%2520salt-inducible%2520kinses%2520as%2520therapeutic%2520strategy%2520to%2520enhance%2520immunoregulatory%2520functions%2520of%2520dendritic%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D12468%26epage%3D12473%26doi%3D10.1073%2Fpnas.1412308111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latorre, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span> <span> </span><span class="NLM_article-title">Development of chemical probes for investigation of salt-inducible kinase function in vivo</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2105</span>– <span class="NLM_lpage">2111</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00217</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00217" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFaku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2105-2111&author=T.+B.+Sundbergauthor=Y.+Liangauthor=H.+Wuauthor=H.+G.+Choiauthor=N.+D.+Kimauthor=T.+Simauthor=L.+Johannessenauthor=A.+Petroneauthor=B.+Khorauthor=D.+B.+Grahamauthor=I.+J.+Latorreauthor=A.+J.+Phillipsauthor=S.+L.+Schreiberauthor=J.+Perezauthor=A.+F.+Shamjiauthor=N.+S.+Grayauthor=R.+J.+Xavier&title=Development+of+chemical+probes+for+investigation+of+salt-inducible+kinase+function+in+vivo&doi=10.1021%2Facschembio.6b00217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo</span></div><div class="casAuthors">Sundberg, Thomas B.; Liang, Yanke; Wu, Huixian; Choi, Hwan Geun; Kim, Nam Doo; Sim, Taebo; Johannessen, Liv; Petrone, Adam; Khor, Bernard; Graham, Daniel B.; Latorre, Isabel J.; Phillips, Andrew J.; Schreiber, Stuart L.; Perez, Jose; Shamji, Alykhan F.; Gray, Nathanael S.; Xavier, Ramnik J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2105-2111</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Salt-inducible kinases (SIKs) are promising therapeutic targets for modulating cytokine responses during innate immune activation.  The study of SIK inhibition in animal models of disease has been limited by the lack of selective small-mol. probes suitable for modulating SIK function in vivo.  We used the pan-SIK inhibitor HG-9-91-01 as a starting point to develop improved analogs, yielding a novel probe 5 (YKL-05-099) that displays increased selectivity for SIKs vs. other kinases and enhanced pharmacokinetic properties.  Well-tolerated doses of YKL-05-099 achieve free serum concns. above its IC50 for SIK2 inhibition for >16 h and reduce phosphorylation of a known SIK substrate in vivo.  While in vivo active doses of YKL-05-099 recapitulate the effects of SIK inhibition on inflammatory cytokine responses, they did not induce metabolic abnormalities obsd. in Sik2 knockout mice.  These results identify YKL-05-099 as a useful probe to investigate SIK function in vivo and further support the development of SIK inhibitors for treatment of inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyaf4sRvYdDrVg90H21EOLACvtfcHk0lhnuuBBYubXKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFaku70%253D&md5=fa634038675ff3ab8198ebd3c223e36b</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00217%26sid%3Dliteratum%253Aachs%26aulast%3DSundberg%26aufirst%3DT.%2BB.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DJohannessen%26aufirst%3DL.%26aulast%3DPetrone%26aufirst%3DA.%26aulast%3DKhor%26aufirst%3DB.%26aulast%3DGraham%26aufirst%3DD.%2BB.%26aulast%3DLatorre%26aufirst%3DI.%2BJ.%26aulast%3DPhillips%26aufirst%3DA.%2BJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DPerez%26aufirst%3DJ.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26atitle%3DDevelopment%2520of%2520chemical%2520probes%2520for%2520investigation%2520of%2520salt-inducible%2520kinase%2520function%2520in%2520vivo%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D2105%26epage%3D2111%26doi%3D10.1021%2Facschembio.6b00217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fries, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottom, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweitzer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, G. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span></span> <span> </span><span class="NLM_article-title">Identification of purines and 7-deazapurines as potent and selective type I inhibitors of troponin I-interacting kinase (TNNI3K)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7431</span>– <span class="NLM_lpage">7448</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00931</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00931" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7431-7448&author=B.+G.+Lawhornauthor=J.+Philpauthor=S.+Zhaoauthor=C.+Louerauthor=M.+Hammondauthor=M.+Cheungauthor=H.+Friesauthor=A.+P.+Gravesauthor=L.+Shewchukauthor=L.+Wangauthor=J.+E.+Cottomauthor=H.+Qiauthor=H.+Zhaoauthor=R.+Totoritisauthor=G.+Zhangauthor=B.+Schwartzauthor=H.+Liauthor=S.+Sweitzerauthor=D.+A.+Holtauthor=G.+J.+Gattoauthor=L.+S.+Kallander&title=Identification+of+purines+and+7-deazapurines+as+potent+and+selective+type+I+inhibitors+of+troponin+I-interacting+kinase+%28TNNI3K%29&doi=10.1021%2Facs.jmedchem.5b00931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Purines and 7-Deazapurines as Potent and Selective Type I Inhibitors of Troponin I-Interacting Kinase (TNNI3K)</span></div><div class="casAuthors">Lawhorn, Brian G.; Philp, Joanne; Zhao, Yongdong; Louer, Christopher; Hammond, Marlys; Cheung, Mui; Fries, Harvey; Graves, Alan P.; Shewchuk, Lisa; Wang, Liping; Cottom, Joshua E.; Qi, Hongwei; Zhao, Huizhen; Totoritis, Rachel; Zhang, Guofeng; Schwartz, Benjamin; Li, Hu; Sweitzer, Sharon; Holt, Dennis A.; Gatto, Gregory J., Jr.; Kallander, Lara S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7431-7448</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of cardiac troponin I-interacting kinase (TNNI3K) inhibitors arising from 3-((9H-purin-6-yl)amino)-N-methyl-benzenesulfonamide (1) is disclosed along with fundamental structure-function relationships that delineate the role of each element of 1 for TNNI3K recognition.  An X-ray structure of 1 bound to TNNI3K confirmed its Type I binding mode and is used to rationalize the structure-activity relationship and employed to design potent, selective, and orally bioavailable TNNI3K inhibitors.  Identification of the 7-deazapurine heterocycle as a superior template (vs purine) and its elaboration by introduction of C4-benzenesulfonamide and C7- and C8-7-deazapurine substituents produced compds. with substantial improvements in potency (>1000-fold), general kinase selectivity (10-fold improvement), and pharmacokinetic properties (>10-fold increase in poDNAUC).  Optimal members of the series have properties suitable for use in in vitro and in vivo expts. aimed at elucidating the role of TNNI3K in cardiac biol. and serve as leads for developing novel heart failure medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRFuxLWuXyP7Vg90H21EOLACvtfcHk0lhnuuBBYubXKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7rN&md5=d4a66f1ee1b5d62a5443225aca9bcb12</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00931%26sid%3Dliteratum%253Aachs%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DPhilp%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLouer%26aufirst%3DC.%26aulast%3DHammond%26aufirst%3DM.%26aulast%3DCheung%26aufirst%3DM.%26aulast%3DFries%26aufirst%3DH.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCottom%26aufirst%3DJ.%2BE.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DTotoritis%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DKallander%26aufirst%3DL.%2BS.%26atitle%3DIdentification%2520of%2520purines%2520and%25207-deazapurines%2520as%2520potent%2520and%2520selective%2520type%2520I%2520inhibitors%2520of%2520troponin%2520I-interacting%2520kinase%2520%2528TNNI3K%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7431%26epage%3D7448%26doi%3D10.1021%2Facs.jmedchem.5b00931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">Compound IC<sub>50</sub> values were determined in a panel of internal kinase assays at GSK at a highest tested concentration of 10 μM. The composition of the kinase panel was fluid over the course of the project so that compounds were evaluated against an overlapping, but nonidentical number and set of kinases. This data provides a rough approximation of general kinome selectivity for a given compound. For early compounds, a 10-fold selectivity margin was chosen to allow an equitable comparison of general kinase selectivity for weakly active compounds (IC<sub>50</sub> ≈ 1 μM) where no greater than 10-fold selectivity could be assessed given the 10 μM highest test concentration. Selected compounds (<b>3</b>, <b>33</b>, and <b>43</b>) were evaluated in a broader kinase panel and show favorable selectivity using a more stringent 100-fold selectivity measure (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tari, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensen, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nix, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McRee, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, R. V.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the inhibition of Aurora A kinase by a novel class of high affinity disubstituted pyrimidine inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.10.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.bmcl.2006.10.086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=688-691&author=L.+W.+Tariauthor=I.+D.+Hoffmanauthor=D.+C.+Bensenauthor=M.+J.+Hunterauthor=J.+Nixauthor=K.+J.+Nelsonauthor=D.+E.+McReeauthor=R.+V.+Swanson&title=Structural+basis+for+the+inhibition+of+Aurora+A+kinase+by+a+novel+class+of+high+affinity+disubstituted+pyrimidine+inhibitors&doi=10.1016%2Fj.bmcl.2006.10.086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.10.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.10.086%26sid%3Dliteratum%253Aachs%26aulast%3DTari%26aufirst%3DL.%2BW.%26aulast%3DHoffman%26aufirst%3DI.%2BD.%26aulast%3DBensen%26aufirst%3DD.%2BC.%26aulast%3DHunter%26aufirst%3DM.%2BJ.%26aulast%3DNix%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DK.%2BJ.%26aulast%3DMcRee%26aufirst%3DD.%2BE.%26aulast%3DSwanson%26aufirst%3DR.%2BV.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520Aurora%2520A%2520kinase%2520by%2520a%2520novel%2520class%2520of%2520high%2520affinity%2520disubstituted%2520pyrimidine%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D688%26epage%3D691%26doi%3D10.1016%2Fj.bmcl.2006.10.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandberg, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spalding, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iskandar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanewsky, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyrimidine benzimidazoles as Lck inhibitors: Part I</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5618</span>– <span class="NLM_lpage">5621</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.08.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.bmcl.2008.08.104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5618-5621&author=G.+Zhangauthor=P.+Renauthor=N.+S.+Grayauthor=T.+Simauthor=Y.+Liuauthor=X.+Wangauthor=J.+Cheauthor=S.-S.+Tianauthor=M.+L.+Sandbergauthor=T.+A.+Spaldingauthor=R.+Romeoauthor=M.+Iskandarauthor=D.+Chowauthor=H.+M.+Seidelauthor=D.+S.+Karanewskyauthor=Y.+He&title=Discovery+of+pyrimidine+benzimidazoles+as+Lck+inhibitors%3A+Part+I&doi=10.1016%2Fj.bmcl.2008.08.104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.08.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.08.104%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DS.-S.%26aulast%3DSandberg%26aufirst%3DM.%2BL.%26aulast%3DSpalding%26aufirst%3DT.%2BA.%26aulast%3DRomeo%26aufirst%3DR.%26aulast%3DIskandar%26aufirst%3DM.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DKaranewsky%26aufirst%3DD.%2BS.%26aulast%3DHe%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520pyrimidine%2520benzimidazoles%2520as%2520Lck%2520inhibitors%253A%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5618%26epage%3D5621%26doi%3D10.1016%2Fj.bmcl.2008.08.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamabe, T.</span></span> <span> </span><span class="NLM_article-title">Ab initio MO study of diphenyl derivatives: diphenylamine, diphenylaminium, diphenylaminyl and diphenylnitroxide</span>. <i>Chem. Phys. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/0009-2614(94)00416-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2F0009-2614%2894%2900416-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=1994&pages=27-34&author=A.+Itoauthor=K.+Otaauthor=K.+Yoshizawaauthor=K.+Tanakaauthor=T.+Yamabe&title=Ab+initio+MO+study+of+diphenyl+derivatives%3A+diphenylamine%2C+diphenylaminium%2C+diphenylaminyl+and+diphenylnitroxide&doi=10.1016%2F0009-2614%2894%2900416-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1016%2F0009-2614%2894%2900416-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-2614%252894%252900416-1%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DA.%26aulast%3DOta%26aufirst%3DK.%26aulast%3DYoshizawa%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DYamabe%26aufirst%3DT.%26atitle%3DAb%2520initio%2520MO%2520study%2520of%2520diphenyl%2520derivatives%253A%2520diphenylamine%252C%2520diphenylaminium%252C%2520diphenylaminyl%2520and%2520diphenylnitroxide%26jtitle%3DChem.%2520Phys.%2520Lett.%26date%3D1994%26volume%3D223%26spage%3D27%26epage%3D34%26doi%3D10.1016%2F0009-2614%2894%2900416-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Manley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balitza, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coll, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFall, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodman, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, K. A.</span></span> <span> </span><span class="NLM_article-title">2,4-disubstituted pyrimidines: A novel class of KDR kinase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1677</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00244-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2FS0960-894X%2803%2900244-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1673-1677&author=P.+J.+Manleyauthor=A.+E.+Balitzaauthor=M.+T.+Bilodeauauthor=K.+E.+Collauthor=G.+D.+Hartmanauthor=R.+C.+McFallauthor=K.+W.+Rickertauthor=L.+D.+Rodmanauthor=K.+A.+Thomas&title=2%2C4-disubstituted+pyrimidines%3A+A+novel+class+of+KDR+kinase+inhibitors&doi=10.1016%2FS0960-894X%2803%2900244-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900244-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900244-0%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BJ.%26aulast%3DBalitza%26aufirst%3DA.%2BE.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DColl%26aufirst%3DK.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DMcFall%26aufirst%3DR.%2BC.%26aulast%3DRickert%26aufirst%3DK.%2BW.%26aulast%3DRodman%26aufirst%3DL.%2BD.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26atitle%3D2%252C4-disubstituted%2520pyrimidines%253A%2520A%2520novel%2520class%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1673%26epage%3D1677%26doi%3D10.1016%2FS0960-894X%2803%2900244-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortlock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the tyrosine kinase EphB4. Part 1: structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2776</span>– <span class="NLM_lpage">2780</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.bmcl.2008.04.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2776-2780&author=C.+Bardelleauthor=D.+Crossauthor=S.+Davenportauthor=J.+G.+Kettleauthor=E.+J.+Koauthor=A.+D.+Leachauthor=A.+Mortlockauthor=J.+Readauthor=N.+J.+Robertsauthor=P.+Robinsauthor=E.+J.+Williams&title=Inhibitors+of+the+tyrosine+kinase+EphB4.+Part+1%3A+structure-based+design+and+optimization+of+a+series+of+2%2C4-bis-anilinopyrimidines&doi=10.1016%2Fj.bmcl.2008.04.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DBardelle%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DD.%26aulast%3DDavenport%26aufirst%3DS.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DKo%26aufirst%3DE.%2BJ.%26aulast%3DLeach%26aufirst%3DA.%2BD.%26aulast%3DMortlock%26aufirst%3DA.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DN.%2BJ.%26aulast%3DRobins%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DE.%2BJ.%26atitle%3DInhibitors%2520of%2520the%2520tyrosine%2520kinase%2520EphB4.%2520Part%25201%253A%2520structure-based%2520design%2520and%2520optimization%2520of%2520a%2520series%2520of%25202%252C4-bis-anilinopyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2776%26epage%3D2780%26doi%3D10.1016%2Fj.bmcl.2008.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Force, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Etten, R. A.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1038/nrc2106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1038%2Fnrc2106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=17457301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=332-344&author=T.+Forceauthor=D.+S.+Krauseauthor=R.+A.+Van+Etten&title=Molecular+mechanisms+of+cardiotoxicity+of+tyrosine+kinase+inhibition&doi=10.1038%2Fnrc2106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition</span></div><div class="casAuthors">Force, Thomas; Krause, Daniela S.; Van Etten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">332-344</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer therapy has progressed remarkably in recent years.  In no area has this been more apparent than in the development of 'targeted therapies', particularly those using drugs that inhibit the activity of certain tyrosine kinases, activating mutations or amplifications of which are causal, or strongly contributory, to tumorigenesis.  However, some of these therapies have been assocd. with toxicity to the heart.  Here we summarize what is known about the cardiotoxicity of cancer drugs that target tyrosine kinases.  We focus on basic mechanisms through which interruption of specific signalling pathways leads to cardiomyocyte dysfunction and/or death, and contrast this with therapeutic responses in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIyJIGdG9hv7Vg90H21EOLACvtfcHk0lgdUzCz4hu_bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7w%253D&md5=b574f420e2a09de9bae3aa2313e76c3e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrc2106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2106%26sid%3Dliteratum%253Aachs%26aulast%3DForce%26aufirst%3DT.%26aulast%3DKrause%26aufirst%3DD.%2BS.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26atitle%3DMolecular%2520mechanisms%2520of%2520cardiotoxicity%2520of%2520tyrosine%2520kinase%2520inhibition%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D332%26epage%3D344%26doi%3D10.1038%2Fnrc2106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, G. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span></span> <span> </span><span class="NLM_article-title">Substituent effects on drug-receptor H-bond interactions: correlations useful for the design of kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10629</span>– <span class="NLM_lpage">10641</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01342</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01342" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVymtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10629-10641&author=B.+G.+Lawhornauthor=J.+Philpauthor=A.+P.+Gravesauthor=D.+A.+Holtauthor=G.+J.+Gattoauthor=L.+S.+Kallander&title=Substituent+effects+on+drug-receptor+H-bond+interactions%3A+correlations+useful+for+the+design+of+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.6b01342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Substituent Effects on Drug-Receptor H-bond Interactions: Correlations Useful for the Design of Kinase Inhibitors</span></div><div class="casAuthors">Lawhorn, Brian G.; Philp, Joanne; Graves, Alan P.; Holt, Dennis A.; Gatto, Gregory J.; Kallander, Lara S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10629-10641</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Investigation of troponin I-interacting kinase (TNNI3K) as a potential target for the treatment of heart failure has produced a series of substituted N-methyl-3-(pyrimidin-4-ylamino)benzenesulfonamide inhibitors that display excellent potency and selectivity against a broad spectrum of protein kinases.  Crystal structures of prototypical members bound to the ATP-binding site of TNNI3K reveal two anchoring hydrogen bond contacts: (1) from the hinge region amide N-H to the pyrimidine nitrogen and (2) from the sulfonamide N-H to the gatekeeper threonine.  Evaluation of various para-substituted benzenesulfonamides defined a substituent effect on binding affinity resulting from modulation of the sulfonamide H-bond donor strength.  An opposite electronic effect emerged for the hinge NH-pyrimidine H-bond interaction, which is further illuminated in the correlation of calcd. H-bond acceptor strength and TNNI3K affinity for a variety of hinge binding heterocycles.  These fundamental correlations on drug-receptor H-bond interactions may be generally useful tools for the optimization of potency and selectivity in the design of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjFZcXi9ebFrVg90H21EOLACvtfcHk0lgdUzCz4hu_bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVymtbbI&md5=af40d68aeac88239b629b21cb3f218d7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01342%26sid%3Dliteratum%253Aachs%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DPhilp%26aufirst%3DJ.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DKallander%26aufirst%3DL.%2BS.%26atitle%3DSubstituent%2520effects%2520on%2520drug-receptor%2520H-bond%2520interactions%253A%2520correlations%2520useful%2520for%2520the%2520design%2520of%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10629%26epage%3D10641%26doi%3D10.1021%2Facs.jmedchem.6b01342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selzer, P.</span></span> <span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3714</span>– <span class="NLM_lpage">3717</span>, <span class="refDoi"> DOI: 10.1021/jm000942e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties&doi=10.1021%2Fjm000942e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lgdUzCz4hu_bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717%26doi%3D10.1021%2Fjm000942e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Palm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">Polar molecular surface properties predict the intestinal absorption of drugs in humans</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1023/A:1012188625088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1023%2FA%3A1012188625088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=9165525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=568-571&author=K.+Palmauthor=P.+Stenbergauthor=K.+Luthmanauthor=P.+Artursson&title=Polar+molecular+surface+properties+predict+the+intestinal+absorption+of+drugs+in+humans&doi=10.1023%2FA%3A1012188625088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Polar molecular surface properties predict the intestinal absorption of drugs in humans</span></div><div class="casAuthors">Palm, Katrin; Stenberg, Patric; Luthman, Kristina; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">568-571</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">A theor. method was devised for prediction of drug absorption after oral administration to humans.  Twenty structurally diverse model drugs, ranging from 0.3 to 100% absorbed, were investigated.  The compds. also displayed diversity in physicochem. properties such as lipophilicity, hydrogen bonding potential and mol. size.  The dynamic mol. surface properties of the compds. were calcd., taking into account their 3-dimensional shape and flexibility.  An excellent sigmoidal relationship was established between the absorbed fraction after oral administration to humans (FA) and the dynamic polar mol. surface area (PSAd) (r2 = 0.94).  The relationship was stronger than those obtained for more established predictors of drug absorption.  Drugs that are completely absorbed (FA > 90%) had a PSAd ≤ 60 Å2 while drugs that are < 10% absorbed had a PSAd ≥ 140 Å2.  PSAd can be used to differentiate poorly absorbed drugs at an early stage of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPW66hupHIyLVg90H21EOLACvtfcHk0lgS0Y-Q6UVPzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlSksrk%253D&md5=1394f0d1059e7d99ee02be977b92da8b</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1023%2FA%3A1012188625088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1012188625088%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%26aufirst%3DK.%26aulast%3DStenberg%26aufirst%3DP.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DPolar%2520molecular%2520surface%2520properties%2520predict%2520the%2520intestinal%2520absorption%2520of%2520drugs%2520in%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1997%26volume%3D14%26spage%3D568%26epage%3D571%26doi%3D10.1023%2FA%3A1012188625088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kelder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grootenhuis, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayada, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbressine, L. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploemen, J.-P.</span></span> <span> </span><span class="NLM_article-title">Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1514</span>– <span class="NLM_lpage">1519</span>, <span class="refDoi"> DOI: 10.1023/A:1015040217741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1023%2FA%3A1015040217741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10554091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=1514-1519&author=J.+Kelderauthor=D.+J.+Grootenhuisauthor=D.+M.+Bayadaauthor=L.+P.+C.+Delbressineauthor=J.-P.+Ploemen&title=Polar+molecular+surface+as+a+dominating+determinant+for+oral+absorption+and+brain+penetration+of+drugs&doi=10.1023%2FA%3A1015040217741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs</span></div><div class="casAuthors">Kelder, Jan; Grootenhuis, Peter D. J.; Bayada, Denis M.; Delbressine, Leon P. C.; Ploemen, Jan-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1514-1519</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Purpose: To study oral absorption and brain penetration as a function of polar mol. surface area.  Methods: Measured brain penetration data of 45 drug mols. were investigated.  The dynamic polar surface areas were calcd. and correlated with the brain penetration data.  Also the static polar surface areas of 776 orally administered CNS drugs that have reached at least Phase II efficacy studies were calcd.  The same was done for a series of 1590 orally administered non-CNS drugs that have reached at least Phase II efficacy studies.  Results: A linear relationship between brain penetration and dynamic polar surface area (A2) was found (n = 45, R = 0.917, F1,43 = 229).  Brain penetration decreases with increasing polar surface area.  A clear difference between the distribution of the polar surface area of the 776 CNS and 1590 non-CNS drugs was found.  It was deduced that orally active drugs that are transported passively by the transcellular route should not exceed a polar surface area of about 120 A2.  They can be tailored to brain penetration by decreasing the polar surface to <60-70 A2.  This conclusion is supported by the inverse linear relationship between exptl. brain penetration data and the dynamic polar surface area of 45 drug mols.  Conclusions: The polar mol. surface area is a dominating determinant for oral absorption and brain penetration of drugs that are transported by the transcellular route.  This property should be considered in the early phase of drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmc3v7TzWM4LVg90H21EOLACvtfcHk0lgS0Y-Q6UVPzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D&md5=868fe1e9491dd3b8b92b326d28ee48f9</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015040217741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015040217741%26sid%3Dliteratum%253Aachs%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DGrootenhuis%26aufirst%3DD.%2BJ.%26aulast%3DBayada%26aufirst%3DD.%2BM.%26aulast%3DDelbressine%26aufirst%3DL.%2BP.%2BC.%26aulast%3DPloemen%26aufirst%3DJ.-P.%26atitle%3DPolar%2520molecular%2520surface%2520as%2520a%2520dominating%2520determinant%2520for%2520oral%2520absorption%2520and%2520brain%2520penetration%2520of%2520drugs%26jtitle%3DPharm.%2520Res.%26date%3D1999%26volume%3D16%26spage%3D1514%26epage%3D1519%26doi%3D10.1023%2FA%3A1015040217741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treskov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinheimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muslin, A. J.</span></span> <span> </span><span class="NLM_article-title">Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.0000138190.50127.6A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1161%2F01.CIR.0000138190.50127.6A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2004&pages=718-723&author=L.+S.+Harrisauthor=S.+Zhangauthor=I.+Treskovauthor=A.+Kovacsauthor=C.+Weinheimerauthor=A.+J.+Muslin&title=Raf-1+kinase+is+required+for+cardiac+hypertrophy+and+cardiomyocyte+survival+in+response+to+pressure+overload&doi=10.1161%2F01.CIR.0000138190.50127.6A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000138190.50127.6A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000138190.50127.6A%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DL.%2BS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DTreskov%26aufirst%3DI.%26aulast%3DKovacs%26aufirst%3DA.%26aulast%3DWeinheimer%26aufirst%3DC.%26aulast%3DMuslin%26aufirst%3DA.%2BJ.%26atitle%3DRaf-1%2520kinase%2520is%2520required%2520for%2520cardiac%2520hypertrophy%2520and%2520cardiomyocyte%2520survival%2520in%2520response%2520to%2520pressure%2520overload%26jtitle%3DCirculation%26date%3D2004%26volume%3D110%26spage%3D718%26epage%3D723%26doi%3D10.1161%2F01.CIR.0000138190.50127.6A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Muslin, A. J.</span></span> <span> </span><span class="NLM_article-title">Role of Raf proteins in cardiac hypertrophy and cardiomyocyte survival</span>. <i>Trends Cardiovasc. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.tcm.2005.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.tcm.2005.06.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=225-229&author=A.+J.+Muslin&title=Role+of+Raf+proteins+in+cardiac+hypertrophy+and+cardiomyocyte+survival&doi=10.1016%2Fj.tcm.2005.06.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.tcm.2005.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcm.2005.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DMuslin%26aufirst%3DA.%2BJ.%26atitle%3DRole%2520of%2520Raf%2520proteins%2520in%2520cardiac%2520hypertrophy%2520and%2520cardiomyocyte%2520survival%26jtitle%3DTrends%2520Cardiovasc.%2520Med.%26date%3D2005%26volume%3D15%26spage%3D225%26epage%3D229%26doi%3D10.1016%2Fj.tcm.2005.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, G. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span></span> <span> </span><span class="NLM_article-title">GSK114: a selective inhibitor for identifying the biological role of TNNI3K</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3355</span>– <span class="NLM_lpage">3358</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.bmcl.2016.05.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3355-3358&author=B.+G.+Lawhornauthor=J.+Philpauthor=A.+P.+Gravesauthor=L.+Shewchukauthor=D.+A.+Holtauthor=G.+J.+Gattoauthor=L.+S.+Kallander&title=GSK114%3A+a+selective+inhibitor+for+identifying+the+biological+role+of+TNNI3K&doi=10.1016%2Fj.bmcl.2016.05.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DPhilp%26aufirst%3DJ.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DKallander%26aufirst%3DL.%2BS.%26atitle%3DGSK114%253A%2520a%2520selective%2520inhibitor%2520for%2520identifying%2520the%2520biological%2520role%2520of%2520TNNI3K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3355%26epage%3D3358%26doi%3D10.1016%2Fj.bmcl.2016.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">The calculated TPSA (143 Å<sup>2</sup>) of the 4-sulfone analogs exceeds the limit required for oral bioavailability within the series. However, these analogs were expected to retain oral bioavailability (as observed) based on their presumed internal H-bond with the neighboring aniline NH, which is unaccounted for in the TPSA calculation, leading to an overestimated value of PSA.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, M.</span>; <span class="NLM_string-name">Kallander, L. S.</span>; <span class="NLM_string-name">Lawhorn, B. G.</span>; <span class="NLM_string-name">Philp, J.</span>; <span class="NLM_string-name">Sarpong, M. A.</span>; <span class="NLM_string-name">Seefeld, M. A.</span></span> <span> </span><span class="NLM_article-title">Azolopyrimidine Compounds as Kinase Inhibitors and Their Preparations and Use in the Treatment of Diseases and Methods</span>. PCT Int. Appl. <span class="NLM_patent">WO2011149827</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+Hammond&author=L.+S.+Kallander&author=B.+G.+Lawhorn&author=J.+Philp&author=M.+A.+Sarpong&author=M.+A.+Seefeld&title=Azolopyrimidine+Compounds+as+Kinase+Inhibitors+and+Their+Preparations+and+Use+in+the+Treatment+of+Diseases+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DM.%26atitle%3DAzolopyrimidine%2520Compounds%2520as%2520Kinase%2520Inhibitors%2520and%2520Their%2520Preparations%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diseases%2520and%2520Methods%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span>; <span class="NLM_string-name">Lawhorn, B. G.</span>; <span class="NLM_string-name">Philp, J.</span>; <span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">3-[(6-Aminopyrimidin-4-yl)amino]benzenesulfonamide Compounds Useful as TNNI3K Inhibitors, Their Preparation, and Methods of Use in the Treatment of Congestive Heart Failure</span>. PCT Int. Appl. <span class="NLM_patent">WO2011088027</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=L.+S.+Kallander&author=B.+G.+Lawhorn&author=J.+Philp&author=Y.+Zhao&title=3-%5B%286-Aminopyrimidin-4-yl%29amino%5Dbenzenesulfonamide+Compounds+Useful+as+TNNI3K+Inhibitors%2C+Their+Preparation%2C+and+Methods+of+Use+in+the+Treatment+of+Congestive+Heart+Failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKallander%26aufirst%3DL.%2BS.%26atitle%3D3-%255B%25286-Aminopyrimidin-4-yl%2529amino%255Dbenzenesulfonamide%2520Compounds%2520Useful%2520as%2520TNNI3K%2520Inhibitors%252C%2520Their%2520Preparation%252C%2520and%2520Methods%2520of%2520Use%2520in%2520the%2520Treatment%2520of%2520Congestive%2520Heart%2520Failure%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallander, L. S.</span>; <span class="NLM_string-name">Philp, J.</span></span> <span> </span><span class="NLM_article-title">Compounds for Treating Congestive Heart Failure</span>. PCT Int. Appl. <span class="NLM_patent">WO2011088031</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=L.+S.+Kallander&author=J.+Philp&title=Compounds+for+Treating+Congestive+Heart+Failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKallander%26aufirst%3DL.%2BS.%26atitle%3DCompounds%2520for%2520Treating%2520Congestive%2520Heart%2520Failure%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, C.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backes, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philipp, A.</span></span> <span> </span><span class="NLM_article-title">Efficient microwave-assisted synthesis of highly functionalized pyrimidine derivatives</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">10055</span>– <span class="NLM_lpage">10064</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2006.08.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;key=10.1016%2Fj.tet.2006.08.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=10055-10064&author=C.%0AG.+Hartungauthor=A.+C.+Backesauthor=B.+Felberauthor=A.+Missioauthor=A.+Philipp&title=Efficient+microwave-assisted+synthesis+of+highly+functionalized+pyrimidine+derivatives&doi=10.1016%2Fj.tet.2006.08.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.08.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.08.065%26sid%3Dliteratum%253Aachs%26aulast%3DHartung%26aufirst%3DC.%2BG.%26aulast%3DBackes%26aufirst%3DA.%2BC.%26aulast%3DFelber%26aufirst%3DB.%26aulast%3DMissio%26aufirst%3DA.%26aulast%3DPhilipp%26aufirst%3DA.%26atitle%3DEfficient%2520microwave-assisted%2520synthesis%2520of%2520highly%2520functionalized%2520pyrimidine%2520derivatives%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D10055%26epage%3D10064%26doi%3D10.1016%2Fj.tet.2006.08.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YFI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YFI','PDB','4YFI'); return false;">PDB: 4YFI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J','PDB','6B5J'); return false;">PDB: 6B5J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I23" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I23','PDB','4I23'); return false;">PDB: 4I23</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YHT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YHT','PDB','4YHT'); return false;">PDB: 4YHT</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i57"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00125">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62783"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00125">10.1021/acs.jmedchem.8b00125</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Kinase selectivity results for <b>3</b>, <b>33</b>, and <b>43</b>, table of statistics for X-ray crystal structures and tabulated data used to generate <a id="rightTab-" class=" internalNav" href="#fig4">Figure <a id="rightTab-" class=" internalNav" href="#fig4">4</a></a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Coordinates for docking models of compound <b>3</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_002.pdb">PDB</a>, <a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_003.pdb">PDB</a>), compound <b>37</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_004.pdb">PDB</a>, <a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_005.pdb">PDB</a>), and compound <b>43</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_006.pdb">PDB</a>, <a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_007.pdb">PDB</a>)</p></li><li><p class="inline">SMILES representation of compounds with key data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_008.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_001.pdf">jm8b00125_si_001.pdf (750.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_002.pdb">jm8b00125_si_002.pdb (165.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_003.pdb">jm8b00125_si_003.pdb (196.63 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_004.pdb">jm8b00125_si_004.pdb (166.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_005.pdb">jm8b00125_si_005.pdb (168.28 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_006.pdb">jm8b00125_si_006.pdb (166.36 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_007.pdb">jm8b00125_si_007.pdb (168.52 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00125/suppl_file/jm8b00125_si_008.csv">jm8b00125_si_008.csv (2.68 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B5J">6B5J</a> (TNNI3K-<b>4</b>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00125&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00125%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00125" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799f6506d403c94","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
